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Chronic stress is known to be a risk factor for the development of depression and anxiety, 
disorders which often begin during adolescence. Restraint stress is a commonly used 
stressor in adult rodents, however the effects of repeated restraint stress in juvenile mice 
have not been well characterised. Here, I have shown for the first time the behavioural 
and hormonal effects of repeated restraint stress in both adult and juvenile BALB/c and 
C57BL/6 mice, as well as the effect of repeated stress on gene expression of 
components of the HPA axis. Repeated daily restraint stress (2h/day for 3, 7 or 14 days) 
provoked a robust physiological response evident as increased corticosterone levels and 
decreased body weight after 14 days (↓8% adults, ↓12% juveniles) compared to controls. 
Increases in corticosterone after 3 days stress appeared to be greater in juvenile mice 
(2000% over baseline) than in adults (710% over baseline), in both strains of mice, 
suggestive of an increased sensitivity of the HPA axis. However, habituation of the 
stress-response was evident during longer durations of daily exposure to the stressor in 
both adult and juvenile mice. No changes in gene expression were observed following 
repeated stress. The behavioural changes seen in response to repeated restraint stress 
were complex. In juvenile mice, repeated restraint stress evoked an increase in 
exploratory behaviours in the elevated plus maze, a decrease in time spent immobile in 
the forced swim test and a decrease in sucrose preference. In adult mice fewer 
behavioural changes were seen. Interestingly BALB/c and C57BL/6 mice showed 
qualitatively similar response to 3 days repeated restraint stress despite previous reports 
that BALB/c mice are more stress-sensitive. The behavioural changes we observed, as 
a result of prior stress exposure, may represent an adaptive stress-coping response or 
resilience. Both the hormonal and behavioural effects of stress were more pronounced 
in juvenile mice than in adults. This wider range of behavioural responses seen in 
juvenile mice might reflect a greater ability to engage in adaptive stress-coping strategies 
that likely have beneficial effects evident in future stress challenges.   
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1.1 Depression  
Depression is a complex and heterogeneous disorder characterised by a wide variety of 
psychological, behavioural  and physiological disturbances (Cryan et al., 2005a), 
including low mood, lack of interest or pleasure (anhedonia), inability to concentrate, 
recurring thoughts of guilt and worthlessness, fatigue, weight changes, alterations in 
sleep patterns and thoughts of suicide (American Psychiatric Association, 2000). 
Depression is highly prevalent, with almost 4 million people in the UK suffering from a 
mood disorder in 2010 (Fineberg et al., 2013). Several distinct clinical subtypes of 
depression have been suggested, as outlined in Table 1.1. Adolescent depression falls 
into the early onset depression subtype, which has been defined as a first episode 
occurring before age 18 years (Baumeister and Parker, 2012). 
 
Table 1.1: Frequently proposed subtypes of depression, differentiated by symptoms, 
aetiology, time of onset, gender and treatment response. Arrows indicate that categories 
are not necessarily distinct from each other, and patients may fall under more than one 




1.1.1 Adolescent depression 
There is increasing evidence that up to half of all adult psychiatric disorders, including 
depression, have begun by the teenage years (Jones, 2013). It is estimated that 
depression affects up to up to 6% of adolescents (Masi et al., 2010, Bhatia and Bhatia, 
2007, Costello et al., 2006). Depression has a significant impact on relationships with 
family and friends, performance at school and normal development, and is a leading 
cause of suicide in this age group (Bhatia and Bhatia, 2007). Adolescent depression 
tends to recur (Kaufman et al., 2001), and those who experience depression, or 
subclinical depressive symptoms, during adolescence have a two to three-fold increased 
risk of depressive illness in adulthood (Jones, 2013, Pine et al., 1999, Dunn and 




Stressful life events have been consistently correlated with an increased risk of 
depression (Kessler, 1997). In adolescents at high-risk of depression, such as those with 
a parental history of psychiatric disorder, recent stressful life events are associated with 
the onset of major depression (Goodyer et al., 2000). Similarly, psychosocial adverse 
events (such as poverty or maltreatment) during young adulthood are predictive of the 
onset of young adulthood depression (Shanahan et al., 2011). These findings are also 
observed in adults, when stressful life events significantly increase the risk of a 
subsequent depressive episode (Kendler et al., 1999). It is known that adolescence is 
associated with increased experiences of stressful life events, such as problems in family 
relationships and difficulties at school, compared with childhood (Larson and Ham, 
1993). In addition, although both boys and girls experience similar levels of stress during 
childhood, adolescent girls experience more stressors, and report greater distress to 
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them, than do adolescent boys, due to the differing nature of their interpersonal 
relationships (Rudolph, 2002). This correlates with both an increase in the incidence of 
depression among adolescents compared to children, and with the fact that from 
adolescence onwards depression is more common in females than males (Guerry and 
Hastings, 2011). 
An increase in circulating cortisol has repeatedly been shown to increase the risk of 
developing depression. High cortisol, together with higher self-reported depressive 
symptoms, has been shown to increase the risk of depression in adolescent boys 
(Owens et al., 2014). In adolescents who are at high-risk of depression, increased 
cortisol is also associated with the onset of depressive illness (Goodyer et al., 2000). 
Increased morning salivary cortisol in older adolescents (average age 17.5 years) was 
associated with increased incidence of depression into adulthood (Ellenbogen et al., 
2011). Healthy adolescents with a family history of depression also tend to have elevated 
evening and nocturnal cortisol (Rao et al., 2009). Given that this elevation in cortisol 
increases the risk of subsequent depression in both those with and without a family 
history of depression, it has been suggested that elevated cortisol is a vulnerability 
marker of depression (Rao et al., 2009). However, it has also been suggested that 
dysfunction of the hypothalamic pituitary adrenal (HPA) axis occurs as a result of chronic 
stress, and hence this HPA dysfunction may serve as a mechanism by which stress can 
lead to the onset of depression (Guerry and Hastings, 2011). This correlates with findings 
that chronic stress (low socioeconomic status) is associated with hypercortisolaemia in 
children (Lupien et al., 2000). 
 
1.1.3 Pharmacotherapy 
Since fluoxetine (Prozac) was first marketed in 1988, selective serotonin reuptake 
inhibitors (SSRIs) have become the first-line pharmacological treatment for depression 
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in both adults and adolescents (Maalouf and Brent, 2010). Whilst all currently available 
SSRIs are effective in treating depression in adults, response rates are low, with only 
around 50-60% of patients responding to a first trial of an SSRI, compared with 30% on 
placebo (Gibbons et al., 2012, Walsh et al., 2002). In adolescents, individual studies of 
the SSRIs fluoxetine, citalopram, sertraline and paroxetine are inconsistent, with findings 
both for and against the efficacy of these medications in the treatment of depression 
(Moreno et al., 2007, Maalouf and Brent, 2010, Masi et al., 2010). A meta-analysis of 
randomised controlled trials of different SSRIs shows a similar overall response rate of 
60% in adolescents, but a higher placebo response rate of  almost 50% compared with 
adults, indicating little benefit of SSRI treatment over placebo (Tsapakis et al., 2008). 
There is evidence that fluoxetine is more effective than other SSRIs, primarily from the 
Treatment for Adolescents with Depression Study (TADS) (Maalouf and Brent, 2010, 
Tsapakis et al., 2008), which revealed that fluoxetine was significantly more effective 
than placebo in improving depressive symptoms. TADS also showed that fluoxetine in 
combination with cognitive behavioural therapy (CBT) showed an even greater benefit 
than fluoxetine alone (March et al., 2004). CBT has also been shown to be beneficial in 
preventing relapse in adolescents who have previously shown an improvement in 
response to fluoxetine treatment (Kennard et al., 2014), and a meta-analysis has 
demonstrated that a combination of antidepressant treatment and psychological therapy 
is most effective for the treatment of adolescents with treatment-resistant depression 
(Zhou et al., 2014). However, other studies, such as the Adolescent Depression and 
Psychotherapy Trial (ADAPT) showed no evidence that the combination of SSRI 
treatment and CBT resulted in improved outcomes than SSRI treatment alone (Goodyer 
et al., 2007). Following 6-9 months of treatment, up to 40% of adolescents were still 
showing depressive symptoms (Kennard et al., 2009, Goodyer et al., 2007), indicating a 
clear unmet clinical need in the treatment of depression in adolescents. 
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Older tricyclic antidepressants are also clinically effective in the treatment of depression 
in adults, although their use in children and adolescents has shown very limited benefit 
(Hazell et al., 2002, Moreno et al., 2007). The serotonin-noradrenaline reuptake inhibitor 
(SNRI) venlafaxine, also widely used for the treatment of depression in adults, has 
demonstrated little or no efficacy in children and adolescents (Emslie et al., 2007, 
Moreno et al., 2007). Venlafaxine, along with the SSRIs fluoxetine, citalopram and 
paroxetine, did show efficacy in the TORDIA (Treatment of SSRI-Resistant Depression 
in Adolescents) study when used as a second treatment in adolescents who showed no 
improvement to an initial SSRI. 40% of participants showed clinical improvement to a 
second medication, and there was no difference in the response rate to SSRIs or 
venlafaxine. A combination of medication and CBT was more effective, with a response 
rate of 54%. Although there was no difference in the response rate to SSRIs or 
venlafaxine, the use of venlafaxine was associated with more adverse effects (Brent et 
al., 2008). 
 
1.1.3.1 Adverse effects of antidepressant use in adolescents 
Concerns have been raised over the safety profile of SSRIs, as they have been reported 
to increase the risk of suicidal thoughts and behaviour, particularly when used in children 
and adolescents (Masi et al., 2010). Several studies based both in the UK and the USA 
have reported a modest (1.5-2 fold) but significant increase in the incidence of suicidal 
ideation and suicide attempts in adolescents, but not adults, treated with antidepressant 
medication (Hammad et al., 2006, Maalouf and Brent, 2010, Olfson et al., 2006, Bridge 
et al., 2007). The risk of suicide attempts appears greater in the first week of 
antidepressant treatment than in the following 3 months (Jick et al., 2004, Simon et al., 
2006). However, the risk is highest in the month before the start of treatment, possibly 
because antidepressant treatment is initiated following a suicide attempt (Simon et al., 
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2006). A meta-analysis of published and un-published trials of the SSRIs fluoxetine, 
paroxetine, sertraline and citalopram, and the SNRI venlafaxine, revealed that only 
fluoxetine has a favourable risk-benefit profile when used in adolescents. For all other 
treatments analysed, the increased risk of suicidality outweighed any clinical benefit 
(Whittington et al., 2004). These findings were followed by a black box warning from the 
Food and Drug Administration (FDA) in the USA on all antidepressant medications, 
advising of the risk of increased suicidal behaviour when used in adolescents. Similar 
warnings from the UK Committee on Safety of Medicines advise against the use of 
antidepressants in adolescents, with the exception of fluoxetine, where the benefits have 
been shown to outweigh the risks in this age group (Masi et al., 2010). Consequently, 
fluoxetine is the only pharmacological treatment currently licensed for the treatment of 
depressive illness in children and adolescents in the UK (Cousins and Goodyer, 2015), 
although other SSRIs can be prescribed by specialists. 
As deaths by suicide are relatively rare, most data, including the study conducted by the 
FDA which led directly to the black box warning (Hammad et al., 2006), use suicide 
attempts as a surrogate marker for an increased risk of suicide. As such, it is not known 
whether antidepressants increase the risk of completed suicide in adolescents (Olfson 
et al., 2006). Epidemiological studies examining changes in antidepressant use in 
adolescents show a clear drop in prescribing following the warnings by both the FDA and 
the EU regulatory agency (Gibbons et al., 2007, Lu et al., 2014). If the use of 
antidepressants was associated with an increase in the risk of suicide, this drop in the 
use of antidepressants would be expected to be associated with a reduction in the rate 
of suicide among adolescents. However, during this time period where antidepressant 
use has declined, studies have shown either no change in suicide rate (Lu et al., 2014), 
or an increase in suicide rate among adolescents (Gibbons et al., 2007). This suggests 
that the increased risk of untreated depression in adolescents may outweigh the 
increased risk of antidepressant treatment (Cousins and Goodyer, 2015). 
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1.2 Stress and the HPA axis 
1.2.1 The HPA axis 
The hypothalamic-pituitary-adrenal (HPA) axis plays a vital role in regulating the stress 
response. Stress results in the release of corticotrophin-releasing hormone (CRH) and 
arginine vasopressin (AVP) from the paraventricular nucleus (PVN) of the hypothalamus, 
resulting in the release of adrenocorticotrophic hormone (ACTH) from the anterior 
pituitary. ACTH enters the circulation and acts on the adrenal glands to cause the 
synthesis and release of glucocorticoids, predominantly cortisol in humans and 
corticosterone in rodents, which act via a negative feedback loop to inhibit the further 
release of CRH, as outlined in Figure 1.1 (Howell and Muglia, 2006, Porter and 
Gallagher, 2006, Romeo, 2010). Release of cortisol follows a circadian rhythm, with a 
maximum level shortly after waking, and a minimum at around midnight (Howell and 




Figure 1.1: The hypothalamic-pituitary-adrenal axis. MR, mineralocorticoid receptor; GR, 
glucocorticoid receptor; CRHR1, corticotrophin releasing hormone receptor 1; V1b, 
vasopressin receptor 1b;  (-), negative feedback. 
 
CRH is found both in the central nervous system (PVN and amygdala) and in the 
periphery (gut, skin and adrenal glands). It acts on two different receptors, corticotrophin-
releasing hormone receptor 1 (CRHR1) and corticotrophin-releasing hormone receptor 
2 (CRHR2), and has a ten-fold higher affinity for CRHR1 than CRHR2 (Bale and Vale, 
2004). CRHR1 is more widely distributed in the CNS, and is expressed in the 
hippocampus, amygdala, pituitary, cortex, cerebellum and olfactory bulb. CRHR2 is 
expressed in the lateral septum and hypothalamus, but is predominantly expressed in 
the periphery where it is found in the heart, gastrointestinal tract, lung, skeletal muscle 
and vasculature (Bale and Vale, 2004). It is CRH activation of CRHR1 in the anterior 
pituitary which causes the release of ACTH during activation of the HPA axis (Bale and 
Vale, 2004).  
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AVP is co-localised with CRH in neurones of the PVN. It only weakly stimulates ACTH 
release on its own, but acts synergistically with CRH to modulate ACTH release (Aguilera 
and Rabadan-Diehl, 2000, Scott and Dinan, 2002). Although several different receptor 
types for AVP exist, it is V1b receptors in the anterior pituitary which are of importance 
for activation and modulation of the HPA axis (Scott and Dinan, 2002).  
Several different glucocorticoids are released on activation of the adrenal cortex, but the 
most predominant are cortisol in humans, and corticosterone in rodents. Circulating 
cortisol and corticosterone act on glucocorticoid receptors (GR) and mineralocorticoid 
receptors (MR) inhibiting release of CRH and hence inhibiting further release of cortisol. 
This results in a pulsatile secretion pattern of glucocorticoids in response to both stress 
and circadian variation (Porter and Gallagher, 2006).  
GR and MR have been shown to have different roles in the modulation of the stress 
response through glucocorticoid feedback. MRs have a high affinity for circulating 
glucocorticoids, are mostly occupied at all stages of the circadian rhythm, and hence are 
important in modulating basal levels of glucocorticoids. Conversely, GRs have a low 
affinity for glucocorticoids and so are only occupied when glucocorticoid levels are high. 
They are therefore important in regulation of the HPA axis when levels of circulating 
glucocorticoids are high, such as during stress (Howell and Muglia, 2006, Porter and 
Gallagher, 2006, Scott and Dinan, 2002). Activation of GR and MR during stress results 
in altered CRH transcription. Raised levels of circulating glucocorticoids reduce 
transcription of both CRH and CRHR1, resulting in reduced CRHR1 activation and hence 





1.2.2 Stress and the HPA axis in adolescence  
It has been shown that circadian rhythms undergo development throughout 
adolescence, in both humans and laboratory mice  (Hagenauer et al., 2009). These 
changes are summarised in Table 1.2. 
  Human (Homo sapiens) Laboratory Mouse (Mus musculus) 
Magnitude of 
delay 1-3h 1h? 
Sex difference males > females only females examined 
Rhythms 
delayed sleep, melatonin activity, corticosterone, temperature 
No. of 
experiments > 20 2 
Age of peak 
delay 15-21 years 




overt cyclicity in 
females 
menarche: 12-13 years, 
regular ovulation: 13-16 
years 
first ovulation: 27-40 days, regular 
ovulation: 30-80 days 
Age of 
establishing 
spermatogenesis 12-16 years n/a 
Gonadal 
dependent maybe unknown  
 
Table 1.2: A delay in circadian phase has been observed around the time of puberty in 
both humans and mice. Table adapted from Hagenauer et al. (2009). 
There is a growing body of evidence to suggest that both basal cortisol levels and HPA 
activity in response to stress increase with both age and sexual maturation during 
adolescence (Gunnar et al., 2009, Romeo et al., 2016). This is consistent with studies in 
rats, showing that basal corticosterone increases gradually from 2 weeks of age until 
adult levels are reached when rats are still adolescent at approximately 6 weeks of age 
(McCormick and Mathews, 2010). In addition, there are differences in the reaction of the 
HPA axis to stress in juvenile and adult rats. The increase in corticosterone and ACTH 
in response to acute stress is more prolonged in prepubertal rats (28 days old) compared 
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to adults. Conversely, following chronic stress, prepubertal rats initially show a higher 
increase in ACTH and corticosterone than adults, but these levels return to baseline 
more quickly (Lui et al., 2012, Romeo et al., 2006). Feedback inhibition of the HPA axis 
is thought to be reduced in juvenile animals compared to adults, as assessed by a 
reduction in dexamethasone-induced suppression of corticosterone release (Eiland and 
Romeo, 2013). However, this is not thought to be related to a reduction in GR or MR 
expression, which are similar between age groups (Romeo et al., 2013). These 
differences in HPA reactivity between juvenile and adult animals are thought to be 
independent of differences in levels of sex hormones between the different age groups 
(Romeo, 2010). Together, this suggests that adolescence is a sensitive period in terms 
of the effect of stress exposure on emotional development (Romeo, 2010). 
 
1.2.3 Abnormalities of the HPA axis in depression 
Mild to moderate overactivity of the HPA axis has been reported in 30-50% of adult 
patients with depression (Scott and Dinan, 2002). Elevated cortisol levels in the plasma, 
the CSF and the urine of depressed patients, along with a flattening of the diurnal 
variation of cortisol secretion, have been consistently reported in studies over many 
years (Carroll et al., 1976, Deuschle et al., 1997, Wong et al., 2000). Conversely, in 
depressed children and adolescents data are conflicting. Baseline cortisol is often normal 
(Kaufman et al., 1997, Kaufman et al., 2001, Guerry and Hastings, 2011), and any 
increases in cortisol are generally limited to alterations in diurnal rhythm (a rise in evening 
cortisol when levels are normally lowest) in a small number of patients (Kaufman et al., 
2001). However, a meta-analysis of 17 individual studies revealed that depressed 
children and adolescents do tend to have significantly higher basal cortisol levels than 
healthy controls (Lopez-Duran et al., 2009).  
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Levels of CRH have also been reported to be increased in the cerebral spinal fluid of 
depressed patients, and in the prefrontal cortex of depressed suicide victims (Merali et 
al., 2004, Nemeroff et al., 1984). Similarly, depressed patients have increased numbers 
of CRH-expressing cells in the hypothalamus (Raadsheer et al., 1994), suggesting that 
increased secretion of CRH may contribute to hyperactivity of the HPA axis in 
depression. Reports of AVP levels in depressed patients have been conflicting, either 
showing no change or an elevation, although correlations have been shown between 
plasma AVP levels and hypercortisolaemia (Scott and Dinan, 2002). 
The most commonly used test of HPA function in depression is the dexamethasone 
suppression test (DST), which gives an indication of the function of the feedback 
inhibition. Briefly, in the DST, dexamethasone is administered in the late evening and 
cortisol levels are monitored the following day. In healthy subjects, dexamethasone 
suppresses cortisol release, but this suppression is not seen in depressed patients 
(Porter and Gallagher, 2006). Approximately 40-60% of depressed adults and 
adolescents show this abnormality (Kaufman et al., 2001, Guerry and Hastings, 2011). 
While rates of cortisol non-suppression reach 50-70% in depressed children, this is 
thought to be due to the lower dose of dexamethasone used in children (Guerry and 
Hastings, 2011).  It has been suggested that the lack of cortisol suppression is due to 
reduced responsiveness of the GR in depressed patients (Pariante and Miller, 2001, 
Baes et al., 2012). Higher levels of non-suppression are often seen in studies of both 
adult and adolescent patients with increased severity of depressive illness, such as those 
treated as inpatients, suggesting that the DST may serve as an indicator of clinical 
severity of depression (Guerry and Hastings, 2011). It has been suggested that the use 
of a prednisolone suppression test may be more biologically relevant as it is more similar 
to endogenous glucocorticoids in its ability to bind to both GR and MR, as opposed to 
dexamethasone which only binds to GR (Pariante et al., 2002). However, as the DST is 
still widely used in the literature, the DST was used in this thesis. 
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It is the actions of AVP, rather than CRH, which are thought to contribute to the 
overactivity of the HPA axis during chronic stress (Aguilera and Rabadan-Diehl, 2000). 
Studies in both mice and rats using chronic stress paradigms have reported an increase 
in AVP expression and storage in the hypothalamus, with no increase in CRH expression 
(Keeney et al., 2006, Scott and Dinan, 2002). Similarly, V1b mRNA is upregulated by 
high levels of glucocorticoids, contributing to the relative resistance of AVP-mediated 
ACTH release to glucocorticoid inhibition (Aguilera and Rabadan-Diehl, 2000, Scott and 
Dinan, 2002). Together, these data suggests that AVP becomes the predominant 
mediator of the HPA axis during chronic stress.  
Overall, hyperactivity of the HPA axis in depressed adults is one of the most consistent 
biological findings in psychiatry. Similar HPA dysfunction is evident in depressed 
adolescents, including increased basal cortisol levels and cortisol non-suppression in the 
DST, and there is evidence that this dysfunction increases with age (Guerry and 
Hastings, 2011). Furthermore, the difference in HPA function between depressed 
adolescents and healthy controls appears to be somewhat smaller than in adults, 
suggesting gradual changes in HPA functioning with age (Guerry and Hastings, 2011). 
 
1.2.4 The effect of treatment of depression on HPA abnormalities 
The reduction of elevated cortisol levels in depressed patients on successful treatment 
of their depressive episode, by both antidepressant drugs and electroconvulsive therapy, 
has been consistently reported in numerous studies (Gibbons, 1966, Ventura-Junca et 
al., 2014). Further work has reported that the abnormal DST in depressed patients 
normalizes on remission of symptoms, particularly in those who remain in remission for 
at least 6 months (Ising et al., 2007, Ventura-Junca et al., 2014, Zobel et al., 1999), 
suggesting that relapse is more likely if HPA function doesn’t return to normal (Porter 
and Gallagher, 2006). 
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It has also been shown that antidepressants increase GR and MR function, by increasing 
both receptor expression and trafficking (Holsboer, 2000, McQuade and Young, 2000, 
Pariante and Miller, 2001). There is conflicting evidence of the effect of antidepressants 
on levels of AVP and CRH, although studies suggest that antidepressant treatment 
reduces levels of AVP and CRH in the cerebral spinal fluid (Scott and Dinan, 2002).  
Together, this suggests that antidepressants may act, in part, by resolving abnormalities 
in HPA function (Pariante and Miller, 2001, Holsboer, 2000). However, the reasons 
underlying reduced efficacy of antidepressants in adolescents are not known.  
 
1.3 Stress and the adolescent brain 
Adolescence has been shown to be a period of vulnerability for the development of 
psychiatric disorders, including depression, anxiety, schizophrenia and drug abuse, with 
up to half of all adult psychiatric disorders beginning by the teenage years (Jones, 2013, 
Holder and Blaustein, 2014). The experience of stressful events, both psychosocial (such 
as bullying, social isolation, problems in families and relationships, or death of a close 
family member) and physical (such as abuse, illness, natural disaster or accident) during 
adolescence is also associated with an increased risk of developing depression (Holder 
and Blaustein, 2014, Grant et al., 2004, Eiland and Romeo, 2013). This may in part be 
attributed to adolescence being a period of marked psychosocial and physiological 
development (Andersen, 2003, Dahl, 2004). There is also evidence that chronic stress 
may be more likely to increase the risk of depression than exposure to an acute stressor 
(McGonagle and Kessler, 1990).   
Another important factor that marks adolescence is that it is a period of significant brain 
maturation in humans and in animal models, which may be linked to the onset of puberty 
(Spear, 2000, Fuhrmann et al., 2015, Blakemore et al., 2010). Importantly, while absolute 
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time in rodents and humans are different, in terms of the timeline of development these 
are somewhat similar, as outlined in Figure 1.2.  
 
 
Figure 1.2: Developmental timelines of rodents (A) and humans (B) with approximate 
age ranges of different stages of development. Abbreviations: d, day; wk, week; yr, year. 
From Eiland and Romeo (2013). 
 
Of specific relevance to depression, the prefrontal cortex (PFC) and limbic regions 
undergo significant maturational change. For example, the volume of the PFC declines 
in adolescence in humans and in rats with the density of spines on pyramidal cells also 
declining (Spear, 2000). In the PFC, as in other cortical areas, adolescence is also a time 
of marked synapse elimination particularly of presumed glutamatergic excitatory inputs. 
Similarly in limbic regions, including the hippocampus there is substantial synaptic 
pruning evident as a loss of about 25% of NMDA receptors between P28 and P60 in rats 
(Insel et al., 1990). In addition, significant maturational changes occur in monoaminergic 
systems during adolescence. For example, forebrain dopaminergic projections to the 
PFC increase in density during adolescence, but later in adolescence there is a decline 
in dopamine synthesis and/or turnover in this region (Spear, 2000). Similarly, serotonin 
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turnover in the nucleus accumbens (but not in the striatum) has been reported to be 4-
fold lower in adolescent (P30-P40) rats relative to younger (P10-15) and adult (>P60) 
animals (Spear, 2000). This complex pattern of brain maturation in a region specific and 
temporally dynamic manner during adolescence likely contributes to the reported 
vulnerability for developing psychiatric disorders. 
A further factor that contributes to the risk of developing depression is peri-pubertal or 
adolescent exposure to stressful life experiences (Holder and Blaustein, 2014). However 
very little is known about how stress impacts on adolescent brain development. 
Emerging evidence based on studies of adolescent rats indicate that exposure to 
stressors at prepubertal and early adolescent stages affects cortical and limbic brain 
regions and that the effects of adolescent stress persist in the adult (Reviewed by Eiland 
and Romeo, 2013). To understand why antidepressants have reduced efficacy in the 
adolescent it is important to understand the development of depression in juvenile 
animals and identify how stress impacts on the brain. 
   
1.4 Animal models of depression  
There has been much debate over what criteria are necessary for the evaluation and 
validation of animal models of depression, particularly in recent years (Nestler and 
Hyman, 2010, Hendrie and Pickles, 2013, Slattery and Cryan, 2014, Willner and 
Belzung, 2015). McKinney and Bunney (1969) suggested four minimum requirements 
for all animal models of depression; 1) the symptoms should be reasonably similar to 
those in human depression; 2) there should be measurable and clearly defined 
behavioural changes; 3) the behavioural changes should be reversed by treatments 
effective in clinical depression; and 4) the results should be reproducible between 
laboratories. However, more recently, it has been suggested that, given that the main 
aim of scientific research is to predict what happens in the human disorder, the only 
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criteria necessary for initially evaluating a model are predictive validity (the ability of the 
model to predict what happens in the human disorder) and reliability (the consistency 
with which variables are measured, both within and between laboratories). Other forms 
of validity include construct validity (whether an animal model measures what it is 
intended to measure), aetiological validity (similarities between the causes of the 
response in the animal model and the human disorder) and face validity (similarities 
between animal behaviour and human symptoms).Whilst these may still be relevant to 
animal models, they may be considered to be of lesser importance (Geyer and Markou, 
1995). 
Given the heterogeneity of depression, and that some of the core features of the 
disorder, such as excessive feelings of guilt and` thoughts of suicide, are impossible to 
model in rodents, it has been difficult to develop animal models of depression as a whole 
(Cryan et al., 2002, Yan et al., 2010). In addition, the pathophysiology and aetiology of 
depression, as well as the complex mechanism of action of clinically useful 
antidepressant drugs, are still not fully understood, further increasing the difficulty in 
developing animal models of the entire disorder (Cryan and Mombereau, 2004). Instead, 
a number of animal models have been developed, which each mimic a specific symptom 
of the disorder, known as endophenotypes (Cryan et al., 2002, Geyer and Markou, 
1995).  Animal models of depression have been developed using a combination of 
genetic approaches, including selective breeding and gene targeting; pharmacological 
manipulation; environmental exposure to stress; electrical stimulations and brain lesions 
(Nestler and Hyman, 2010). For example, chronic unpredictable mild stress involves 
exposing rats or mice to a series of mild physical stressors, such as changes in lighting 
conditions or temperature, cage tilt, food or water restriction, in an unpredictable manner 
for several weeks. This procedure has been shown to induce a depression-related 
phenotype (for example using the sucrose preference test, see Chapter 5.1), which can 
be reversed by chronic antidepressant treatment (Nestler and Hyman, 2010, Willner et 
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al., 1987). Social defeat stress involves placing a test mouse into the cage of an 
unfamiliar, individually housed aggressive mouse, so that the test mouse shows signs of 
subordination. Often this is followed by sensory exposure of the defeated test mouse to 
the aggressive resident mouse, without full physical contact, by separating the cage with 
a perforated divider. Mice undergoing several days of repeated social defeat stress have 
been shown to develop depression-related behaviours in the forced swim test (see 
Chapter 5.1), which was reversed by antidepressant treatment (Razzoli et al., 2011). 
There are also several genetic models of depression, for example the noradrenaline 
transporter knockout mice and 5-HT1A knockout mice, which show reduced depression-
related behaviour in the FST and related tail suspension test (Xu et al., 2000, Czéh et 
al., 2016). 
Alongside these animal models, a number of behavioural paradigms have been 
developed for assessing depression-related and anxiety-related phenotypes (Lucki, 
1997, Cryan et al., 2002, Cryan and Holmes, 2005). These include the forced swim test, 
sucrose preference test and elevated plus maze (see Chapter 5.1). Although their 
predictive validity has been increasingly questioned, these behavioural tests have been 
pharmacologically validated with clinically useful antidepressants and anxiolytics and 
remain well-established and widely used (Hendrie and Pickles, 2013, Cryan and 
Sweeney, 2011). 
 
1.5 Hypothesis and Aims  
Depression is a mental illness that is increasingly recognized to emerge in adolescence. 
The available antidepressants have reduced efficacy and increased risks associated with 
their use in adolescence. Furthermore adolescent depression is characterized by altered 
HPA activity that is distinct from adult depressed patients. In adults stressful life events 
lead to HPA activation resulting in hypercortisolaemia and depressive states. In contrast 
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in adolescence stress is also associated with depression, but with a less robust change 
in hypercortisol response. In this thesis, I have tested the hypothesis that altered stress-
responsiveness in juvenile mice produces a depressive state that is resistant to current 
monoaminergic antidepressant treatments.  
The main aim of this thesis was to develop a model of adolescent depression in juvenile 
mice. Kim and Han (2006) have shown in adult mice that 2h restraint per day for 14 days 
induces a pro-depressive behaviour (increased immobility in the forced swim test) and 
an increase in anxiety-related behaviours (reduced time spent in, and entries into, the 
open arms of the elevated plus maze). In this thesis, this model was used as a starting 
point for developing a model of adolescent depression using repeated restraint stress in 
juvenile mice. In order to assess the effects of repeated restraint stress, I needed to 
measure corticosterone levels as a measure of HPA function in both adults and juveniles. 
This necessitated the development of a low stress method for collecting repeated blood 
samples from juvenile mice with small blood volumes (typically 0.8ml or less) (Chapter 
3). I also developed a methodology for assessing mouse welfare while undergoing this 
protocol to establish humane endpoints in the repeated stress procedure (adapted from 
Lloyd and Wolfensohn, 1999). The next specific objective was to assess whether or not 
stress provoked a similar neuroendocrinological response in both adults and juvenile 
animals. Changes in the function of the HPA axis following repeated stress was also 
determined using the DST (Chapter 4). Having established that the repeated restraint 
stress model produced a robust physiological and endocrinological stress response, the 
next specific objective was to test whether repeated restraint stress in juvenile mice 
provoked a behavioural change consistent with an increase in depression-related and/or 
anxiety-related behaviours (Chapter 5). The final objective was to investigate whether 
repeated stress altered the expression of key components of HPA signalling in juvenile 
mice, compared to adult mice, which may contribute to altered stress-responsiveness 













Male BALB/cAnNCrl mice (Charles River, Margate, UK) and male C57BL/6 mice (bred 
at the University of Bath from a colony originally derived from Charles River) were used 
throughout these studies. BALB/c and C57BL/6 mice have been shown to differ in their 
stress responsiveness, with BALB/c mice considered to be more sensitive to the effects 
of stress than the more stress-resilient C57BL/6 strain (Anisman and Matheson, 2005, 
Jacobson and Cryan, 2007). Male mice were used as the stress models and behavioural 
tasks used throughout this thesis are well validated in adult male mice, with experiments 
extending this to juvenile animals. Pilot studies towards the end of the thesis examined 
behaviours in female and male mice (see Appendix). Juvenile mice were 4-5 weeks old, 
and adult mice were 9-10 weeks old at the start of experiments. Mice aged 4-6 weeks 
can be considered to model human adolescence, as at this age they undergo sexual 
maturation, have a growth spurt and undergo brain changes markedly similar to 
adolescent humans (Spear, 2000). C57BL/6 mice were housed in groups of 3-4, and 
BALB/c mice were housed individually to avoid fighting, in 35 x 20 x 15cm polysulfone 
cages (Plexx, Elst, The Netherlands) with woodchip bedding (Datesand, Manchester UK) 
and paper nesting material (Lillico/LBS Biotechnology, Horley, UK). Cages of group 
housed mice were cleaned weekly, and those of individually housed mice were cleaned 
fortnightly, following completion of behavioural testing. Mice were maintained on a 12 
hour light:dark cycle (lights on at 07:00 h), in a temperature (21 ± 1℃) and humidity (50–
60%) controlled environment with food and water available ad libitum. All mice were 
habituated to the animal facility for 4-7 days prior to the start of experiments. Mice were 
habituated to handling by gentle cupping (Hurst and West, 2010) for 2-3 mins on 1-4 
occasions prior to the start of experiments. In all experiments mice were randomly 
assigned to control or stress treated groups. All procedures were carried out in 





All drugs were diluted in 0.9% w/v sodium chloride for injection (saline, Hameln 
Pharmaceuticals) and administered intraperitoneally (i.p.) in a volume of 10ml/kg. 
Diazepam (Hameln Pharmaceuticals) was supplied as 2ml vials containing 10mg 
diazepam, and administered at a dose of 1mg/kg. Fluoxetine hydrochloride (Abcam 
Biochemicals) was administered at a dose of 10 or 20mg/kg fluoxetine base, where 
1.1mg fluoxetine hydrochloride equates to 1mg fluoxetine base. Dexamethasone 21-
phosphate disodium (Alfa Aesar) was administered at a dose of 0.1 or 0.01 mg/kg. For 
acute treatments, drugs were administered 30 minutes prior to behavioural testing. For 
chronic treatment, drugs were administered once daily between 3-4pm for up to 26 days.  
 
2.3 Stress protocols 
2.3.1 Restraint stress 
Mice were placed first into a modified 50ml syringe with ventilation holes, which was 
plugged with the syringe plunger and adjusted depending on the size of the mouse, so 
that mice were unable to move forwards or backwards. Mice remained in the restraint 
device for 2 hours (unless otherwise stated), during which time they were monitored 
constantly. The restraint tubes used in this project are shown in Figure 2.1. Mice 
underwent restraint stress either once (acute stress), or daily for 3, 7, or 14 consecutive 
days (repeated stress). For all restraint stress sessions, restraint stress typically occurred 





Figure 2.1: Image of a restraint stress tube used throughout this thesis.  
 
2.3.2 Variable stress 
A 3 day variable stress protocol was developed from methods previously described 
(Jacobson-Pick and Richter-Levin, 2010, Brydges et al., 2014). On day 1, mice 
underwent a 10 min forced swim stress. Stress sessions were conducted in a glass 
beaker with a diameter of 21cm, height 49cm, filled to a depth of approximately 23cm 
with water at a temperature of 25 ± 1°C. Following stress, mice were dried with paper 
towels and placed in a warm holding cage, before being returned to the home cage. The 
water was replaced, and the beaker cleaned with 70% ethanol, between each mouse. 
On day 2, mice underwent elevated platform stress. Mice were placed individually in the 
centre of a small (15cm x15cm) platform, with a 1cm high rim around the edge, elevated 
1m above the floor. The platform was a minimum of 55cm from walls or benches in the 
room. Each mouse had 3 exposures to the elevated platform for 30 min each, with 60 
min between each session. The elevated platforms used in the variable stress protocol 
are shown in Figure 2.2. On day 3, mice underwent 2 hours restraint stress, as described 




Figure 2.2: Image of an elevated platform used during the variable stress protocol. 
 
 
2.3.3 Control, non-stressed mice 
Age-matched, sex-matched control mice were used in all experiments. To control for 
daily handling in repeated stress protocols, control mice were briefly gently handled daily 
for 1-2 min (09:00-11:00h) by cupping, weighed and returned to their home cage for a 
similar number of days/duration as the stress protocol required.  
 
2.3.4 Welfare monitoring 
For both restraint stress and variable stress protocols, stressed mice were weighed daily 
and monitored daily for signs of distress using a scoring system (Figure 2.3). This was 
adapted in conjunction with the named animal care and welfare officer (NACWO) and 
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named veterinary surgeon (NVS) from Lloyd and Wolfensohn (1999), and monitored 
mice for changes in bodyweight, appearance and behaviour throughout the stress 
protocol. Aggregate daily scores were recorded and a score of 0-4 was rated normal. 
Animals scoring 5-9 required careful monitoring, and scores above 10 required 
consultation with the NACWO so that relief could be provided. If severe distress was 




Animal ID:      
  Date:       
Body Weight Daily Body Weight (g)         
  Normal 0       
  Weight Loss <5% 1       
  Weight Loss 5-15% 2       
  Weight Loss >15% 3       
Appearance Normal 0       
  General Lack of Grooming 1       
  Coat Staring, ocular and nasal discharges 2       
  Piloerection, hunched up 3       
Breathing Normal Breathing 0       
  Laboured Breathing 3       
Natural Behaviour Normal 0       
  Minor Changes 1       
  Less mobile and alert, isolated 2       
  Vocalisation, self mutilation, restless or still 3       
Provoked Behaviour Normal 0       
  Minor depression or exaggerated response 1       
  Moderate change in expected behaviour 2       
  Reacts violently, or very weak and precomatose 3       
Score 
If you have scored a 3 more than once, score an 
extra point for each 3 2-5       
 Total 0-20       
 
Figure 2.3: Welfare monitoring sheet used throughout all stress studies. Mice were 








3 Validation of a refined technique for taking repeated blood 






In order to assess the impact of stress and resulting activation of the HPA axis throughout 
this thesis, it was necessary to find a suitable method of taking repeated blood samples 
from both juvenile and adult mice in order to measure changes in corticosterone levels. 
This presented several challenges when considering blood sampling methodology.  
There are several techniques which exist for the collection of blood from mice. Sampling 
from the tail vein is a commonly used method, although restraint of the mouse is required 
(such as in a restraint tube), and vasodilation is often necessary in order to insert a 
needle into the tail vein (Diehl et al., 2001, Fluttert et al., 2000). The saphenous vein is 
also widely used in mice, which requires shaving of the area and restraint of the mouse. 
Warming the mouse prior to blood collection may be necessary in order to facilitate blood 
collection (Hem et al., 1998, Hoff, 2000, Diehl et al., 2001). Tail snip, involving removal 
of the tip of the tail in order to facilitate bleeding, has also been used as a method of 
blood collection in mice. However, anaesthesia is recommended, and repeated sampling 
from the same mouse over a period of time is not possible due to the shortening of the 
tail (Diehl et al., 2001). Use of the tail snip method without anaesthesia has been found 
to be stressful, as shown by higher levels of corticosterone in mice following tail bleeding 
compared with control mice which had only been killed (Tuli et al., 1995).  
Collection of repeated blood samples from a single mouse is possible following 
intravenous cannulation. However, this requires anaesthesia and surgical implantation 
of the cannula, and animals must be housed individually following surgery (Diehl et al., 
2001, Fluttert et al., 2000). These procedures may be stressful to the animal due to the 
restraint, anaesthesia or warming of the mouse involved (Hoff, 2000, Fluttert et al., 2000). 
The stressful nature of the blood sampling technique may confound the results of 




   
Taking repeated blood samples from the same mouse before and after stress allows a 
significant reduction in the number of mice used over the course of an experiment. Hence 
a refined minimally invasive method of blood sampling, which allows multiple samples to 
be taken from the same animal, is desirable (Festing et al., 2002). However, UK Home 
Office guidelines limit repeated sampling and indicate that no more than 10% of the total 
blood volume of a mouse may be taken on each occasion, with no more than 25% taken 
over a 28-day period (NC3Rs, 2015). When working with juvenile mice (4–6 weeks old), 
which weigh as little as 12g, this limits the volume that can be taken on each occasion 
to less than 60µl. Therefore blood sampling techniques used in juvenile mice must 
facilitate the collection of small volumes of blood (up to 40µl), and allow blood flow to be 
started and stopped easily. 
The lateral tail vein is an appropriate route for repeated sampling of small blood volumes 
from mice without anaesthesia, although vasodilation may be required (Diehl et al., 2001, 
NC3Rs, 2015). We compared three different blood collection techniques in adult mice 
before adapting and validating the method developed by Fluttert et al. (2000) as a refined 








3.2.1 Blood sampling  
Preliminary studies aimed to develop a suitable method for taking repeated blood 
samples from juvenile mice. Three different methods were used initially. To avoid 
confounding effects of circadian rhythms on corticosterone levels, all blood samples were 
taken between 11:00h and 13:00h. 
 
3.2.1.1 Warming cabinet method 
The warming cabinet method involved heating the mice in a thermostatically-controlled 
veterinary recovery chamber (Mediheat V1200DT, Peco Services Ltd) for 15 minutes at 
38°C, in line with guidelines on the NC3Rs blood sampling website (NC3Rs, 2015) . Mice 
were then briefly restrained in a restraining tube, a 25G needle was inserted into the 
lateral tail vein, and the resulting blood droplets collected in heparinised capillary tubes 
(Hawksley, Sussex, UK). Capillary tubes had a total volume of 80µl, and typically 40µl of 
blood was collected from each sample. 
 
3.2.1.2 Tail warming method 
For the tail warming method, mice were held by hand and the tail was immersed into 
warm water at 42°C for 20 seconds. A 25G needle was again inserted into the lateral tail 
vein, and resulting blood droplets were collected in capillary tubes. Again, typically 40µl 




3.2.1.3 Tail incision method 
The tail incision method was developed from the technique established by Fluttert et al. 
(2000) for use in rats. Mice were held by gentle cupping (Hurst and West, 2010) by one 
person, while the operator held the tail gently on the bench. The tail was rotated through 
90° to expose the lateral tail vein, and a small nick (approximately 2mm wide and 0.5mm 
deep) was made in the tail with a razor blade, perpendicular to the tail vein, approximately 
2 cm from the tip of the tail. Blood droplets were directly collected into capillary tubes. 
Blood flow was encouraged by gently stroking the tail and in the majority of cases, blood 
flow stopped spontaneously when stroking was stopped. On occasion it was necessary 
to apply a small amount of pressure to the tail to stop bleeding. Typically 40µl of blood 
was collected from each sample. 
 
3.2.2 Corticosterone analysis 
In all methods, blood samples were immediately transferred to microcentrifuge tubes 
containing EDTA (final concentration in sample 3 µg/µl), and stored on ice. Samples 
were centrifuged at 2000 relative centrifugal force (rcf) for 20 min at 4°C. Plasma 
(approximately 10-15µl per sample) was removed and stored at -20°C until analysis. The 
concentration of corticosterone in each plasma sample was determined using a 
corticosterone enzyme-linked immunosorbent assay (ELISA) (IBL International, 
Hamburg, Germany). Plasma was diluted 1:10 in Standard 0, and the ELISA was carried 
out according to the manufacturer’s instructions using a reference range of 0-240 nM 
corticosterone. All samples were measured in duplicate. Briefly, samples and standards 
were added to a 96-well plate coated with anti-corticosterone antibody, which detects 
mouse, rat and human corticosterone. Horseradish peroxidase enzyme conjugated to 
corticosterone was also added to the plate. The plate was thoroughly mixed for 10 
seconds, then incubated for 1 hour at room temperature, washed, and enzyme substrate 
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added. After 15 min incubation, the reaction was halted by the addition of a stop solution 
and the optical density was read at 450nm using a microplate reader (FLUOstar Optima, 
BMG Labtech). A standard curve was constructed using a 4 Parameter Logistics curve 
fit, as calculated by MARS data analysis software (BMG Labtech). Average optical 
density values from each duplicate sample were determined, and the corticosterone 
concentration was calculated directly from the standard curve. Intra and inter assay 
coefficients of variability were reported to be 3.1% and 6.0% respectively. 
 
3.2.3 Statistical analysis 
Data were analysed using a repeated measures mixed model analysis (InVivoStat 
software, version 2.5.0.0) (Clark et al., 2012). Bonferonni’s correction was used to adjust 
for multiple comparisons. Data were log10 transformed prior to analysis to stabilise the 
variance. All sample sizes are indicated in the figure legends. All data are presented as 







Initial studies sought to determine a suitable method of obtaining blood samples. 
Guidance from the NC3Rs blood sampling website (NC3Rs, 2015) suggested use of 
either the saphenous vein or lateral tail vein, although pilot studies were unsuccessful in 
obtaining sufficient blood samples from the saphenous vein. When taking samples from 
the tail vein, it was found during pilot studies to be necessary to heat the mice, at 38°C 
for 15 min, to sufficiently dilate the tail vein in order to insert a needle and reliably obtain 
blood samples (NC3Rs, 2015, Diehl et al., 2001).  
To assess the suitability of the use of the tail vein for taking blood as part of a stress 
protocol, adult and juvenile BALB/c mice had blood samples taken by the warming 
cabinet method (see Chapter 3.2.1.1). Blood samples were taken at baseline, and 
immediately following 2h restraint stress. As corticosterone levels reach their peak level 
approximately 15-30 minutes after the onset of stress, and then fall slowly to baseline 
levels 60-90 minutes following stress (de Kloet et al., 2005), these post stress blood 
samples were taken when corticosterone levels were at their peak. 4h following stress, 
once the peak corticosterone level had fallen, mice were killed by cervical dislocation 
and a terminal trunk blood sample was taken. 2-way repeated measures mixed model 
analysis revealed a significant effect of timepoint (F(2,12)=312.25, P<0.001), and 
age*timepoint interaction (F(2,12)=8.1, P=0.006) on plasma corticosterone levels (Figure 
3.1). While there was a 55% increase in corticosterone immediately following stress in 
both adult and juvenile mice, this was not statistically significant. Blood samples taken 
post-mortem following cervical dislocation, 4h after stress, showed corticosterone levels 
which were 1000% lower than those taken at baseline  in adult mice, and 3500% lower 
in juvenile mice (P<0.001).  Thus, the difference between these post-mortem sample 
values and the high corticosterone levels obtained at baseline showed that taking blood 
samples using the warming cabinet method was stressful, precluding the use of this 






























Figure 3.1: Effect of acute restraint stress (2h) on plasma corticosterone in adult and 
juvenile BALB/c mice. Blood samples were taken from the tail vein using the warming 
cabinet method at baseline and immediately following restraint. Mice were killed 4h later 
by cervical dislocation and a terminal blood sample was obtained. Results expressed as 
mean ± SEM, n=4/group. *P<0.05, ***P<0.001 (post-hoc LSD test). 
 
A comparison was then made between three different methods of taking blood to 
determine the most refined method, as determined by low basal corticosterone levels. 
As heating the whole mouse in a warming cabinet, and restraint in a restraint device to 
obtain a blood sample had proved to be stressful, an alternative method of vasodilation 
was attempted. The tail warming method (chapter 3.2.1.2) involved warming the tail by 
immersion in a water bath (42°C for 20s), prior to blood sampling (Parasuraman et al., 
2010). This was also compared with the tail incision method (chapter 3.2.1.3), adapted 




Adult BALB/c mice had a blood sample taken either by the warming cabinet, tail warming 
or tail incision method. Mice were then killed 24h later by cervical dislocation and terminal 
trunk blood samples were obtained. 2-way repeated measures mixed model analysis 
showed a significant effect of sampling method (F(2,12)=7.1, P<0.01), baseline or terminal 
sample (F(1,12)=21.2, P<0.001) and method*sample interaction (F(2,12)=10.8, P<0.005) on 
plasma corticosterone. As found previously, restraining mice and heating in a warming 
cabinet to take blood was stressful, shown by 300% higher corticosterone levels at 
baseline compared to a terminal sample 24h later (P<0.001). Corticosterone levels 
following use of the warming cabinet method were also 220% greater than those in blood 
taken by the tail warming method (P<0.05), and 350% greater than the tail incision 
method (P<0.01). For both the tail warming and tail incision methods, corticosterone 
levels at baseline did not differ from those taken post-mortem following cervical 




































Figure 3.2: Effect of three different blood sampling methods on plasma corticosterone 
levels in adult BALB/c male mice. ‘Baseline’ samples were obtained from the lateral tail 
vein following either warming in a cabinet, or tail warming by immersion in water or tail 
incision method (no warming). Animals were killed 24 h later by cervical dislocation and 
‘terminal’ samples were obtained. Results are expressed as mean ± SEM, n=5/group. 
*P<0.05, **P<0.005, ***P<0.001 (post-hoc LSD test). 
 
To confirm the suitability of the tail incision method as a refined method of repeated blood 
sampling for use in a restraint stress model, the effect of acute restraint stress on 
corticosterone was determined. Adult and juvenile BALB/c mice had a blood sample 
taken by the tail incision method at baseline. 24h later, mice were restrained for 2h, with 
a second blood sample taken immediately following stress. A third sample was taken 
24h following restraint stress. 2-way repeated measures mixed model analysis revealed 
a significant effect of age (F(1,8)=13.27, P=0.007) and timepoint (F(2,16)=85.58, P<0.001) 
on corticosterone. At baseline, juvenile mice had 67% lower corticosterone than adults 
(P<0.05). 2h restraint stress resulted in a 1000% increase in corticosterone in adult mice, 
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and a 3000% increase in juvenile mice (P<0.001). Corticosterone was no longer 
significantly different from baseline 24h following stress (Figure 3.3). 
On each occasion the total volume of blood collected in the capillary tube was 20-80µl. 
In a typical experiment, mice had 2 blood samples taken, each of a volume of 40µl. The 
total volume of blood taken (80µl) was equivalent to 5% of the total blood volume (1.5ml) 
of a typical adult mouse weighing 25g, and 9% of the total blood volume (0.9ml) of a 

























Figure 3.3: Effect of acute restraint stress on plasma corticosterone in adult and juvenile 
BALB/c mice. Blood samples were taken by the tail incision method at baseline, 
immediately following 2h restraint stress, and 24h post restraint stress. Results 







To be suitable for use in studies examining the effects of stress, methods of blood 
sampling must be refined and minimally invasive to avoid confounding the results of 
corticosterone analyses. Here, the stressful nature of heating and restraining mice to 
take blood, as shown by increased corticosterone levels obtained from samples using 
this method, precluded the use of these techniques for future studies. Conversely, low 
basal levels of corticosterone were obtained using the tail incision method, indicating that 
the procedure is not stressful. Furthermore, the levels of corticosterone obtained from 
the third sample using the tail incision method (24h following stress) are not increased 
above the baseline samples, demonstrating that repeated sampling is not stressful. 
The pattern of corticosterone secretion following stress observed here is similar to that 
found in other studies. For example, basal levels of corticosterone obtained here 
(60ng/ml) are similar to those observed by others (<100ng/ml) (Gong et al., 2015, Kim 
and Han, 2006). Other reports have shown that acute restraint stress for 2h, 8h and 24h 
has resulted in a significant 250-700% increase in corticosterone above either baseline 
levels, or above levels in unstressed, control mice (Kim and Han, 2006, Gong et al., 
2015, Mizobe et al., 1997). 
Bioanalytical techniques have advanced and many assays now require only small sample 
volumes (microsamples, typically defined as <50µl) to assess drug and chemical exposure 
in blood, plasma and/or serum (Spreadborough et al., 2013). Microsampling is used in the 
drug discovery process and in toxicology studies, and a number of methods employing 
capillary collection have been developed and published in the last two years (Powles-Glover 
et al., 2014, Caron et al., 2015). The method used here was originally developed for use 
in adult rats (Fluttert et al., 2000), particularly for use in behavioural studies where  
implantation of indwelling cannulae is not desirable or methods like tail-cuts are 
unsuitable for repeated sampling. These studies show that the tail incision or tail nick 
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method is also suitable for use in adult and juvenile mice. Additionally, mice are not 
required to be restrained in a restraint device but can be gently cupped throughout the 
procedure. A further benefit of the tail incision method is that it allows blood flow to be 
started and stopped easily, facilitating the collection of very small volumes of blood 
(typically 20–40µl) from juvenile mice. This tail incision method for use in mice has been 
published as a validated, refined technique for repeated capillary microsampling in 





















4.1.1 Restraint Stress 
Restraint stress is straightforward to administer, painless and does not cause bodily 
harm to the animals (Buynitsky and Mostofsky, 2009). The procedures for restraint stress 
vary hugely between labs, in terms of method of restraint, duration, frequency, intensity 
and in the methods and time-points of evaluating the effects of stress (Buynitsky and 
Mostofsky, 2009). While restraint stress has been widely used in rats (Romeo et al., 
2006, Chiba et al., 2012), there are fewer studies using mice. Some attempts have been 
made to validate different protocols for use in mice, with Kim and Han (2006) finding that 
2 or 8 hour daily restraint stress for 14 days is more effective at inducing anxiety and 
depression-related behaviours in C57BL/6 mice than 6 hours daily for 10 days.  
In this thesis, the methodology of Kim and Han (2006) was chosen as it allowed the 
stress to be delivered to juvenile mice in a time frame where their behaviour could be 
assessed while they were still juvenile. However, this methodology needed to be 
validated in terms of its neuroendocrinological effects in juvenile mice as there are no 
studies where this has been investigated. Both acute and chronic restraint stress have 
repeatedly been shown to activate the HPA axis, resulting in an increase in plasma 
corticosterone levels in both rats and mice (Anisman et al., 2001, Gong et al., 2015, Kim 
and Han, 2006, Romeo et al., 2006). Additionally, monitoring adrenal gland weight has 
also been used as a marker of stress and persistent HPA activation (Ulrich-Lai et al., 
2006).  
Disturbance of the HPA axis in depression is evident as impaired glucocorticoid receptor 
(GR)-mediated negative feedback (see Chapter 1.2.3). This has been verified indirectly, 
using tests designed to measure the integrity of the mechanism, that include 
demonstrating non-suppression of cortisol secretion following administration of the 
synthetic glucocorticoid, dexamethasone (dexamethasone suppression test, DST) 
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(Porter and Gallagher, 2006). Clinically, the relevance of DST comes from the finding 
that the response to this test may represent a biomarker of depression, but also a 
biomarker of treatment success. Indeed, efficacious antidepressant treatment is 
associated with resolution of the disturbance in the negative feedback in patients who 
are non-suppressors before treatment, with up to 75% of non-suppressor patients 
switching to suppressor status coincident with a treatment response (Heuser et al., 1996, 
Linkowski et al., 1987). Dexamethasone suppression of corticosterone responses has 
also been demonstrated in mice and rats (Bartolomucci et al., 2004, Moles et al., 2008). 
In this thesis, we conducted preliminary experiments to establish whether there was any 
evidence that 3 days repeated restraint stress induced impairments in GR-mediated 
negative feedback of the HPA axis. 
 
4.1.2 Variable stress 
It is known that predictable stressors, such as repeated daily restraint stress, are 
comparatively less stressful than unpredictable stressors, such as chronic mild 
unpredictable stress (Anisman and Matheson, 2005). Furthermore, habituation of the 
corticosterone response is often evident after predicable stress in both mice and rats, 
demonstrated by lower increases in corticosterone after multiple exposures to the same 
stressor compared with initial exposures to the stressor (Gong et al., 2015, Kearns and 
Spencer, 2013). Conversely, unpredictable stress (a different stressor each day) has 
been shown to result in no significant habituation of the corticosterone response, with 
corticosterone levels remaining high after each consecutive day of stress in mice (Gong 
et al., 2015). Unexpectedly increasing the duration of predictable repeated restraint 
stress has also been shown to increase the corticosterone response compared with rats 
experiencing the same, predicted, duration of restraint (Kearns and Spencer, 2013). 
Similarly, altering the physical context in which the predictable stressor is applied can 
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result in attenuation of the habituation of the corticosterone response, leading to 
increased corticosterone release in rats (Grissom et al., 2007). 
To reduce the possibility of habituation, here I have investigated the effects of variable 
stress using the paradigm of Tsoory and Richter-Levin (2006), which was developed and 
shown in juvenile rats. The use of different stressors, such as forced swim stress, 
exposure to an elevated platform, restraint and footshocks, over 3 consecutive days has 
repeatedly been used in juvenile mice and rats both to activate the HPA axis, resulting 
in a stress response, and to induce depression and anxiety-related behaviours Since 
variable stress protocols elicit stronger stress responses, and reduce the possibility of 
habituation, than acute or repeated stress protocols, I will use this model developed in 
pre-pubertal rats and pilot this protocol in juvenile mice.                                                                                                                             
 
4.1.3 Chapter aims 
In this chapter I have investigated the neuroendocrinological effects of both 3, 7 and 14 
days repeated restraint stress, and 3 days variable stress in both adult and juvenile mice. 
Changes in plasma corticosterone levels following repeated restraint were examined to 
determine the stressful nature of restraint. This was coupled with analysis of body weight 
and adrenal gland weight in stressed mice compared with controls. To determine function 
of negative feedback inhibition of the HPA axis in stressed mice, the effect of repeated 
restraint stress on suppression of corticosterone release in the DST was also examined. 
It has previously been shown that different strains of mouse differ in their response to 
stress, with BALB/c mice more sensitive to the effects of stress than the C57BL/6 strain 
(Anisman et al., 2001, Jacobson and Cryan, 2007). This chapter also compares the 
neuroendocrinological effects of stress in BALB/c mice with the reported more stress 





Adult and juvenile BALB/c and C57BL/6 mice underwent either the restraint stress or 
variable stress protocol as described in Chapter 2.3. The tail incision method of taking 
blood was validated as a refined method for repeated blood sampling in adult and 
juvenile mice (see Chapter 3), and so was used throughout restraint stress and variable 
stress protocols. Blood samples were taken at baseline, immediately following stress 
and 24h following stress. Typically 40µl of blood was taken from each sample. A 
maximum of 10% total blood volume was taken on any one occasion, and no more than 
20% blood volume in total from up to 5 samples in adult mice, or 25% blood volume from 
up to 3 samples in juvenile mice. Baseline blood samples and those following stress 
were taken at the same time each day (11:00-13:00h) to avoid any confounding effects 
of circadian variation on corticosterone levels. Blood samples were processed and 
corticosterone levels in plasma determined by ELISA as previously described (Chapter 
3.2.2).  
 
4.2.2 Dexamethasone suppression test (DST) 
Function of the HPA axis following stress was also assessed using the DST. Mice had a 
baseline blood sample taken between 15:00-16:00h the day after the last day of stress. 
The next day, mice were administered dexamethasone (0.01 or 0.1mg/kg, i.p.) 
(Bartolomucci et al., 2004) between 09:00-10:00h. Blood samples were taken 6h later, a 
timepoint commonly used in the DST (Bartolomucci et al., 2004, Groenink et al., 2002), 
between 15:00-16:00h. Blood samples were processed and corticosterone levels in 




4.2.3 Dissection of adrenal glands 
To determine any differences in adrenal gland weight between stressed and control 
mice, mice were killed by cervical dislocation, an incision was made ventrally, adrenal 
glands were carefully excised and fresh tissue weight was determined.  
 
4.2.4 Statistical analysis 
All statistical analysis was performed using InVivoStat software Version 2.5.0.0 (Clark et 
al., 2012). Corticosterone data were analysed using a repeated measures mixed model 
analysis with Bonferonni’s correction for multiple comparisons, and were log10 
transformed prior to analysis to stabilise the variance. Adrenal gland data were analysed 
using either an unpaired t-test, or 2-way ANOVA as determined by the experimental 
design. Least significant difference (LSD) test with Bonferonni’s correction for multiple 
comparisons was used for post-hoc comparisons.  Bodyweight data were analysed using 
a repeated measures mixed model analysis, with Bonferonni’s correction for multiple 
comparisons.  The relationship between corticosterone and adrenal gland weight was 
determined using a Pearson’s correlation. All sample sizes are indicated in the figure 
legends. All data are presented as mean ± SEM, and significance was taken as P<0.05, 
as is convention in the literature. However, there has been increasing debate about using 
P<0.05 as an arbitrary cut-off for significance (Dahiru, 2008), and hence in this thesis I 






4.3.1 Animal welfare monitoring 
For both restraint stress and variable stress protocols, stressed mice were weighed daily 
and monitored daily for signs of distress using the adapted Lloyd and Wolfensohn (1999) 
scoring system shown in Chapter 2.3.4. Total daily scores for individual mice were 
typically 1 or 2, with no mouse ever scoring higher than 3.  
 
4.3.2 Neuroendocrinological effects of acute restraint stress  
To confirm the stressful nature of restraint stress in adult and juvenile mice, changes in 
corticosterone were determined following a single session of restraint stress. In adult 
BALB/c mice, there was a significant effect of stress (F(1,7)=14.78, P=0.006), timepoint 
(F(1,8)=32.57, P=0.0005), and stress*timepoint interaction (F(1,8)=23.65, P=0.001) on 
corticosterone (Figure 4.1). In stressed mice, there was a significant 1400% increase in 
corticosterone above baseline following 2h restraint stress (P<0.001). Similarly, in 
juvenile mice, there was a significant effect of stress (F(1,7)=34.81, P=0.0006), timepoint 
(F(1,8)=10.04, P=0.01) and stress*timepoint interaction (F(1,8)=38.34, P=0.0003) on 
plasma corticosterone (Figure 4.1). 2h restraint stress resulted in a significant 900% 


















































Figure 4.1: Effect of acute restraint stress on plasma corticosterone in (A) adult and (B) 
juvenile BALB/c mice. Blood samples are taken at baseline and immediately following 
2h restraint stress. Results are expressed as mean ± SEM, n=5/group. **P<0.01, 





4.3.3 Neuroendocrinological effects of repeated restraint stress  
To determine HPA activation in response to repeated restraint stress, blood samples 
were taken at baseline and following 3, 7 or 14 days restraint, and plasma levels of 
corticosterone were determined (Figure 4.2). There were no differences between control 
and stressed groups in baseline plasma corticosterone measures. Average baseline 
corticosterone values measured 49ng/ml in adults, and 33ng/ml in juvenile mice. After 3 
days restraint stress, there was a significant effect of stress on plasma corticosterone in 
both adult (F(1,29)=49.75, P<0.001) and juvenile BALB/c mice (F(1,27)=35.76, P<0.001), 
with stress resulting in a 710% increase in corticosterone over baseline in adults, and a 
2000% increase in juveniles (P<0.001). Similarly, there was a significant effect of 7 days 
restraint on corticosterone in both adults (F(1,28)=18.17, P<0.001) and juveniles 
(F(1,30)=13.9, P<0.001) although this was attenuated compared with 3 days. 14 days 
restraint significantly increased plasma corticosterone in both adult (F(1,29)=69.86, 
P<0.001) and juvenile mice (F(1,14)=10.49, P<0.01), and again these were attenuated 
compared with 7 days restraint. In adult mice corticosterone was no longer significantly 
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Figure 4.2: Effect of 3, 7 or 14 days restraint stress on plasma corticosterone in adult 
(A,C,E) and juvenile (B,D,F)  BALB/c mice. Blood samples are taken at baseline, 
immediately following 3, 7 and 14 days restraint, and 24h following the last session of 
restraint. Results are expressed as mean ± SEM, n=4-16/group. *P<0.05, **P<0.01, 
***P<0.001 (post-hoc LSD test). 
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Adrenal gland weight, corrected for body weight, also demonstrated that the restraint 
stress procedure impacted on the HPA axis (Figure 4.3). Following 3 days restraint 
stress, there was a trend towards a significant effect of stress (F(1,25)=3.65, P<0.07), and 
a significant effect of age (F(1,25)=12.23, P<0.01) on adrenal gland weight. Stress resulted 
in a 3% increase in adrenal gland weight in adult mice, and a 10% increase in juvenile 
mice compared with control, although this was not statistically significant. Extending the 
duration of the restraint stress to 7 days revealed a significant effect of stress 
(F(1,26)=8.66, P<0.01) and age (F(1,26)=19.72, P<0.001) on adrenal gland weight. There 
was an 8% increase in adrenal gland weight in adult mice (P=0.2), and a 9% increase in 
juvenile mice (P=0.08), compared with non-stressed controls. Juvenile control mice had 
significantly heavier adrenal glands than adult control mice (P<0.05). After 14 days 
restraint, there was a significant effect of stress (F(1,25)=8.55, P<0.01) and age 
(F(1,25)=23.93, P<0.0001) on adrenal gland weight. Whilst there was an increase in 
adrenal gland weight in both stressed adults (9% above control, P=0.2) and juveniles 
(8% above control, P=0.1), this was not significant following correction for multiple 
comparisons. Juvenile control mice had significantly heavier adrenal glands than adult 





























































































Figure 4.3: Effect of 3, 7 or 14 days restraint stress on adrenal gland weight of adult and 
juvenile BALB/c mice. Adrenal glands were removed and weighed 2 days after restraint. 






A Pearson correlation coefficient was calculated to determine whether there was a 
relationship between corticosterone levels immediately following stress, and adrenal 
gland weight in adult and juvenile BALB/c mice. There was a positive correlation between 
corticosterone and adrenal gland weight in both adult (r=0.44, n=49, P<0.005) and 
juvenile (r=0.50, n=46, P<0.001) mice (Figure 4.4), although interpretation of this data 
may be limited due to the group design of the experiments. 
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Figure 4.4: Correlation of corticosterone measurement immediately following the last 
session of restraint/no stress, and adrenal gland weight of adult and juvenile BALB/c 







Finally, body weight was recorded daily to assess the effects of repeated restraint stress 
(Figure 4.5). In BALB/c adult mice, there was a significant effect of stress on bodyweight 
(F(1,14)=36.07, P<0.001), with stressed mice having up to 8% lower bodyweight than 
controls (P<0.01). Similarly, in juveniles there was a significant effect of stress on 
bodyweight (F(1,14)=8.92, P<0.01), with stressed mice having up to 12% lower bodyweight 
than non-stressed control mice (P<0.01). 
 

























































Figure 4.5: Effect of 14 days restraint stress on body weight of (A) adult and (B) juvenile 
BALB/c mice. Results expressed as mean ± SEM, n=8/group. *P<0.05, **P<0.01 






To determine whether a shorter duration of restraint led to less habituation of the HPA 
response following chronic stress, the effect of 30min restraint for 1 and 3 days on 
corticosterone was assessed in BALB/c adult mice. Repeated measures mixed model 
analysis revealed a significant effect of stress (F(1,14)=58.2, P<0.001), timepoint 
(F(2,28)=27.81, P<0.001) and stress*timepoint interaction (F(2,28)=33.64, P<0.001). Both 
acute restraint and 3 days repeated restraint resulted in a significant 8-900% increase in 
corticosterone compared to both baseline (P<0.001) and non-stressed control mice 































Figure 4.6: Effect of 1 and 3 days restraint stress (30 min/day) on plasma corticosterone 
in adult BALB/c mice. Blood samples were taken at baseline and immediately following 
1 and 3 days restraint stress. Results are expressed as mean ± SEM, n=8/group. 





Chronic stress has been shown to alter function of the HPA axis in mice, resulting in 
long-lasting changes in the HPA response to future stressors (Brockhurst et al., 2015).  
To determine any long-term alterations in HPA function following chronic restraint stress, 
BALB/c adult mice who had previously undergone 14 days restraint stress underwent a 
single 2h session of restraint, 12-13 days following the end of the original chronic 
restraint. Corticosterone levels following acute restraint in previously stressed mice were 
compared with control mice who were undergoing their first session of restraint. No 
differences were seen in the corticosterone response of previously stressed and control 



















Figure 4.7: Effect of acute restraint stress (2h) on plasma corticosterone in BALB/c adult 
mice who had previously undergone 14 days restraint stress, compared with control mice 






4.3.4 Neuroendocrinological effects of restraint stress in C57BL/6 mice 
BALB/c mice have been reported to be stress sensitive whereas the C57BL/6 strain is 
relatively stress resilient (Jacobson and Cryan, 2007). The stress responsiveness of 
C57BL/6 mice was therefore determined in comparison with BALB/c mice. 
To determine the effects of acute restraint stress in C57BL/6 mice, blood samples were 
taken at baseline and immediately following a single 2h session of restraint stress (Figure 
4.8). As with BALB/c mice, there was a significant effect of stress (F(1,14)=120.16, 
P<0.001), timepoint (F(1,14)=157.26, P<0.001) and stress*timepoint interaction 
(F(1,14)=182.18, P<0.001) on plasma corticosterone. Acute restraint resulted in a 
significant 330% increase in corticosterone in adult mice (P<0.001), and a smaller 73% 













































Figure 4.8: Effect of acute restraint stress on plasma corticosterone in (A) adult and (B) 
juvenile C57BL/6 mice. Blood samples are taken at baseline and immediately following 
2h restraint stress. Results are expressed as mean ± SEM, n=8/group (adults), 




The neuroendocrinological effects of 3 days repeated restraint stress in C57BL/6 adult 
and juvenile mice were also assessed. There was a significant effect of stress on 
corticosterone in both adult (F(1,27)=109.79, P<0.001) and juvenile (F(1,29)=190.51, 
P<0.001) C57BL/6 mice (Figure 4.9). 3 days restraint stress resulted in a 220% increase 
in corticosterone over baseline in adult mice, and a 310% increase in juvenile mice 
(P<0.001). This was accompanied by a 9% increase in adrenal gland weight in adult 
stressed mice,  and a 12% increase in juvenile stressed mice, compared with non-
stressed controls (P<0.01, Figure 4.10). Following both acute and 3 days repeated stress 
in juvenile mice (Figure 4.8B and 4.9B), there is a reduction in corticosterone in the 
control groups, which may limit the interpretation of the increase in corticosterone in 
stressed mice. However, in both experiments restraint stress resulted in a significant 
increase in corticosterone compared with both baseline measures of stressed mice, and 

















































Figure 4.9: Effect of 3 days restraint stress on plasma corticosterone in (A) adult and (B) 
juvenile C57BL/6 mice. Blood samples were taken at baseline and immediately following 
3 days restraint stress. Results are expressed as mean ± SEM, n=15/group. ***P<0.001 



























































Figure 4.10: Effect of 3 days restraint stress on adrenal gland weight in adult and juvenile 
C57BL/6 mice. Adrenal glands were removed and weighed the day after the last session 






Changes in bodyweight were also observed following 3 days restraint stress in C57BL/6 
mice (Figure 4.11). The bodyweight of adult mice was 4% lower in stressed mice than in 
controls following 3 days restraint (F(1,12)=15.63, P=0.002). Conversely, in juvenile mice, 
the reduction in bodyweight in stressed mice was not significant (F(1,14)=1.97, P=0.18).  
The neuroendocrinological effects of 7 and 14 days restraint stress were not examined 





















































Figure 4.11: Effect of 3 days restraint stress on bodyweight of (A) adult and (B) juvenile 
C57BL/6 mice. Results expressed as mean ± SEM, n=7-8/group. ***P<0.001 compared 





4.3.5 Dexamethasone Suppression Test in BALB/c and C57BL/6 mice 
The DST is a commonly used test to assess negative feedback control of HPA function 
both in depressed patients and in animals following stress (Porter and Gallagher, 2006, 
Bartolomucci et al., 2004). Initial experiments aimed to determine a suitable dose of 
dexamethasone to use in the DST (Figure 4.12). There was a significant effect of dose 
of dexamethasone on suppression of corticosterone release in both BALB/c (F(2,17)=8.35, 
P=0.003) and C57BL/6 (F(2,17)=58.03, P<0.0001) mice, in comparison with saline-treated 
animals. 0.01mg/kg dexamethasone had no effect on corticosterone release in either 
adult or juvenile, BALB/c or C57BL/6 mice. However, 0.1mg/kg dexamethasone resulted 
in a significant 80-90% reduction of corticosterone release in BALB/c adult mice, but not 
juveniles, in this pilot study due to high variability (Figure 4.12A). This variability is likely 
to be due to a low sample size (n=4/group). Subsequent experiments did show 
suppression in BALB/c juvenile mice. Suppression of corticosterone release was also 
seen in C57BL/6 adult and juvenile mice (Figure 4.12B). 0.1mg/kg dexamethasone was 
the dose used in subsequent DST experiments. 
Further experiments confirmed that suppression of corticosterone release by 
administration of 0.1mg/kg dexamethasone could be observed in comparison to baseline 
corticosterone values. Adult and juvenile C57BL/6 mice had a blood sample taken at 
baseline, then the DST was carried out 24h later (Figure 4.12C). Repeated measures 
mixed model analysis revealed a significant effect of timepoint on corticosterone 
(F(1,6)=43.35, P<0.001), with a significant 90% reduction in corticosterone following 











































































Figure 4.12: DST in adult and juvenile BALB/c (A) and C57BL/6 (B) mice. Blood samples 
were taken 6h following administration of saline, 0.01mg/kg or 0.1mg/kg dexamethasone 
(DEX). (C) Blood samples were taken at baseline, and the DST was carried out 24h later, 
in adult and juvenile C57BL/6 mice. Results expressed as mean ± SEM, n=4/group. 
**P<0.01, ***P<0.001 compared with either the saline group (A+B), or with baseline (C) 




To assess changes in the function of negative feedback inhibition of the HPA axis 
following stress, the effect of 3 days repeated restraint stress on the DST was determined 
in both BALB/c and C57BL/6 mice (Figure 4.13). In BALB/c adult and juvenile mice, 
administration of dexamethasone significantly suppressed corticosterone release by 
around 90% compared with baseline levels (F(1,28)=105.05, P<0.001). There was no 
effect of stress (F(1,27)=1.12, P=0.3) or age (F(1,27)=0.96, P=0.3) on corticosterone levels 
following the DST. Similarly, in C57BL/6 mice, dexamethasone resulted in a significant 
suppression of corticosterone release of around 90% in control mice, and 65% in 
stressed mice, compared with baseline levels (F(1,28)=64.7, P<0.001). Although 
suppression of corticosterone was lower in stressed mice than controls, this was not 


















































Figure 4.13: Effect of 3 days restraint stress on the DST in adult and juvenile BALB/c (A) 
and C57BL/6 (B) mice. Mice were restrained daily for 3 days (2h/day). Baseline blood 
samples were taken on day 4, and the DST occurred on day 5. Results expressed as 
mean ± SEM, n=8/group. *P<0.05, **P<0.01, ***P<0.001 (post-hoc LSD test). 
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4.3.6 Neuroendocrinological effects of variable stress 
As repeated restraint stress is predictable in nature, the neuroendocrinological effects of 
3 days variable stress were investigated in adult and juvenile BALB/c and C57BL/6 mice, 
to determine whether less habituation of the stress response was evident to an 
unpredictable variable stress protocol.  
Plasma corticosterone levels were assessed in adult mice, immediately following 3 days 
of variable stress. There was a significant effect of strain (F(1,29)=6.18, P=0.019), stress 
(F(1,29)=71.95, P<0.001), timepoint (F(1,31)=34.7, P<0.001), strain*stress interaction 
(F(1,29)=8.36, P=0.0072) and stress*test interaction (F(1,31)=85.1, P<0.001) on plasma 
corticosterone (Figure 4.14A). Post-hoc analyses revealed that 3 days variable stress 
resulted in a significant 1000% increase in corticosterone above baseline in BALB/c mice 
(P<0.001), and 400% increase in C57BL/6 mice (P<0.001). Although this stress-induced 
increase in corticosterone was greater in BALB/c mice than C57BL/6 mice, the difference 
was not statistically significant. There was a trend for C57BL/6 mice to have higher 
corticosterone at baseline (55ng/ml) than BALB/c mice (31ng/ml) (P<0.1).  
Similarly, in juvenile mice, there was a significant effect of strain (F(1,29)=29.44, P<0.001), 
stress (F(1,29)=52.64, P<0.001), timepoint (F(1,31)=14, P<0.001), stress*timepoint 
interaction (F(1,31)=100.93, P<0.001) and strain*stress*timepoint interaction (F(1,31)=9.31, 
P=0.0046) on plasma corticosterone (Figure 4.14B). 3 days variable stress resulted in a 
significant 1900% increase in corticosterone above baseline in BALB/c mice (P<0.001), 
and 400% increase in the C57BL/6 strain (P<0.001). Baseline corticosterone was 

































































A: Adults B: Juveniles
 
Figure 4.14: Effect of 3 days variable stress on plasma corticosterone in (A) adult and 
(B) juvenile BALB/c and C57BL/6 mice. Mice had a blood sample taken at baseline and 
immediately following 3 days variable stress. Results expressed as mean ± SEM, n=8-





The effect of 3 days variable stress on adrenal gland weight was also determined in adult 
and juvenile BALB/c and C57BL/6 mice (Figure 4.15). In adult mice, there was a 
significant effect of stress (F(1,27)=10.58, P=0.0031). Stress resulted in a significant 10% 
increase in adrenal gland weight in C57BL/6 mice (P<0.05), whereas in BALB/c mice 
there was a trend towards a significant 8% increase compared with controls. There was 
no difference in adrenal gland weight between BALB/c and C57BL/6 mice (F(1,27)=1.0, 
P=0.3) .  
Conversely, in juveniles, there was no significant effect of stress on adrenal gland weight 
(F(1,28)=1.7, P=0.2), although there was a significant effect of strain (F(1,28)=13.6, 
































































Figure 4.15: Effect of 3 days variable stress on adrenal gland weight in (A) adult and (B) 
juvenile BALB/c and C57BL/6 mice. Adrenal glands were removed and weighed the day 
after 3 days variable stress. Results expressed mean ± SEM, n=7-9/group. *P<0.05 




A summary of the changes in corticosterone following repeated stress in both BLAB/c 
and C57BL/6 mice is given in Table 4.1. Similarly, stress-induced changes in adrenal 
gland weight are summarised in Table 4.2. 
 BALB/c C57BL/6 
 Adult Juvenile Adult Juvenile 
3 days restraint stress ↑ ↑ ↑ ↑ 
7 days restraint stress ↑ ↑ - - 
14 days restraint stress 0 ↑ - - 
3 days variable stress ↑ ↑ ↑ ↑ 
 
Table 4.1: Summary of stress-induced changes in plasma corticosterone following 
repeated stress. ↑, increase in corticosterone; 0, no effect; -, not tested. 
 
 BALB/c C57BL/6 
 Adult Juvenile Adult Juvenile 
3 days restraint stress 0 0 ↑ ↑ 
7 days restraint stress 0 trend to ↑ - - 
14 days restraint stress 0 0 - - 
3 days variable stress trend to ↑ 0 ↑ 0 
 
Table 4.2: Summary of stress-induced changes in adrenal gland weight following 






These data show the effects of repeated stress on corticosterone levels, adrenal gland 
weight, body weight and HPA feedback in both adult and juvenile BALB/c mice and 
C57BL/6 mice. Different stress paradigms were assessed. Repeated restraint stress of 
different durations (3, 7 and 14 days) provoked a robust physiological response in 
BALB/c mice. Plasma corticosterone levels increased and body weight decreased in 
stressed, compared to control non-stressed, adult and juvenile mice. Interestingly, 
adrenal gland weight, expressed as a percentage of body weight, was higher in juvenile 
mice than in adult mice, and showed a trend to increase in stressed, compared to control, 
adult and juvenile mice.  
As already shown in Chapter 3, baseline corticosterone measurements reported here 
are in line with some values reported in the literature, but may be lower because of the 
methodology used to collect the blood samples (Sadler and Bailey, 2013).  Increases in 
corticosterone following 3 days stress appeared to be greater in juvenile mice than in 
adults, in both strains of mice studied, suggestive of the increased sensitivity of the HPA 
axis seen in juvenile animals (Foilb et al., 2011, Eiland and Romeo, 2013), although this 
maybe in part because of a lower basal corticosterone level. Previous studies have 
observed that restraint stress in mice induced increases in corticosterone levels similar 
to those found in the present study. For example, Romeo et al. (2013) showed a 
significant increase in corticosterone levels in trunk blood samples from both 30 day old 
and adult BALB/c and C57BL/6 mice, immediately following a single exposure (30 min) 
to restraint stress. Corticosterone levels reported were much higher (~700-1200 ng/ml) 
than the values we obtained following 3 days repeated restraint stress in blood samples 
collected via the tail nick method (Sadler and Bailey, 2013). Romeo et al. (2013) also 
showed that restraint stress in juvenile BALB/c mice induced a higher corticosterone 
response than in adults. However, this data shows a clear attenuation of the 
corticosterone response in both adult and juvenile BALB/c mice with increasing duration 
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of restraint stress. Corticosterone was no longer significantly increased above baseline 
in adult mice following 14 days restraint, indicating habituation to the stressor. This is 
consistent with previous reports in rats, showing that the HPA axis is less responsive to 
repeated restraint stress following either 8 or 14 days of restraint, compared to an acute 
exposure to the stressor (Grissom et al., 2007, Viau and Sawchenko, 2002). 24h 
following restraint stress, corticosterone levels had returned to normal and were no 
longer elevated above baseline, indicating that there were no long lasting 
neuroendocrinological effects of repeated stress.  
Substantial evidence indicates that the hormonal stress response, mediated by the HPA 
axis, can habituate on repeated exposure to stressors. The term “habituation” refers to 
the reduction in physiological responses elicited by an nth exposure to a repeated 
homotypic (same) stressor, in comparison to the large responses elicited by acute 
exposure to that stressor. A change in the context in which the stress is experienced can 
diminish the magnitude of the habituated HPA response. For example, after exposure to 
repeated restraint with one of two odours (banana, peppermint), exposure to a matching 
scent during a test restraint led to lower corticosterone levels compared to those found 
in animals exposed to the alternate (“switch”) scent during the test restraint (Grissom et 
al., 2007). On the other hand, exposure to any heterotypic stress (particularly where the 
stressor differs in modality from the habituated stressor), after HPA habituation to a 
homotypic stressor, does not elicit cross-stressor habituation but instead facilitation of 
HPA activity (Armario et al., 1988). In all the repeated restraint stress studies performed 
here, the context was kept constant to reduce experimental variability. Hence all restraint 
sessions were at the same time of day, performed in the same room (different to the 
behavioural room) by the same experimenter. A consequence of this rigorous approach 
to the experiments probably accounts for the habituation of corticosterone responses 
after 14 days of a homotypic stressor. In the variable stressor paradigm, where mice 
were exposed to heterotypic stressors over 3 days, similar plasma corticosterone levels 
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were observed compared to 3 days repeated restraint stress. This suggests that 
habituation of the HPA responses must occur over a longer time course than 3 days, and 
is certainly evident at 14 days.  
 
In addition to assessing corticosterone levels, experiments were also conducted to 
assess whether repeated restraint stress altered GR mediated negative feedback of the 
HPA axis. In both BALB/c and C57BL/6 mice, adults and juveniles, showed significant 
suppression of corticosterone responses following administration of 0.1 mg/kg 
dexamethasone. There was no difference between control and stressed animals. In 
these studies the impact of 3 days repeated restraint stress on DST was investigated. It 
would be anticipated that significant impairment of GR mediated negative feedback 
would take time to develop. In future studies, it would be of interest to examine 
dexamethasone suppression in animals exposed to 7 -14 days repeated restraint stress. 
  
These studies have compared the effects of restraint stress on two different strains of 
mice. There have been several studies looking at strain differences in stress 
responsiveness, with BALB/c mice considered to be more sensitive to the effects of 
stress than the more stress-resilient C57BL/6 strain (Anisman and Matheson, 2005, 
Jacobson and Cryan, 2007). Consistent with this, our results show an increased 
corticosterone response to 3 days restraint stress in BALB/c mice (700% increase above 
baseline) compared with C57BL/6 mice (220% increase above baseline). Similarly, 3 
days variable stress resulted in a 1000% increase in corticosterone above baseline in 
BALB/c adult mice, and a 400% increase in C57BL/6 adult mice. Again, in juvenile mice, 
3 days variable stress resulted in a greater increase in corticosterone in BALB/c mice 
(1900% above baseline) than in C57BL/6 mice (400% above baseline). Although these 
stress-induced increases in corticosterone were greater in BALB/c mice than C57BL/6 
mice, the differences were not statistically significant. 
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In conclusion, repeated restraint stress induced a significant increase in plasma 
corticosterone responses compared to control mice at 3, 7, 10 and 14 days of repeated 
stress. Responses at 10 and 14 days were attenuated compared to 3 and 7 days 
suggesting that habituation to a homotypic stressor was occurring. Juvenile mice tended 
to have a higher % change than in adults, in part because of a lower basal corticosterone 
level. The restraint stress procedure also impacted on adrenal gland weight which 
increased and correlated with plasma corticosterone levels. Taken together, these data 
indicate that the restraint stress procedures used produced a robust 
















 A variety of behavioural paradigms have been developed to assess different aspects of 
depression-related behaviour. The particular tests chosen to assess behaviours here are 
commonly used, pharmacologically validated tasks in mice. While these tests have been 
well validated for use in adult mice, it is less clear how well they have been validated for 
use in juvenile mice.  
 
5.1.1 Forced swim test 
The forced swim test (FST) was first developed by Porsolt et al. (1978) for use in rats, 
and subsequently modified for use in mice. The test involves placing the animal into a 
beaker of deep water for 6 minutes, and recording the amount of time it spends 
swimming, climbing and immobile as well as the latency to the first period of immobility. 
An antidepressant effect is defined as a decrease in the amount of time spent immobile, 
resulting in a corresponding increase in climbing and swimming behaviours. Different 
classes of clinically effective antidepressants have shown to have antidepressant effects 
in the FST in mice (Cryan and Holmes, 2005), demonstrating the pharmacological 
validity of the test. These include the SSRIs fluoxetine, paroxetine and citalopram (Cryan 
et al., 2005b, David et al., 2003, Lucki et al., 2001), the tricyclic antidepressants 
imipramine and desipramine (David et al., 2003, Lucki et al., 2001), the monoamine 
oxidase inhibitor (MAOI) moclobemide (Cryan et al., 2005b), the noradrenaline reuptake 
inhibitor (NRI) reboxetine (Cryan et al., 2005b), as well as the atypical antidepressants 
ketamine (Autry et al., 2011) and bupropion (David et al., 2003).    
Different strains of mice have been shown to differ in both their behaviour in the FST, as 
well as their response to antidepressant treatment (Jacobson and Cryan, 2007, Lucki et 
al., 2001, David et al., 2003). BALB/c and C57BL/6 strains have both demonstrated 
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relatively high levels of baseline immobility in the FST compared to other strains (Lucki 
et al., 2001, Jacobson and Cryan, 2007). Furthermore, both BALB/c and C57BL/6 mice 
have demonstrated an antidepressant response (reduction in immobility) in response to 
various antidepressants, including fluoxetine, paroxetine and desipramine (Lucki et al., 
2001, David et al., 2003). 
There have been different hypotheses for the meaning of immobility in the FST, from a 
reduction in escape-directed behaviour (behavioural despair) to an alteration in coping 
strategies in stressful situations (Cryan et al., 2002, Cryan and Mombereau, 2004). The 
FST shows one of the highest levels of predictive validity of all animal models of 
depression, and is reliable and reproducible between and within laboratories, making it 
one of the most widely used tests of depression-related behaviour (Cryan et al., 2002). 
A reduction in immobility in the FST has been observed following both acute 
administration of antidepressants (Cryan et al., 2002), as well as chronic antidepressant 
treatment (Cryan et al., 2005b, Dulawa et al., 2004). 
However, there are some limitations of the FST. While it shows predictive validity, face 
and construct validity are minimal. Furthermore, it has been suggested that considering 
immobility seen in the FST as behavioural despair may be anthropomorphic, and that as 
immobility is best for energy conservation it may reflect a more efficient way of coping 
(Powell et al., 2012). 
There has been some debate as to whether the FST would be better described as a test 
of antidepressant action, rather than depression-related behaviour, given that it was 
developed and validated based on the effects seen with antidepressant drugs available 
at the time (Cryan and Mombereau, 2004). However, it has been shown that the FST not 
only demonstrates the effects of antidepressants, but also shows a pro-depressive effect 
(increased immobility) in rodents following interventions known to cause depression in 
humans, such as genetic predisposition, stress and withdrawal from psychostimulants 
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(Cryan and Mombereau, 2004). This can be seen to further validate its role as a test of 
depression-related behaviour. 
 
5.1.2 Sucrose Preference Test 
The sucrose preference test (SPT) was first used by Willner et al. (1987), in rats 
undergoing chronic unpredictable mild stress, but has subsequently been used in mice 
following chronic stress (Strekalova et al., 2004). The SPT is a measure of anhedonia, 
one of the key symptoms of depression. The task involves giving animals a choice of 
drinking from two bottles, one containing water and the other containing a sucrose 
solution. Rodents have an innate preference for sucrose over water, although those 
displaying depressive-related behaviours following a periods of chronic stress show 
significantly reduced sucrose preference (Willner et al., 1987). 
Stress-induced reductions in sucrose preference have been reversed by chronic 
treatment of several different antidepressant drugs, including fluoxetine, imipramine and 
desipramine, in both rats and mice (Willner et al., 1987, Bessa et al., 2013, Zhang et al., 
2014), making the SPT a pharmacologically validated model of depression-related 
behaviour. However, there are limitations of the SPT. Strain differences of intake of low 
concentrations of sucrose have been reported, which correlate to differences in 
expression of a taste receptor gene (Lewis et al., 2005), suggesting innate differences in 
the ability to taste sucrose (Powell et al., 2012). As mice experience sucrose for the first 
time during the SPT, neophobia may confound the interpretation of changes in sucrose 




5.1.3 Elevated plus maze 
The elevated plus-maze (EPM) is a test of anxiety-related behaviour, developed for use 
in the mouse by Lister (1987). It consists of two enclosed arms with high walls, and two 
open arms, arranged in the shape of a ‘plus’ around a central square. The entire maze 
is elevated above the floor. Mouse behaviour in the EPM is based on a conflict between 
exploration of a novel environment, and avoidance of the aversive open arms of the 
maze (Bourin et al., 2007). Mice placed in the centre of the maze will predominantly 
explore the closed arms, whilst avoiding the open arms. An anxiolytic effect is defined 
as an increase in both the proportion of time spent in the open arms, and the number of 
entries into the open arms (Treit et al., 2010). 
The EPM is a pharmacologically validated test of anxiety-related behaviour, showing 
predictive validity for anxiolytic compounds. Drugs used clinically to treat anxiety in 
humans, such as benzodiazepines, reliably show an anxiolytic effect in the EPM (Treit 
et al., 2010). Conversely, the effects of antidepressant drugs on mouse behaviour in the 
EPM is conflicting. A number of studies have reported either an anxiolytic effect, an 
anxiogenic effect, or no effect, after either chronic or acute administration (Cole and 
Rodgers, 1995, Silva and Brandao, 2000, Treit et al., 2010). However, there are 
limitations of the EPM. It has been suggested that the EPM should be considered more 
a test of benzodiazepine drug action rather than a test of anxiety-related behaviour. In 
addition, changes in overall activity levels may confound the results. 
 
5.1.4 Behavioural effects of chronic stress 
As chronic stress is well known to increase the risk of depression in humans, there has 
been considerable interest in assessing the behavioural effects of chronic stress in 
rodents. Various chronic stress paradigms have been developed, predominately using 
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adult animals, which have been shown to increase depression and anxiety-related 
behaviours in the FST, SPT and EPM. An increase in immobility in the FST, reflective of 
an increase in depression-related behaviour, has been shown following social stress 
(exposure to an unfamiliar male mouse), restraint stress and chronic mild stress (Huang 
et al., 2013, Kim and Han, 2006, Zhu et al., 2014). Similarly, in the EPM, social stress, 
restraint stress and chronic mild stress have all resulted in a decrease in the number of 
open arm entries, or time spent in the open arms, indicating an increase in anxiety-
related behaviour (Kim and Han, 2006, Schmidt et al., 2007, Stone and Quartermain, 
1997, Zhu et al., 2014). Chronic mild stress paradigms have frequently been shown to 
reduce preference for sucrose, indicative of anhedonia, in the SPT (Strekalova et al., 
2004, Willner et al., 1987, Zhu et al., 2014).  
While the behavioural effects of various chronic stress paradigms have been well 
validated in adult animals, there are relatively few reports of the behavioural effects of 
chronic stress in juvenile animals. In addition, where the effects of juvenile stress have 
been investigated, behaviour is often assessed when mice have reached adulthood 
(Huang et al., 2013, Schmidt et al., 2007, Brydges et al., 2014). 
 
5.1.5 Chapter aims 
This chapter aims to assess the behavioural effects of chronic stress in both juvenile and 
adult mice. The effects of 3, 7 and 14 days repeated restraint stress on depression and 
anxiety-related behaviours in the FST, SPT and EPM was determined in both juvenile 
and adult BALB/c mice. As the BALB/c mouse strain has been reported to be relatively 
stress sensitive compared with the more resilient C57BL/6 strain (Jacobson and Cryan, 
2007), the behavioural effects of 3 days restraint stress in C57BL/6 adult and juvenile 
mice were also assessed.  
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In addition, as predictable stressors are considered less stressful than unpredictable 
stress (Anisman and Matheson, 2005), the changes in anxiety-related behaviour in the 
EPM following 3 days variable stress were determined in both BALB/c and C57BL/6 
mice. 
Finally, it was determined whether mice who exhibited a higher HPA response to stress, 
as shown by increased corticosterone release immediately following stress and 
increased adrenal gland weight, were more susceptible to the behavioural effects of 
stress. For each individual mouse, corticosterone levels and adrenal gland weight, as 
measured in Chapter 4, were correlated with behavioural readouts in the FST, SPT and 
EPM. These correlations were very exploratory analyses to look for patterns in the data, 
given that we had behavioural and neuroendocrinological measures from the same 







To assess the behavioural effects of repeated stress in both juvenile and adult mice, 
BALB/c and C57BL/6 mice underwent either 3, 7 or 14 days restraint stress, or 3 days 
variable stress, as described in Chapter 2.3. The behavioural effects of acute stress, and 
of a shorter duration of restraint (30 min/day for 3 days) were also assessed. Behavioural 
testing in the EPM and FST occurred in a dimly lit room adjacent to the animal holding 
room, between 09:00-14:00h. Mice were left to acclimatise in the behavioural room for 
at least 1 hour prior to testing. Testing in the EPM, FST and SPT occurred one day 
following 3 days restraint to determine whether there was any lasting impact on the 
behaviour of the animal from repeated restraint stress. Behavioural testing occurred two 
days following 7 or 14 days restraint to allow for blood sampling 24h after restraint. 
Separate groups of mice were used for each behavioural test for ethical reasons and to 
avoid confounds due to prior behavioural testing.  The use of the same animals for 
behavioural testing and neuroendocrinological analysis resulted in a reduction in the total 
number of animals used, as well as enabling comparisons of the behavioural and 
neuroendocrine measures for each individual mouse.  An outline of the experimental 




Figure 5.1: Experimental design for mice undergoing either 3, 7 or 14 days restraint 
stress (A, B and C), or 3 days variable stress (D). CORT, blood taken for corticosterone 
analysis; Brain dissection, brain tissue taken for molecular analysis; DST, 
dexamethasone suppression test; EPM, elevated plus maze; FST, forced swim test; 
SPT, sucrose preference test. 






















































































































































5.2.2 Forced swim test (FST) 
The forced swim test (FST) was carried out essentially as described by Lucki (1997). 
Mice were placed in a glass beaker (diameter 22cm, height 34cm), filled to a depth of 
23cm with water (25 ± 1°C). Each 6 minute test session was recorded using a camcorder 
(Sony DCR-SR52) and behaviour in the last 4 minutes of the test was scored by an 
experimenter blind to treatment. Swimming was defined as horizontal movement, 
climbing as vertical movement, while immobility was defined as the minimal activity 
needed to stay afloat (Cryan et al., 2002). Following the test session, mice were dried 
with paper towels and placed in a warm holding cage, before being returned to the home 
cage. The water was replaced, and the beaker cleaned with 70% ethanol, between each 
mouse. 
 
5.2.3 Sucrose preference test (SPT) 
The sucrose preference test was adapted from methods described by Willner et al. 
(1987). All mice undergoing the SPT were housed individually for at least 3 days prior to 
testing. Mice were first habituated to drinking from 2 bottles of water in the home cage, 
for 12h (19:00-07:00). The following day, mice were given the choice to drink either water 
or 2.5% or 5% w/v sucrose (D-sucrose, Fisher) in the home cage in a 12h test during the 
dark phase of the light cycle (19:00-07:00). Bottles were weighed before and after the 
test, and the preference for sucrose was determined as a percentage of the total volume 




5.2.4 Elevated plus maze (EPM) 
The elevated plus maze (EPM) has been previously been used as a test to measure 
anxiety-related behaviour in the mouse (Lister, 1987). The EPM (CM EPM2000 Mouse 
Plus Maze, Campden Instruments) consisted of four arms (38 x 5cm), arranged at right 
angles around a central intersection (5 x 5cm). Two of the arms were open, with a 0.5cm 
rim, whilst the other two were enclosed with 9.5cm high walls. The entire maze was 
elevated 65cm off the floor. Lighting on the open arms measured 20 lux for experiments 
with BALB/c mice, and 50 lux for experiments using C57BL/6 mice, with light levels of 
less than 1 lux in the closed arms. The lighting conditions were determined empirically 
and the aversive nature of the open arms was validated pharmacologically using 1mg/kg 
diazepam as a positive control. Mice were placed in the central intersection facing an 
open arm and allowed to freely explore the maze for 5 minutes. Time spent in, and 
number of entries into the open arms, and total locomotion over the whole maze, were 
recorded by MotorMonitor™ software using infrared photobeams. The maze was 
cleaned with 70% ethanol after each mouse. 
 
5.2.5 Statistical analysis 
All statistical analysis was performed using InVivoStat software Version 2.5.0.0 (Clark et 
al., 2012). Elevated plus maze and forced swim test experiments were conducted as 
separate experiments in adult and juvenile mice, so data were analysed using unpaired 
t-tests to compare the effects of stress with non-stressed control mice. Sucrose 
preference tests in adult and juvenile mice were conducted as one experiment, and so 
were analysed using two-way ANOVA with age and stress as factors. Least significant 
difference (LSD) test with Bonferonni’s correction for multiple comparisons was used for 
post-hoc comparisons. All sample sizes are indicated in the figure legends. All data are 




5.3.1 Validation of behavioural tests in juvenile mice 
Initial experiments aimed to validate the suitability of the FST, SPT and EPM for use with 
both adult and juvenile BALB/c mice. During preliminary studies the effect of chronic 
fluoxetine treatment (20mg/kg i.p. for up to 28 days) was investigated. An adverse effect 
was noted on the seminal vesicles following treatment (see appendix). 
 
5.3.1.1 Validation of the FST 
The effect of acute fluoxetine (10 and 20mg/kg) on behaviour was assessed in adult and 
juvenile BALB/c mice (Figure 5.2). Fluoxetine treatment had a significant effect on both 
the time spent immobile and swimming (F(2,40)=4.1, P=0.02). In juvenile mice, 10 and 
20mg/kg fluoxetine resulted in a 24% decrease in the time spent immobile, and a 30% 
increase in the time spent swimming compared with saline-treated mice, which had a 
trend towards statistical significance (P=0.1). In adult mice, fluoxetine resulted in a 10% 
decrease in the time spent immobile, and 25% increase in the time spent swimming, 
although this was not statistically significant. There was also a significant effect of age 
on both the time spent immobile and swimming in the FST (F(1,40)=26, P<0.001), with 
juvenile saline-treated mice spending 20% less time immobile, and 45% more time 
swimming, than adult saline-treated mice. Time spent climbing was found to be 











































Figure 5.2: Effect of fluoxetine on behaviour of adult and juvenile BALB/c mice in the 
FST. Time spent immobile and swimming were recorded in the last 4 minutes of a 6 
minute test. Test session began 30 minutes after i.p. administration (10ml/kg) of either 
10 or 20 mg/kg fluoxetine, or 0.9% w/v saline. Results are expressed as mean ± SEM, 
n=8/group (post-hoc LSD test). 
 
5.3.1.2 Validation of the SPT 
In preliminary experiments, the innate preference of BALB/c mice to drink from a bottle 
positioned at either the front or the back of the cage was determined. Mice were given 
the choice to drink from two bottles, both containing water, in a 12h test period during 
the dark phase of the light cycle (19:00-07:00), and their preference for each bottle 
position was determined (Figure 5.3A). Mice had no significant preference for either the 
front or back bottle (F(1,22)=0.5, P=0.5). Average total consumption was 3.4 ± 0.2ml for 




The ability of a 5% sucrose solution to produce a sucrose preference in BALB/c mice 
was also confirmed (Figure 5.3B). Mice were given the choice to drink from two bottles, 
one containing water and the other containing either water, or 2.5% or 5% w/v sucrose. 
A 2-way ANOVA revealed a significant effect of sucrose concentration (F(2,18)=7.86, 
P=0.004) on preference for sucrose. Juvenile mice showed significant preference for 5% 
sucrose over water (P<0.05), with adult mice showing a trend towards a preference for 
5% sucrose (P=0.1). 2.5% sucrose did not result in a significant preference over water 












































Figure 5.3: (A) Preference to drink from a water bottle positioned at either the front or 
back of the cage. Dotted line represents position of no preference. Results are expressed 
as mean ± SEM, n=12/group.  (B) Preference for 2.5% or 5% sucrose solution, compared 
with water, in adult and juvenile BALB/c mice. Preference was measured over a 12h test 
period (19:00-07:00). Dotted line represents position of no preference. Results are 





In C57BL/6 mice, previous work in our lab has established that consumption of 2.5% 
sucrose is significantly higher than water (P<0.01), and is sufficient to elicit a preference 
























Figure 5.4: Consumption of water, 2.5% or 5% sucrose solution in adult C57BL/6 mice 
during a 1h test period at the beginning of the dark cycle (19:00h). Mice were water 
restricted for 4h prior to the start of the test. Results are expressed as mean ± SEM, 
n=4/group. *P<0.05, **P<0.01 compared with water (Dunnett’s post-hoc test). Data from 





5.3.1.3 Validation of the EPM 
The anxiolytic effects of diazepam (1mg/kg) were evaluated in adult and juvenile BALB/c 
mice, under lighting conditions of 20 lux on the open arms (Figure 5.5). Diazepam had a 
significant effect on the time spent in the open arms (F(1,27)=10.9, P=0.003), and resulted 
in a significant 300% increase in the time spent in the open arms in adult mice (P<0.001). 
There was also a significant effect of diazepam on the number of entries into the open 
arms (F(1,27)=7.9, P=0.009), with a 175% increase in open arm entries in adult mice 
following diazepam treatment (P<0.01). Conversely, in juvenile mice diazepam had no 
significant effect on the time spent in, or entries into the open arms. Diazepam treatment 
resulted in a significant 130% increase in total locomotion over the whole maze in both 




































































Figure 5.5: Effect of diazepam on behaviour of adult and juvenile BALB/c mice in the 
EPM. Time spent in the open arms, number of entries into the open arms and total 
locomotion over the whole maze were assessed by beam breaks in a 5 minute test 
period. Test session began 30 min after i.p. administration (10ml/kg) of diazepam 
(1mg/kg), or 0.9% w/v saline. Results are expressed as mean ± SEM, n=8/group. 
**P<0.01, ***P<0.001 (post-hoc LSD test). 
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5.3.2 Effect of restraint stress on depression and anxiety-related behaviours 
5.3.2.1 Forced Swim Test 
Adult and juvenile BALB/c mice experienced daily restraint stress (2 hours per day) for 
either 3, 7 or 14 days. Behaviour in the FST was assessed 24-48 hours following the last 
restraint (Figure 5.6). A significant effect of restraint stress was only observed in adult 
mice following 3 days of restraint stress. This resulted in a 17% decrease in the time 
spent immobile, and a 35% increase in the time spent swimming in the FST (P<0.05, t-
test). Extending the restraint stress for 7 or 14 days in adult mice had no significant effect 
on either the time spent swimming or immobile (all P’s >0.3). In juvenile mice, behaviours 
in the FST were not affected by 3 or 7 days of restraint stress (all P’s >0.6). Conversely, 
increasing the duration of restraint to 14 days resulted in a significant 27% decrease in 


















































































































































































































Figure 5.6: Effect of 3, 7 or 14 days restraint stress on behaviour in the FST in adult and 
juvenile BALB/c mice. Time spent swimming and immobile were recorded in the last 4 
minutes of a 6 minute test. Results are expressed as mean ± SEM, n=7-12/group. 






5.3.2.2 Sucrose Preference Test 
The effect of 3, 7 and 14 days restraint stress in BALB/c mice was also assessed in the 
SPT (Figure 5.7). The effect of both stress and age on sucrose preference was 
determined for each duration of stress using a two-way ANOVA, with age and stress as 
factors. There was a significant main effect of stress in 3 days restraint stressed mice 
(F(1,25)=4.58, P<0.05). While this was associated with a 10% decrease in sucrose 
preference in both adult and juvenile stressed mice compared with control, this was not 
statistically significant following pairwise comparisons (P=0.2). There was no significant 
difference in total consumption of both water and sucrose between stressed and control 
mice in either adults or juveniles following 3 days restraint (P’s>0.1). Following 7 days 
stress, there was a significant effect of stress (F(1,27)=7.29, P<0.05), age (F(1,27)=7.91, 
P<0.01) and age*stress interaction (F(1,27)=5.35, P<0.05)  on sucrose preference. In 
adults, there was a 33% increase in sucrose preference in stressed mice compared with 
controls (P<0.01). There was no effect of 7 days stress on sucrose preference in juvenile 
mice. There was no effect of 7 days restraint on total consumption (F(1,27)=0.75, P=0.4). 
14 days restraint resulted in a 12% reduction in sucrose preference in adult mice, and a 
16% reduction in juveniles (F(1,26)=16.59, P<0.001). This was accompanied by a 
significant decrease in consumption in juvenile, but not adult, stressed mice compared 
with control (P<0.05). 
Repeated restraint stress therefore provoked an apparent antidepressant-like effect on 
behaviours in the FST after 3 days restraint stress in adults or 14 days restraint stress in 
juveniles. However, in the SPT, the behavioural response to repeated stress manifested 
as a significant decrease in preference for sucrose in juveniles, and a trend towards a 
significant decrease in adults, suggestive of an anhedonic or pro-depressant response 




























































































































































Figure 5.7: Effect of 3, 7 or 14 days restraint stress on sucrose preference in adult and 
juvenile BALB/c mice. Preference for 5% sucrose solution, and total consumption of both 
sucrose and water were measured over a 12h test period (7pm-7am). Dotted line 
represents position of no preference. Results are expressed as mean ± SEM, n=6-




5.3.2.3 Elevated Plus Maze 
Separate groups of BALB/c mice underwent a similar restraint stress protocol and 
behaviour was evaluated in the EPM 24-48 hours following the last restraint session 
(Figure 5.8). In adult mice, only 7 days restraint stress resulted in a significant change in 
behaviour, evident as a 130% increase in the time spent in the open arms in stressed 
mice compared with control (P<0.05). However, in juvenile mice, 3 days restraint resulted 
in a 200% increase in the number of open arm entries (P<0.01), although this was 
associated with a 160% increase in locomotor activity (P<0.001). There was no change 
in the time spent in the open arms (P=0.8). 7 days restraint resulted in a 220% increase 
in the time in the open arms (P<0.05), and a 170% increase in the number of open arm 
entries (P<0.01). A significant 71% increase in locomotor activity was evident following 
14 days restraint (P<0.01) in juvenile mice (but not in adults), although there was no 
change in either the time spent in, or entries into, the open arms of the EPM (both P’s 






















































































































































































































































































































































































Figure 5.8: Effect of 3, 7 or 14 days restraint stress on behaviour in the EPM in adult and 
juvenile BALB/c mice. Time spent in the open arms, number of entries into the open arms 
and total locomotion over the whole maze were assessed by beam breaks in a 5 minute 
test period. Results are expressed as mean ± SEM, n=7-12/group. *P<0.05, **P<0.01, 







To determine whether a shorter duration of restraint led to less habituation to the stressor 
following repeated stress, the effect of 30min restraint for 3 days on behaviour in the 
EPM was assessed in BALB/c adult mice (Figure 5.9). There was no significant effect of  
30min/day restraint stress on time spent in the open arms or the number of open arm 
entries, which was similar to results seen following 2h/day restraint stress for 3 days in 
adult mice. Conversely, there was an 80% increase in total locomotion following 
30min/day restraint stress, which showed a trend towards statistical significance 






















































Figure 5.9: Effect of 3 days restraint (30min/day) on behaviour in the EPM in adult BALB/c 
mice. Time spent in the open arms, number of entries into the open arms and total 
locomotion over the whole maze were assessed by beam breaks in a 5 minute test period. 






5.3.3 Behavioural effects of acute restraint stress 
To compare the behavioural effects of repeated restraint stress with a single application 
of restraint, adult and juvenile mice were tested in either the FST, SPT or EPM the day 
after one 2h session of restraint (Figure 5.10). There was no significant effect of acute 
stress on the time spent either swimming or immobile in the FST (P=0.5), on sucrose 
preference (P=0.5), or on the time spent in the open arms, number of open arm entries, 
or total locomotion in the EPM (all P‘s >0.2).  
In the FST, there was also a significant effect of age on the time spent both immobile 
and swimming (F(1,,28)=19.3, P<0.001), with juvenile control mice spending 25% less time 
immobile than adults (P<0.01). There was no significant effect of age on sucrose 
preference (F(1,25)=0.3, P=0.6), or on the time spent in the open arms (F(1,28)=0.3, P=0.6) 






































































































































A: Forced Swim  Test
B: Sucrose Preference  Test
C: Elevated Plus Maze
Figure 5.10: Effect of acute restraint stress (2h) on behaviour of adult and juvenile 
BALB/c mice in the forced swim test (A), sucrose preference test (B) and elevated plus 
maze (C). (A) Time spent immobile and swimming were measured in the last 4 minutes 
of a 6 minute test. (B) Preference for 5% sucrose solution, and total consumption of both 
sucrose and water were measured over a 12h test period (19:00-07:00). Dotted line 
represents position of no preference. (C) Time in the open arms, number of open arm 
entries and total locomotion over the whole maze were assessed by beam breaks in a 5 
minute test session. Results are expressed as mean ± SEM, n=7-8/group. **P<0.01 
(post-hoc LSD test). 
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5.3.4 Effects of repeated restraint stress in C57BL/6 mice 
The BALB/c mouse strain has been reported to be relatively stress sensitive whereas 
the C57BL/6 strain is relatively stress resilient (Jacobson and Cryan, 2007). Therefore 
the behavioural effects of 3 days restraint stress in C57BL/6 adult and juvenile mice were 
compared with BALB/c mice.  
Following 3 days restraint stress, adult C57BL/6 mice displayed a 50% decrease in the 
time spent immobile, and a 65% increase in the time spent swimming in the FST (P<0.01, 
Figure 5.11). Conversely, in C57BL/6 juvenile mice, there was no effect of restraint on 
the time spent either immobile (P=0.5) or swimming (P=0.6).  
In the SPT, a two-way ANOVA revealed a significant effect of age (F(1,26)=4.35, P<0.05) 
on sucrose preference, but no significant effect of restraint stress (F(1,26)=2.79, P=0.1) or 
stress*age interaction (F(1,26)=1.58, P=0.2).  
In the EPM, in juvenile mice restraint stress resulted in a 100% increase in the time spent 
in the open arms (P<0.01), consistent with an anxiolytic effect. Similarly, in adult mice, 
there was a 45% increase in time spent in the open arms following 3 days restraint, which 























































































































































































A: Forced Swim Test
C: Elevated Plus Maze


















































Figure 5.11: Effect of 3 days restraint on behaviour in the forced swim test (A), sucrose 
preference test (B) and elevated plus maze (C) in adult and juvenile C57BL/6 mice. (A) 
Time spent immobile and swimming were measured in the last 4 minutes of a 6 minute 
test. (B) Preference for 2.5% sucrose solution, and total consumption of both sucrose 
and water were measured over a 12h test period (19:00-07:00). Dotted line represents 
position of no preference. (C) Time in the open arms, number of open arm entries and 
total locomotion over the whole maze were assessed by beam breaks in a 5 minute test 
session. Results are expressed as mean ± SEM, n=8-12/group. **P<0.01, unpaired t-
tests (A,C), post-hoc LSD test (B). 
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5.3.5 Effect of juvenile stress on behaviour in adult mice 
As the behavioural effects of chronic stress in juvenile mice have been shown to persist 
into adulthood (Tsoory et al., 2007), mice who had undergone 3 days repeated restraint 
stress when juvenile (4-5 weeks old) were retested in either the FST or EPM when they 
reached adulthood (9-10 weeks old). In the FST, there was no effect of juvenile stress 
on either the time spent immobile or swimming (P=0.6, Figure 5.12A). Similarly, in the 
EPM juvenile stress had no significant effect on either the time spent in, or entries into, 



















































































A: Forced Swim Test
B: Elevated Plus Maze
 
Figure 5.12: Effect of 3 days restraint stress in juvenile mice, on behaviour once mice 
reached adulthood. Testing in the forced swim test (A) and elevated plus maze (B) 
occurred 5 weeks after restraint stress. (A) Time spent immobile and swimming were 
measured in the last 4 minutes of a 6 minute test. (B) Time in the open arms, number of 
open arm entries and total locomotion over the whole maze were assessed by beam 




5.3.6 Effect of variable stress on anxiety-related behaviours 
As unpredictable stressors are considered somewhat more stressful than predictable 
stressors (Anisman and Matheson, 2005), the behavioural effects of 3 days variable 
stress were determined in the EPM (Figure 5.13). The effects of variable stress on 
behaviour in the FST were not examined due to the confounding effects of prior swim 
stress in stressed animals. Future studies would investigate the effects of variable stress 
on sucrose preference. The differences between the BALB/c and C57BL/6 strains were 
also directly compared. 
In adult mice, there was a significant effect of strain on the time spent in the open arms 
(F(1,28)=8.23, P=0.008), number of open arm entries (F(1,27)=75.4, P<0.0001) and total 
locomotion (F(1,29)=231.5, P<0.0001). C57BL/6 mice were significantly more active than 
BALB/c mice, showing almost 1000% higher overall locomotion and 650% more open 
arm entries (P<0.001). Similarly, in juvenile mice, C57BL/6 mice exhibited 600% higher 
overall locomotion (F(1,30)=193.1, P<0.0001) and 600% more entries into the open arms 
(F(1,30)=36.6, P<0.0001) than BALB/c mice (Figure 5.13).  
In adult mice, variable stress had no effect on the time spent in the open arms (F(1,28)=1.1, 
P=0.3) or open arm entries (F(1,27)=3.2, P=0.09), although stress resulted in a significant 
75% increase in total locomotion in BALB/c mice (F(1,29)=5.7, P=0.02). Similarly, in 
juvenile mice, stress had no effect on time spent in the open arms (F(1,30)=2.1, P=0.16), 
although it did result in a significant 400% increase in open arm entries (F(1,30)=11.3, 















































































































































Figure 5.13: Effect of 3 days variable stress on behaviour in the EPM in adult (A) and 
juvenile (B) BALB/c and C57BL/6 mice. Testing in the EPM occurred the day after the 
last session of stress. Time in the open arms, number of open arm entries and total 
locomotion over the whole maze were measured in a 5 min test period. Results 




5.3.7 Correlation of behavioural outcomes with measures of HPA activation 
To assess whether mice who show increased HPA activity in response to stress are 
particularly susceptible to stress-induced changes in behaviour, behavioural outcomes 
in the FST, SPT and EPM were correlated with markers of HPA activation following 
stress. Pearson correlation coefficients were calculated between the HPA response 
(corticosterone levels immediately following stress, or adrenal gland weight, as 
described in chapter 4), and behavioural measures (either immobility in the FST, time 
spent in the open arms of the EPM, or sucrose preference) for each individual mouse. 
These were exploratory analyses to look for patterns in the data, and the power was 
limited due to the small sample size. 
In the FST, there was a significant negative correlation between time spent immobile and 
post-stress corticosterone levels following 3 days restraint in BALB/c adult mice (r= -
0.43, n=24, P=0.04) and C57BL/6 adult mice (r= -0.56, n=24, P=0.005). Conversely, a 
trend towards a significant positive correlation between immobility time in the FST and 
post-stress corticosterone levels was seen in BALB/c adult mice following 7 days 
restraint (r=0.53, n=14, P=0.05). No significant correlations were seen in BALB/c adult 
mice following 14 days restraint, or in juvenile mice at any timepoint following stress (-
0.3<r<0.2, n=15-16, P>0.2, Table 5.1). 
In the EPM, time spent in the open arms significantly correlated with post-stress 
corticosterone levels in adult BALB/c mice following 7 days restraint (r=0.59, n=16, 
P=0.02) and in C57BL/6 juvenile mice after 3 days restraint (r=0.62, n=16, P=0.01). 
There was a trend towards a positive correlation in C57BL/6 adult mice following 3 days 
restraint (r=0.40, n=22, P=0.07). No significant correlations were seen at any other 
timepoint following stress (-0.2<r<0.4, n=15-22, P>0.1, Table 5.1). 
The number of open arm entries in the EPM also correlated with post-stress 
corticosterone in juvenile BALB/c mice following 3 days restraint (r=0.55, n=15, P=0.04). 
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No significant correlations were seen at any other timepoint following stress (0.05<r<0.4, 
n=16-23, P>0.1, Table 5.1). 
In the SPT, there was a trend towards a significant negative correlation between 
preference for sucrose and post-stress corticosterone in BALB/c adult mice following 14 
days restraint (r= -0.48, n=16, P=0.06). There were no significant correlations seen at 
any other timepoint following stress (-0.5<r<-0.01, n=6-16, P>0.1, Table 5.1).  
Representative graphs showing an example of a positive correlation, negative correlation 
and no correlation are shown in Figure 5.14. 
 
Table 5.1: Pearson correlation of corticosterone levels immediately following stress, and 
behavioural outcomes in the EPM, FST and SPT, for adult and juvenile BALB/c and 
C57BL/6 mice undergoing 3, 7 or 14 days restraint stress. 0, no significant correlation; 













3 days (BALB/c adults) 0 0 Negative 0 
3 days (BALB/c juveniles) 0 Positive 0 0 
7 days (BALB/c adults) Positive 0 Trend to positive 0 
7 days (BALB/c juveniles) 0 0 0 0 
14 days (BALB/c adults) 0 0 0 Trend to positive 
14 days (BALB/c juveniles) - - - 0 
3 days (C57BL/6 adults) Trend to positive 0 Negative - 
3 days (C57BL/6 juveniles) Positive 0 0 - 
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Figure 5.14: Representative graphs showing an example of a negative correlation, a 
positive correlation and no correlation. (A) Negative correlation between time spent 
immobile in the FST and post-stress corticosterone levels following 3 days restraint in 
C57BL/6 adult mice (r= -0.56, n=24, P=0.005). (B) Positive correlation between time 
spent in the open arms and post-stress corticosterone levels in C57BL/6 juvenile mice 
after 3 days restraint (r=0.62, n=16, P=0.01). (C) No correlation between the number of 
open arm entries and post-stress corticosterone levels in C57BL/6 adult mice after 3 
days restraint (r=0.17, n=22, P=0.4). 
 
Similar Pearson correlations were calculated between adrenal gland weight and 
behavioural outcomes (Table 5.2). In the FST, there was a significant negative 
correlation between the time spent immobile and adrenal gland weight in juvenile BALB/c 
mice following 14 days restraint (r= -0.57, n=14, P=0.04). A trend towards a negative 
correlation was seen in adult BALB/c mice following 3 days restraint (r= -0.71, n=7, 
P=0.07). No significant correlations were seen in juvenile mice, or at any other timepoint 
following stress (-0.2<r<0.05, n=15-23, P>0.4). 
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In the SPT, a significant negative correlation was seen between sucrose preference and 
adrenal gland weight in juvenile mice following 14 days restraint (r= -0.69, n=16, 
P=0.003). No significant correlations were seen at any other timepoints following stress 
(-0.3<r<0.4, n=14-29, P>0.1, Table 5.2). 
In the EPM, there was a trend towards a significant correlation between adrenal gland 
weight and time spent in the open arms (r=0.45, n=18, P=0.06). There was also a trend 
towards a significant correlation between adrenal gland weight and number of open arm 
entries (r=0.50, n=15, P=0.06). No significant correlations were seen at any other 
timepoints following stress, between adrenal gland weight and either time spent in the 
open arms (0.2<r<0.6, n=7-15, P>0.1) or number of open arm entries (-0.1<r<0.5, n=7-
18, P>0.2, Table 5.2). 
Overall, while there are some behavioural outcomes in the FST, SPT and EPM which 
correlate with markers of HPA activation, there appears to be no consistent pattern as to 
which strain or age of mice, duration or type of stress, or which behavioural measure is 
significant. There seems to be a dissociation between neuroendocrine measures (which 
show a consistently increased HPA activation following stress), and behavioural 











Table 5.2: Correlation of adrenal gland weight following stress, and behavioural 
outcomes in the EPM, FST and SPT, for adult and juvenile BALB/c and C57BL/6 mice 
undergoing 3, 7 or 14 days restraint stress. 0, no significant correlation; positive, 
significant positive correlation; negative, significant negative correlation; -, no data. 
 Time spent 









3 days (BALB/c adults) 0 0 Trend to negative 0 
3 days (BALB/c juveniles) - - - 0 
7 days (BALB/c adults) - - - 0 
7 days (BALB/c juveniles) - - 0 0 
14 days (BALB/c adults) - - - 0 
14 days (BALB/c juveniles) 0 Trend to positive Negative Negative 
3 days (C57BL/6 adults) Trend to positive 0 0 - 




The behavioural changes seen in response to repeated restraint stress were complex. 
In the EPM, in juvenile mice, 3, 7 and 14 days of repeated restraint stress produced 
behavioural changes that included an increase in the number of open arm entries and/or 
time spent in the open arms, with and without changes in locomotor activity. This effect 
on locomotion in the EPM was only observed in adult mice following 7 days restraint, 
and no changes in the time spent in the open arms, or in the number of open arm entries 
were observed. Similar anxiolytic-like effects of repeated restraint stress were also 
evident in juvenile but not adult C57BL/6 mice after 3 days of exposure to the stressor. 
Interestingly, there was little effect of restraint stress on behaviours in the FST for BALB/c 
mice, where only the groups of adult mice with 3 days restraint stress, and juvenile mice 
with 14 days restraint stress, showed a decrease in time spent immobile, consistent with 
an antidepressant-like response. The same 3 day treatment in adult C57BL/6 mice also 
produced an antidepressant-like effect in the FST. In the SPT, a change in hedonic 
motivation was evident in both adult and juvenile BALB/c mice. Only after 14 days of 
repeated stress was a significant decrease in preference for sucrose observed, 
consistent with a pro-depressant phenotype. 
One interpretation of these data is that the repeated restraint stress leads to a 
behavioural response that is an adaptive biological process.  As a result of prior stress 
exposure, mice may adapt their behaviour as a stress-coping strategy. This behavioural 
change may be beneficial in future stress challenges. Thus, after repeated restraint 
stress, behaviour in the EPM manifests as an apparent anxiolytic-like response or 
behaviour in the FST manifests as an antidepressant-like response. Resilience in 
humans has been defined as the ability of an individual to avoid the negative effects of 
stress which may otherwise impact upon their mental or physical health (Russo et al., 
2012). It has been shown that exposure to stress, particularly during childhood and 
adolescence, promotes the development of resilience (Lyons et al., 2010, Southwick and 
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Charney, 2012). In animals, resilience has been defined as the ability to avoid 
detrimental changes in behaviour following chronic stress (Russo et al., 2012). 
Resilience may be either an active, adaptive response, resulting in antidepressant and 
anxiolytic-like changes in behaviour (Russo et al., 2012, Suo et al., 2013), or a more 
passive mechanism, manifesting in an absence of pathological changes following 
chronic stress (Russo et al., 2012). The results shown here may reflect a mixture of both 
active and passive mechanisms of resilience, as shown by both an increased exploration 
of the open arms of the EPM following restraint stress in some cohorts of mice, as well 
as an absence of depression- or anxiety-related behaviours in others. The predictable 
nature of the restraint stress protocol used here may make it comparatively less stressful 
than unpredictable stressors (Anisman and Matheson, 2005), also contributing to the 
development of resilience rather than an anxious or depressive phenotype.  
An alternative explanation for these data is that the increase in locomotor activity in the 
EPM may be an active response to stress, rather than a typical passive avoidance of the 
aversive open arms of the EPM. This could reflect an increase in a drive to escape the 
aversive environment (Mozhui et al., 2010). Increased locomotion in an open field has 
also been seen following restraint stress, and this stress-induced hyperlocomotion has 
been used as a marker of stress-responsivity in mice (Zimprich et al., 2014). An increase 
in mobility in the FST, and the similar tail suspension test, have also been reported 
following chronic stress, again suggesting an active defence mechanism in response to 
the aversive nature of the behavioural tests (Boulle et al., 2014). The increase in 
locomotion seen here in the EPM, and the reduction in immobility in the FST following 
stress, may be reflective of an active response to stress, rather than a reduction in 
depression and anxiety-related behaviours.  
The differing nature of the stress-induced behavioural changes in the SPT, compared 
with the FST and EPM, may reflect the differing nature of each behavioural test. Both 
the FST and EPM assess a behavioural response to a stressful environment (a forced 
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swim or the open arms of the EPM), which may be useful for assessing stress-induced 
behavioural changes in response to aversive environments. Conversely, the SPT 
measures preference for a palatable substance (sucrose), in a non-stressful environment 
(the home cage). As such it may be a more suitable measure of depression-related 
behaviour following chronic stress.  Importantly, in pilot studies pharmacological 
validation was conducted to assess the suitability of the FST and EPM for use in juvenile 
mice at the outset of this thesis. Acute administration of fluoxetine reduced the time spent 
immobile in the FST by juvenile but not adult mice (Figure 5.2). In the EPM, acute 
administration of diazepam increased the time spent in the open arms by adult mice but 
not juvenile animals, although total locomotion was increased in both age animals. A 
further complicating factor in interpreting these data is that the innate behaviour of 
juvenile mice in these tasks may be quite different from adult animals. 
A particular strength of these studies is that the collection of multiple data from the same 
animal allowed the correlation of behavioural data in the FST, SPT and EPM with 
measures of HPA activation. While there was no consistent pattern of significant 
correlations, where significance was seen this generally indicated that increased HPA 
activation (higher post-stress corticosterone or increased adrenal gland weight) was 
associated with increased anhedonia in the SPT, and increased activity in both the FST 
and EPM. This indicates that increased HPA activation may make individual mice more 
susceptible to stress-induced changes in behaviour.  
As unpredictable stress is considered more stressful than predictable stress (Anisman 
and Matheson, 2005), behavioural effects of a variable stress paradigm in the EPM were 
also examined. Similar to the data following repeated restraint stress, variable stress did 
not induce an anxious phenotype in the EPM, with no difference in the time spent in the 
open arms between stressed mice and controls. However, increases in locomotion were 
apparent in BALB/c mice following variable stress, and again this may be reflective of an 
active response to stress (Mozhui et al., 2010). In future studies it would be interesting 
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to investigate behaviour in the FST and SPT following a variable stress paradigm, to 
determine whether stress-induced behavioural changes can be observed in these 
assays. In this study we have compared the effects of restraint stress on two different 
strains of mice. There have been several studies looking at strain differences in stress 
responsiveness, with BALB/c mice considered to be more sensitive to the effects of 
stress than the more stress-resilient C57BL/6 strain (Anisman and Matheson, 2005, 
Jacobson and Cryan, 2007). Following 3 days restraint stress, hyperlocomotion was 
seen in the EPM in juvenile BALB/c mice, but not in C57BL/6 mice, reflecting increased 
sensitivity of BALB/c mice to stress. Similarly, increases in locomotor activity following 3 
days variable stress were apparent in both adult and juvenile BALB/c, but not C57BL/6 
mice, again reflecting the increased stress-sensitivity of the BALB/c strain. In the FST, 3 
days restraint stress resulted in antidepressant-like reductions in immobility in both 
BALB/c and C57BL/6 adult mice, and this appeared more pronounced in C57BL/6 mice 
(50% decrease from control) than in the BALB/c strain (20% decrease from control). 
Again, this suggests increased resilience in C57BL/6 mice, compared to the more stress-
sensitive BALB/c strain. 
BALB/c mice used throughout these studies were housed individually to avoid fighting. 
The less aggressive C57BL/6 mice were housed in groups for EPM and FST studies, 
while C57BL/6 mice undergoing the SPT were housed individually. While the effect of 
housing conditions in the present study is unknown, it has previously been shown that 
individual housing of male BALB/c and C57BL/6 mice had no effect on either 
corticosterone levels or anxiety-related behaviour (Arndt et al., 2009), suggesting the 
effect of housing conditions may be limited. Another confound could be the frequency of 
cage cleaning, with cages of group housed mice cleaned weekly, whereas individually 
housed mice were cleaned fortnightly. However, as all mice were handled daily to reduce 
stress of handling, this may minimise any differences. 
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In conclusion, repeated restraint stress appears to induce a range of behavioural 
changes in both juvenile and adult mice. In neither age group tested was there a 
consistent behavioural phenotype that could be described as obviously “depression-like”. 
However, a range of behavioural responses were observed that may represent an 
















6 Analysis of gene expression of HPA components in adult 





The HPA axis plays a central role in the endocrine response to stress (Chapter 1.2). The 
HPA axis matures during adolescence and is important for normal stress reactivity 
(Romeo et al., 2016, Gunnar et al., 2009). For examples, early stages of neonatal life 
are characterized by a stress-hyporesponsive period in rodents. At this stage stress 
induces limited secretion of glucocorticoids (Levine, 1994, Schmidt et al., 2003). This 
early postnatal hyporesponsive period, within the first week of life, is thought to have a 
protective function in limiting the impact of high circulating glucocorticoids in the brain 
and is mediated in part by corticosteroid binding globulins and in part by GR mediated 
feedback (Schmidt et al., 2005). Pre-adolescent rats and mice (25-30 days old) show 
plasma ACTH and corticosterone response that lasted twice as long as those observed 
in adults (Romeo et al., 2016). The adult-like ACTH stress response develops during the 
later stages of adolescence (50-60 days) while the corticosterone response changes 
earlier at 30-40 days of age (Foilb et al., 2011). It is clear that during adolescence the 
HPA stress response develops to an adult pattern, however, the molecular changes 
underlying the maturation of the HPA stress response are not well understood. 
The HPA stress response is also shaped by experience. Chronic stress has been 
reported to affect the functioning of the HPA axis. In humans, early life stressors, such 
as child abuse, can cause persistent changes and lead to HPA dysfunction (Heim et al., 
2000, Heim et al., 2008, Tyrka et al., 2008). This is one mechanism which may account 
for the association of early life stress with the risk of developing major depressive 
disorder (Claes, 2009).  In adult rats and mice exposed to repeated stress, the 
neuroendocrinological stress response habituates such that corticosterone responses 
are reduced (Grissom et al., 2007). In contrast, when juvenile animals are exposed to 
repeated restraint stress no habituation in their hormonal responses is observed (Lui et 
al., 2012, Romeo et al., 2016 and Chapter 4 of this thesis).  However, this habituation to 
stress may be dependent on the nature of the stressor.  Both adolescent and adult rats 
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have been shown to exhibit habituation to repeated episodes of social isolation (Hodges 
and McCormick, 2015). In this thesis, I have tested the hypothesis that changes in gene 
expression of components of the HPA axis underlie the differential response to stress 
observed in adult and juvenile animals. As this thesis principally investigates stress 
responses, gene expression analysis was targeted on components of HPA axis 
signalling rather than a genome wide microarray study. 
This chapter aimed to determine whether expression of key components of HPA 
regulation are altered in juvenile mice compared with adults. Baseline differences in 
expression of AVP, CRH, CRHR1, CRHR2, GR, MR and V1b were determined in the 
hypothalamus, hippocampus, PFC and pituitary gland of juvenile and adult mice. These 
brain areas were selected as they are regions that they hypothalamus projects to, and 
are implicated in mood disorders (Pandya et al., 2012). It has been shown that 
expression of GR is similar in the hippocampus of prepubertal and adult rats, and that 
expression of CRH is greater in prepubertal rats than in adults (Romeo, 2010), although 
little is known about gene expression of components of the HPA axis in juvenile mice. 
Further experiments investigated the effect of repeated restraint stress on expression of 






6.2.1 Dissection of brain regions 
Following either restraint or variable stress and behavioural testing, mice were killed by 
cervical dislocation and decapitated. To avoid the acute effects of behavioural testing on 
gene expression, mice were killed 24h post-testing for gene expression analysis. Brains 
were removed, and microdissection of the PFC was performed by making a coronal cut 
(freehand with a razor blade, with the aid of a mouse brain atlas (Paxinos and Franklin, 
2001) of the anterior portion of the brain. The entire hippocampus, hypothalamus and 
pituitary gland were also rapidly dissected. Brain tissues were placed immediately in 
tubes containing RNAlater® (Applied Biosystems) and kept on ice. Samples were stored 
at 4°C overnight, then RNAlater® was removed and samples were transferred to storage 
at -80°C until RNA extraction.  
 
6.2.2 RNA isolation and quantification 
RNA was extracted from brain tissue using TRIzol® (Invitrogen). 0.5ml TRIzol was added 
to the tissue sample which was homogenised with a pellet pestle (Sigma). A further 0.5ml 
TRIzol was added, and the homogenate passed through a 25G needle. 20µl glycogen 
(1mg/ml, Applied Biosystems) was added and the sample was left to stand at room 
temperature for 5 minutes. 200µl chloroform (Sigma) was added and samples were 
shaken vigorously by hand for 15s, left to stand for 2-3 minutes before centrifugation at 
12000 rcf for 15 minutes at 4°C. The upper aqueous phase was removed and retained. 
RNA was precipitated by the addition of 0.5ml 100% propan-2-ol (Sigma) and incubation 
for 30 minutes at room temperature. Samples were centrifuged at 12000 rcf for 10 
minutes, and the resulting pellets resuspended and washed in 1ml 75% ethanol (Sigma) 
before centrifugation at 7500 rcf for 5 minutes at 4°C. Pellets were air dried for 5-10 
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minutes, and re-suspended in 30µl RNase-free water (Applied Biosystems). Samples 
were then incubated at 55-60°C for 10 min. 
A DNase digest was then performed to remove genomic DNA contamination. 4µl DNase 
I (1U/µl, Fermentas) 4µl 10X reaction buffer for DNase I (Fermentas), 1µl RiboLock 
RNase inhibitor (40U/µl, Fermentas) and 1µl RNase free water were added to RNA 
samples which and incubated for 30 min at 37°C. RNA was then reprecipitated by the 
addition of 10µl glycogen (1mg/ml) and 100µl 100% ethanol, and incubation for 10 min 
at room temperature. Samples were centrifuged at 12000 rcf for 15 min at 4°C, and the 
resulting pellets were washed with 250µl 75% ethanol. Samples were then centrifuged 
at 12000 rcf at 4°C, and the pellets then left to air dry at 37°C for 15 min. Pellets were 
resuspended in 20µl RNase-free water before quantification. 
To determine the concentration of isolated RNA, samples were first diluted 1/25 into a 
total volume of 50µl RNase free water. Absorbance was then determined using a 
Biophotometer (Eppendorf) to measure absorbance at 260nm, where A260 =1 indicates 
a concentration of 40µg/ml. Purity of RNA samples was determined by measuring A260/280 
ratios, where A260/280  of greater than 1.8 indicates a pure RNA sample. 
 
6.2.3 One-step reverse transcription PCR 
SuperScript® One-Step RT-PCR System with Platinum® Taq DNA Polymerase 
(Invitrogen) was used to determine the expression of genes of interest in specific regions 
of mouse brain (hippocampus, PFC, hypothalamus and pituitary gland), using the gene-
specific primers outlined in Table 6.1.  Primers were either derived from published 
sequences, from Primer-BLAST (Basic Local Alignment Search Tool, (Ye et al., 2012)) 
or from PrimerBank (Spandidos et al., 2010). 12.5µl 2X Reaction Mix (containing 0.4mM 
of each dNTP, and 2.4mM MgSO4), 10.1µl RNase free water, 0.4µl RT/Taq mix, 0.5µl 
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forward primer (10µM), 0.5µl reverse primer (10µM) and 1µl template RNA (0.2µg/µl) 
were added to 0.2ml PCR tubes. A “no template” negative control was created by 
omitting the RNA from the reaction mixture, and replacing it with 1µl RNAse free water. 
The PCR tubes were placed in a PCR machine (MJ Research, PTC-200) under the 
following cycling conditions: 30 minutes at 50°C (cDNA synthesis), 2 minutes at 94°C 
(denaturation), 40 cycles of 15 seconds at 94°C (denaturation), 30 seconds at 60°C 
(annealing) and 30 seconds at 72°C (extension), followed by a final extension phase of 
5 minutes at 72°C. The PCR products were then run on a 2% agarose gel containing 
0.625µg/ml ethidium bromide (GeneChoice), and visualised using GeneSnap (SynGene) 
software. 
 
6.2.4 Real-time quantitative reverse transcription PCR (qPCR) 
6.2.4.1 Reverse Transcription 
In order to quantify the expression of genes of interest in mouse brain regions, RNA was 
first reverse transcribed to cDNA using the high capacity cDNA reverse transcription kit 
(Applied Biosystems).  2µl 10x RT Buffer, 0.8µl dNTP mix (100mM), 1µl Reverse 
Transcriptase (50U/µl), 2µl Random Primers, 1µl RNase inhibitor (10U/µl, Fermentas), 
and 250ng RNA were added to a PCR tube and made up to a total volume of 20µl with 
RNase free water. Tubes were incubated at 25°C for 5 min, 37°C for 2h, and 85°C for 5 
min in a PCR machine (MJ Research, PTC-200). The resulting cDNA (20µl containing 
250ng original RNA input) was diluted in RNase free water to a final volume of 450µl, 





For real-time quantitative reverse transcription PCR (qPCR), 9.2µl cDNA (containing 
5.1ng original RNA input) was added to a 96 well PCR plate (MicroAmp®, Applied 
Biosystems) along with 10µl SYBR green PCR master mix (Applied Biosystems), and 
0.4µl each of forward and reverse primers (10µM). Sequences of the primers used for 
qPCR are given in Table 6.1. A negative control was created by omitting the RNA from 
the reaction mixture. Aerosol barrier pipette tips were used to prevent cross-
contamination. The plate was sealed with adhesive film (MicroAmp®, Applied 
Biosystems), and placed in a real-time PCR machine (Applied Biosystems StepOne 
Plus) under the following cycling conditions: 95°C for 10 minutes, followed by 40 cycles 
of 95°C for 15 seconds and annealing temperature of 60°C for 1 minute, for all gene-
specific primers. This was followed by melt curve analysis to check the specificity of the 
primers and amplified PCR product. qPCR was performed in a 96 well plate format. The 
primary objective of this study was to identify differences between control and stressed 
groups in target gene expression. For logistical reasons it was not possible to include all 
genes of interest in all brain regions for both control and stressed groups on a single 96 
well plate, so gene expression in different brain areas were not directly compared. 
 
6.2.4.3 Comparative quantification cycle method (2-ΔΔCq) 
Differences in gene expression were quantified using the comparative quantification 
cycle method (2-ΔΔCq) (Schmittgen et al., 2000). The quantification cycle (Cq) of the gene 
of interest in each sample was first normalised to the Cq of the reference gene 
phosphoglycerate kinase 1 (PGK1) to obtain ΔCq. ΔCq values for the control group were 
averaged, and subtracted from individual ΔCq values for the stressed group to obtain 
ΔΔCq. This was then transformed to the equation 2-ΔΔCq to obtain the fold change from 
the control group.  
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6.2.4.4 Determining reference genes 
As expression levels of each gene of interest is normalised to a reference gene, it is 
important that the expression of any reference gene is stable across different 
experimental conditions (Bustin et al., 2009). Studies have shown that the expression of 
phosphoglycerate kinase 1 (PGK1) is stable throughout development of the mouse brain, 
and hence may be suitable for use as a reference gene in studies comparing gene 
expression in mice of different ages (Boda et al., 2009). The stability of three reference 
genes, 18S ribosomal RNA (18S), β-actin, and PGK1 in adult and juvenile mice, across 
different brain regions, was established at the outset of the qPCR experiments (See 
Table 6.1 for primer sequences). Stability of expression was determined using both 
GeNorm (Vandesompele et al., 2002) and NormFinder (Andersen et al., 2004) softwares.  
 
6.2.5 Statistical analysis 
All statistical analysis was performed using InVivoStat software Version 2.5.0.0 (Clark et 
al., 2012). Comparisons of gene expression in adult and juvenile naïve mice were 
analysed using unpaired t-tests. The effect of stress on gene expression was analysed 
using a 2-way ANOVA to determine differences in stressed vs. control mice, as well as 
adult vs. juvenile mice, for each gene of interest at each duration of stress. Least 
significant difference (LSD) test with Bonferonni’s correction for multiple comparisons 
was used for post-hoc comparisons. All sample sizes are indicated in the figure legends. 


























































































































Table 6.1: Gene specific forward (F) and reverse (R) primers used for both one step RT-
PCR and real-time RT-PCR. Primers were either derived from published sequences, 
from Primer-BLAST (Basic Local Alignment Search Tool, (Ye et al., 2012)) or from 





6.3.1 The expression profile of genes of interest in the mouse brain 
Reverse transcription PCR (RT-PCR) was used to determine the presence or absence 
of genes of interest (AVP, CRH, CRHR1, CRHR2, GR, MR and V1b) in the 
hypothalamus, hippocampus, pituitary gland and PFC of the mouse brain (Figure 6.1). 
Electrophoresis of RT-PCR products confirmed the presence of a single amplicon of the 









Figure 6.1: Expression of 18S, β-actin, AVP, CRH, CRHR1, CRHR2, GR, MR and V1b 
in the hippocampus (A), PFC (B), hypothalamus (C) and pituitary gland (D) of the adult 
BALB/c mouse brain. Further experiments confirmed expression of AVP in the 

























































































































































































6.3.2 Selection of a suitable reference gene for qPCR 
It is important that the expression of any reference gene used for qPCR is stable across 
different experimental conditions (Bustin et al., 2009). Initial experiments aimed to 
compare the stability of three reference genes, 18S ribosomal RNA (18S), β-actin, and 
PGK1 in adult and juvenile mice, across different brain regions. Using both GeNorm 
(Vandesompele et al., 2002) and NormFinder (Andersen et al., 2004) softwares. In all 
brain regions, expression of PGK1 was found to be more stable in adult and juvenile 
mice than either 18S or β-actin (Table 6.2). This is consistent with a previous study 
examining PGK1 gene expression during mouse brain development (Boda et al., 2009). 
Therefore PGK1 was used as the reference gene for all further qPCR experiments in this 
thesis.  
  
Rank Hypothalamus Pituitary Gland Hippocampus Prefrontal Cortex 
1st PGK1 PGK1 PGK1 PGK1 & β-actin 
2nd 18S β-actin β-actin 18S 
3rd β-actin 18S 18S  
 
Table 6.2: Expression of PGK1, 18S and β-actin, ranked according to the stability of 
expression in adult and juvenile mice, as determined by GeNorm (Vandesompele et al., 





In all qPCR experiments, the amplification curve allowed calculation of Cq in order to 
determine relative changes in gene expression. Figure 6.2 shows a representative 
amplification curve for a qPCR experiment using PGK1 and AVP primers in adult BALB/c 
mice. Melt curve analysis was also performed to confirm the amplification of a single 
product. This is important as SYBR green was used as the reporter fluorescence signal 
in these experiments and it binds to all double stranded DNA. Figure 6.3 shows 
representative melt curves for all primers, demonstrating specific amplification of the 
PCR product as shown by the presence of a single peak. 
 
 
Figure 6.2: Representative qPCR amplification curves using PGK1 and AVP primers in 
adult BALB/c mice. The quantification cycle (Cq) is the cycle number at which the 
amplification is exponential and is above a baseline signal (see dotted line) and relative 






















Figure 6.3: Representative melt curves for each primer used, indicating the specificity of 
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6.3.3 Differences in gene expression in juvenile and adult mice 
Initial experiments aimed to determine baseline differences in gene expression in 
juvenile and adult mice. Naïve mice were handled in the same way as experimental mice, 
and were killed on the equivalent of experimental day 0, when adult mice were 9-10 
weeks old and juvenile mice were 4-5 weeks old. mRNA expression of components of 
HPA signalling were determined in the hypothalamus, pituitary gland, hippocampus and 
PFC.  
In the hypothalamus, unpaired t-tests showed that AVP expression was significantly 
higher in juvenile mice than in adult mice (P<0.05). CRHR1 expression was significantly 
lower in juvenile mice than adult mice (P<0.01). There was no difference in expression 
























































































Figure 6.4: Comparison of the expression of AVP, CRH, CRHR1, CRHR2, MR and GR 
in the hypothalamus of naïve adult and juvenile BALB/c mice. Fold changes are relative 
to adult mice and normalised to the reference gene PGK1. Results expressed as mean 








In the pituitary gland, unpaired t-tests showed that there was no difference in expression 
of AVP, CRHR1, GR, MR or V1b between adult and juvenile mice (Figure 6.5). 

































































Figure 6.5: Comparison of the expression of AVP, CRHR1, MR, GR and V1b in the 
pituitary gland of naïve adult and juvenile BALB/c mice. Fold changes are relative to adult 






In the hippocampus, unpaired t-tests showed that CRH expression was significantly 
higher in juvenile mice than in adult mice (P<0.001). There was no significant difference 




















































































Figure 6.6: Comparison of the expression of AVP, CRH, CRHR1, CRHR2, MR and GR 
in the hippocampus of naïve adult and juvenile BALB/c mice. Fold changes are relative 
to adult mice and normalised to the reference gene PGK1.  Results expressed as 




In the PFC, unpaired t-tests showed that there was no significant difference in expression 

























































































Figure 6.7: Comparison of the expression of AVP, CRH, CRHR1, CRHR2, MR and GR 
in the prefrontal cortex of naïve adult and juvenile BALB/c mice. Fold changes are 
relative to adult mice and normalised to the reference gene PGK1. Results expressed 




6.3.4 Effects of stress on expression of HPA components 
To assess the effects of repeated restraint stress on gene expression of components of 
the HPA axis, mice were killed 2 days following either 3, 7 or 14 days restraint stress and 
gene expression in the hypothalamus and pituitary gland were determined. Due to time 
constraints the effects of stress on gene expression were not assessed in the PFC and 
hippocampus. 
In the hypothalamus, there was no significant effect of either 3, 7 or 14 days restraint 
stress on expression of AVP, CRH, CRHR1, GR, or MR (P>0.1, Figure 6.8). There was 
a significant effect of age on expression of GR (F(1,26)=12.2, P=0.002) and MR 
(F(1,26)=11.6, P=0.002) following 14 days restraint, with juvenile control mice showing 
significantly lower expression of both GR (P<0.01) and MR (P<0.05) than adult control 
mice. Following 7 days restraint, there was a significant effect of age on AVP (F(1,27)=4.3, 
P<0.05) and MR (F(1,27)=11.8, P=0.002) expression, with juvenile control mice having 
significantly lower expression of both AVP and MR than adult control mice (P<0.05). 
Following 3 days restraint, there was a trend towards a significant effect of age on 
expression of AVP (F(1,26)=3.0, P=0.09) and GR (F(1,26)=3.4, P=0.08), with expression of 
GR found to be significantly lower in juvenile control mice compared with adults (Figure 
6.8).      
In the pituitary gland, there was no effect of either stress or age on expression of AVP, 
CRHR1, GR, MR or V1b following 3 days restraint stress (P>0.1, Figure 6.9). Following 
7 days restraint, there was a significant effect of both stress (F(1,26)=6.95, P=0.01) and 
age (F(1,26)=31.2, P<0.0001) on expression of CRHR1. Juvenile control mice had 
significantly lower CRHR1 expression than adult control mice (P<0.01). 14 days restraint 
stress had a significant effect on GR expression (F(1,21)=5.3, P=0.03), although there 





































































































































































































Figure 6.8: Effect of 3, 7 or 14 days stress on expression of AVP, CRH, CRHR1, GR and 
MR in the hypothalamus of adult and juvenile BALB/c mice. Fold changes are relative to 
adult control mice and normalised to the reference gene PGK1. Results expressed as 




























































































































































































Figure 6.9: Effect of 3, 7 or 14 days stress on expression of AVP, V1b, CRHR1, GR and 
MR in the pituitary gland of adult and juvenile BALB/c mice. Fold changes are relative to 
adult control mice and normalised to the reference gene PGK1. Results expressed as 





The data presented in this chapter are based on qPCR experiments. There are a number 
of limitations associated with qPCR as set out in the “Minimum Information for publication 
of Quantitative real-time PCR experiments” (MIQE) guidelines (Bustin et al., 2009). 
Experimental variability can arise in the tissue sampling, handling, preparation and 
quality of RNA. In all experiments, control and stressed or adult and juvenile, tissues 
were collected in parallel, stored and RNA extracted in identical ways. For relative 
quantification protocols, the use of housekeeping or reference genes as internal controls 
is an important normalization strategy. Several reference gene mRNAs were 
investigated for stability of expression across juvenile and adult brains and across 
multiple brain regions. The widely used 18S ribosomal RNA (18S) and β-actin genes 
were compared with PGK1 for stability of expression across juvenile and adult brains 
and across multiple brain regions. In this data set PGK1 expression was found to be 
stable in adult and juvenile mice in the brain regions of interest. This is consistent with a 
previous study examining PGK1 gene expression during mouse brain development 
(Boda et al., 2009). Since SYBR green was used as the detection method it was also 
essential to confirm that each qPCR reaction yielded a single product of the correct 
amplicon size. This was confirmed using gel electrophoresis and melting curve analysis. 
In future studies it would be desirable to confirm the qPCR data at the protein level. 
The work in this chapter aimed, for the first time, to determine age-dependent differences 
in gene expression of components of the HPA axis between juvenile and adult BALB/c 
mice. Juvenile mice showed a 35% greater expression of AVP, and 30% lower 
expression of CRHR1 in the hypothalamus, and a 65% greater expression of CRH in the 
hippocampus, compared with adult mice. Altered sensitivity to secreted hormones of the 
hypothalamus and pituitary have been reported. For example, lower levels of applied 
ACTH in preadolescent male rats produced significantly higher corticosterone responses 
than in adults (Romeo et al., 2014). These authors did not investigate the mechanism 
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underlying this response. Here, a reduced expression of CRHR1 in juvenile animals 
could imply a reduced responsiveness to CRH and lower resulting corticosterone 
responses. However, while the baseline corticosterone response seen in juvenile 
animals is lower, the response to stress is actually increased (Chapter 4.3). Alternatively, 
the enhanced stress responsiveness seen in juvenile animals may be mediated by a 
greater expression of AVP. AVP only weakly stimulates ACTH release on its own, but 
acts synergistically with CRH to modulate ACTH release (Aguilera and Rabadan-Diehl, 
2000, Scott and Dinan, 2002). The actions of AVP, rather than CRH, have been 
suggested to contribute to the overactivity of the HPA axis during chronic stress (Aguilera 
and Rabadan-Diehl, 2000). This may also be true in naive juvenile animals compared 
with adults. 
Interestingly, differences in the expression of AVP and CRHR1 in the hypothalamus, 
seen between naïve juvenile and adult mice, were not apparent between control, non-
stressed adult and juvenile mice following the stress studies. Instead, there was lower 
expression of GR and MR in juvenile control mice compared with adults; differences not 
seen between naïve juvenile and adult mice. However, these two groups of animals are 
not directly comparable. The naïve juvenile mice studied here were bought in at 3-4 
weeks and used at 4-5 weeks. They were not handled daily and experienced no blood 
sampling or behavioural experiments prior to brain tissues being removed. The control 
juvenile mice on the other hand were 4-5 weeks old at the start of the experiment and 
were therefore older when brains were removed (depending on the duration of the 
repeated stress), all experienced plasma sampling, sucrose preference behavioural 
testing and daily weighing. Thus, the experience of these control mice is distinct from the 




Additionally, this thesis aimed to determine the effect of repeated restraint stress on gene 
expression of components of the HPA axis in both juvenile and adult BALB/c mice. No 
significant effects of either 3, 7 or 14 days repeated restraint stress were found on any 
of the genes examined. This suggests that our hypothesis that gene expression changes 
in the HPA signalling machinery might underlie the response to stress is not correct. One 
important component not included in these studies is ACTH and its receptor, the 
melanocortin 2 receptor. There is emerging data supporting a role for greater adrenal 
sensitivity to ACTH contributing to the increased corticosterone responses seen in pre-
adolescent animals (Romeo et al., 2016). In future studies changes in ACTH release in 
juvenile and adult mice exposed to repeated restraint stress could be monitored 
alongside adrenal responsiveness and melanocortin 2 receptor expression. 
In this thesis, I have focussed on gene expression of components of the HPA axis. 
However, it has been shown that other genes are involved in depression. Others have 
demonstrated higher levels of the 5HT1A receptor in mice bred to express more 
depressive-related behaviour (Kaufman et al., 2016), and noradrenaline transporter 
knockout mice show reduced depression-related behaviour in the FST (Xu et al., 2000, 
Czéh et al., 2016). In humans, there have been several genome-wide association studies 
investigating potential genes involved in depression. While there is evidence that various 
different genes are associated with depression, including the LHPP gene and the SIRT1 
gene (both involved in cellular metabolism), and the serotonin transporter, their potential 
function in depression is not yet known (Savitz and Drevets, 2009, Hyde et al., 2016, 















Direct comparisons of this study with other reports in the literature are difficult because 
of differences in restraint stress procedures. It is known that the effects of restraint 
depend on the duration, frequency and intensity of restraint (Buynitsky and Mostofsky, 
2009).  Acute restraint stress, a single application, is most commonly used in the 
literature with rats being studied more often than mice. In comparing restraint paradigms 
used in adolescent mice a variety of devices have been used, including a modified 50 ml 
syringe tube as used here (Kim and Han, 2006, Ota et al., 2015), a plastic restraint bag 
(Uzturk et al., 2015, Jacobson-Pick et al., 2011) or a wire mesh cage (Romeo et al., 
2013, Gong et al., 2015). How control animals are handled also varies across 
laboratories where non-stressed animals may not be handled at all (Jones et al., 1998) 
or perhaps removed to a novel environment (Ota et al., 2015). Here, the control non-
stressed animals were gently handled and weighed daily to ascertain that any 
behavioural or hormonal effects are due to the restraint stress itself, rather than the 
handling which is itself a potential stressor (Hurst and West, 2010). This may account for 
changes in control groups observed in some studies, particularly in the longer duration 
studies where mice will have been handled for up to 14 successive days. The duration 
of restraint stress also varies across reports in the literature with some mouse studies 
using single or repeated restraint stress sessions of 15 min (Jacobson-Pick et al., 2011), 
30 min (Romeo et al., 2013), 3h (Ota et al., 2015), 8h (Gong et al., 2015) or longer (Kim 
and Han, 2006). In this study, we used a 2h restraint which had previously been shown 
to produce a robust behavioural phenotype in C57BL/6 mice (Kim and Han, 2006). 
Furthermore, in our pilot studies, a 2h acute restraint stress evoked a significant 
corticosterone response. 
In the literature the timing of behavioural assessments following restraint also varies but 
behavioural tasks typically are conducted 30-60 minutes post restraint stress in a variety 
of paradigms. In this study, behaviour was evaluated in a variety of tests including the 
elevated plus maze, the forced swim test and the sucrose preference test 24-48 hours 
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post-restraint to assess whether there was lasting impact on the behaviour of the animal 
from the repeated restraint stress sessions. For example, it has been shown that acute 
restraint stress in mice does induce anxiety- and depression-related behaviours in the 
EPM and FST, when behaviour was assessed 20-40 minutes following stress (Freitas et 
al., 2014, Hsu et al., 2007). In this thesis (Figure 5.10), 24 h following an acute restraint 
stress, no significant changes in behaviour were seen in the FST, SPT or EPM. This may 
reflect different strains of mice being used, with Freitas et al. (2014) using Swiss mice, 
and Hsu et al. (2007) using NMRI mice, compared with the BALB/c mice used here. This 
timing of behavioural assessment is important in order to distinguish between the acute 
effects of restraint stress and the long-lasting chronic effects of restraint. This appears 
to be a novel feature of this experimental design and therefore comparable data in adult 
and juvenile mice are limited. Thus while this experimental design may preclude the 
observation of acute behavioural effects following a single restraint stress session 
(Figure 5.10), it does show that repeated restraint stress and long-lasting behavioural 
change underlie the adaptive responses seen here. 
In humans it has been shown that exposure to stress, particularly during childhood and 
adolescence, promotes the development of resilience (Lyons et al., 2010, Southwick and 
Charney, 2012). In addition, heightened responses to stress reactivity in adolescents, 
compared with adults, have been shown in both mice and humans (Pattwell et al., 2012). 
Here it is proposed that when juvenile mice are stressed and tested as juveniles, they 
respond with an adaptive behaviour that may represent a stress coping mechanism. 
When it was examined whether stress-induced effects in juvenile animals persisted into 
adulthood (Figure 5.12), there was an apparent increase in open arm entries into the 
EPM. These data is consistent with the idea that juvenile mice show a greater anxiolytic-
like response to stress than adult mice do which may persist into adulthood. This is 
consistent with previous reports that social crowding stress is anxiolytic in juvenile mice, 
but not in adults (Ago et al., 2014). Heightened responses to stress reactivity in 
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adolescents, compared with adults, have also been shown in both mice and humans 
(Pattwell et al., 2012). The juvenile mice used here were aged 4-6 weeks during 
exposure to stress and this period corresponds to adolescence in humans (Spear, 2000). 
It is known that brain areas such as the hippocampus, hypothalamus, PFC and 
amygdala, key regions involved in the stress response and regulation of emotion and 
behaviour, continue to develop throughout adolescence and into young adulthood 
(Spear, 2000). 
Together, these findings support the idea that adolescence may be a particularly 
sensitive period to the effects of stress exposure (Romeo, 2010, Spear, 2000, Eiland and 
Romeo, 2013); repeated exposure to a predictable stressor may promote resilience and 
adaptive stress coping behaviours. While this is contrary to the original aims of this 
thesis, to develop a model of adolescent depression, these studies do provide a potential 
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Adverse effects of chronic fluoxetine on seminal vesicles in 
BALB/c mice 
In preliminary experiments the effect of chronic fluoxetine was investigated. Adult and 
juvenile BALB/c mice were treated once daily with fluoxetine 20mg/kg i.p. for up to 28 
days. At the end of the experiment, terminal blood samples were collected and adrenal 
glands were dissected from all mice for analysis of hormone function. In all fluoxetine 
treated mice, but not saline treated animals, the seminal vesicles looked unusual and 
apparently fused or knotted into a single blob, rather than the more usual distinctive two 
separate curling structures (Figure A-1). 
No welfare issues were noted during the chronic treatment period, the fluoxetine treated 
animals appeared essentially normal. The starting weights of both adult and juvenile 
animals were the same in saline and fluoxetine treated groups (adult saline: 25.7g ± 1.0g; 
adult fluoxetine: 25.2g ± 0.5g; juvenile saline: 13.1g ± 0.8g; juvenile fluoxetine: 13.8g ± 
0.9g, mean ± S.D., n=8 per group). All animals gained weight during the experiment, 
were weighed regularly for correct dosing and were weighed at the end (adult saline: 
29.7g ± 1.2g; adult fluoxetine: 28.4g ± 1.0g; juvenile saline: 26.2g ± 1.0g; juvenile 
fluoxetine: 24.9g ± 1.0g, mean ± S.D., n=8 per group). The pH of the fluoxetine solution 
was approximately 6.5. Histopathological studies of the seminal vesicles revealed no 
pathological changes in the seminal vesicles associated with fluoxetine treatment, 
however there was some oedema noted in the surrounding fibrous tissue. This is not a 
well-described phenomenon in the literature, although one report (Bataineh and 
Daradka, 2007) has shown that fluoxetine caused seminal vesicle contraction and 






       
 
   
Appendix A-1: Images of seminal vesicles of BALB/c mice following 28 days i.p. 
treatment with either saline (A) or 20mg/kg fluoxetine (B,C,D). Arrows indicate the 
seminal vesicles. 
 
A: Saline B: Fluoxetine 
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Repeated daily restraint stress induces adaptive behavioural changes in
both adult and juvenile mice
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• Repeated daily restraint stress in mice induced a complex behavioural adaptation of anxiolytic-like and anhedonic responses
• Juvenile mice showed a wider range of behavioural responses following repeated daily restraint stress than adults
• Novel features of the methodology show behavioural changes result from lasting, not acute, effects of restraint stress
• Behavioural responses to repeated restraint stress were qualitatively similar in C57BL/6 and “stress-sensitive” BALB/c mice
• Adaptive behavioural changes seen may reflect resilience and be beneficial in future stress challenges
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Chronic stress is known to be a risk factor for the development of depression and anxiety, disorders which often
begin during adolescence. Restraint stress is a commonly used stressor in adult rodents, however the effects of
repeated restraint stress in juvenile mice have not been well characterised. Here we have shown for the first
time the behavioural and hormonal effects of repeated restraint stress in both adult and juvenile BALB/c and
C57BL/6 mice. Repeated daily restraint stress (2 h/day for 3, 7 or 14 days) provoked a robust physiological re-
sponse evident as increased corticosterone levels and decreased bodyweight after 14 days. However, habituation
of the stress-response was evident during repeated exposure to the stressor in both adult and juvenile mice. The
behavioural changes seen in response to repeated restraint stress were complex. In juvenile mice, repeated re-
straint stress evoked an increase in exploratory behaviours in the elevated plus maze, a decrease in time spent
immobile in the forced swim test and a decrease in sucrose preference. In adult mice fewer behavioural changes
were seen. Interestingly BALB/c and C57BL/6 mice showed qualitatively similar response to 3 days repeated re-
straint stress. The behavioural changes we observed, as a result of prior stress exposure, may represent an adap-
tive stress-coping response or resilience. Both the hormonal and behavioural effects of stress were more
pronounced in juvenile mice than in adults. This wider range of behavioural responses seen in juvenile mice
might reflect a greater ability to engage in adaptive stress-coping strategies that likely have beneficial effects ev-
ident in future stress challenges.







Chronic stress is known to be amajor risk factor for the development
of many psychiatric disorders, including depression [1–3]. During ado-
lescence, brain development and physical changes associated with pu-
berty are thought to make individuals particularly vulnerable to the
effects of stress [4–6]. There is also increasing evidence that the onset
of many psychiatric disorders occurs during adolescence, with up to
half of adult disorders having begun by the teenage years [7,8].
Changes in the function of the hypothalamic-pituitary-adrenal
(HPA) axis also occur during adolescence [9]. In humans, levels of
basal cortisol increase with age and pubertal development throughout
the adolescent years [9–11]. This pattern has also been shown in ro-
dents, with an increase in corticosterone from birth through to adult-
hood [12,13]. Changes in the reactivity of the HPA axis in response to
stress have also been reported during adolescence. For example, in-
creases in cortisol release in response to a social stress test have been
seen in adolescents over the age of 13 years, compared to those under
13 years old [9]. In rats, chronic restraint stress induces greater increases
in corticosterone release in juvenile animals compared with adults [14,
15]. These differences in stress-responsiveness between adolescents
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and adults may result in increased vulnerability to the effects of stress
during adolescence [13].
Restraint stress is a widely used model of stress in rodents, as it is
straightforward to administer, painless and does not cause physical
harm to the animals [16]. There have been several studies examining
the effects of repeated restraint stress on changes in depression and
anxiety-related behaviours. For example, in adult C57BL/6 and NMRI
mice, repeated restraint stress has been shown to increase depression
and anxiety-related behaviours, in the forced swim test, tail suspension
test and elevated plus maze [17–19]. These changes in behaviour have
been shown to persist for up to 3 months after the period of stress
[20]. In contrast, there are few reports of the behavioural effects of re-
straint stress in juvenile animals.
Adolescence is a period of vulnerability for the development of de-
pression. Here, we have examined whether repeated restraint stress in
juvenile mice induces a behavioural change consistent with an increase
in depression-related behaviour. Juvenilemice aged 4–6weeks are con-
sidered to model human adolescence, as at this age they undergo a
growth spurt, sexual maturation and developmental brain changes sim-
ilar to those seen in adolescent humans [5]. In this study, we have inves-
tigated the effects of different durations of repeated restraint stress in
both adult and juvenile BALB/cmice on depression- and anxiety-related
behaviours, coupled with an assessment of HPA function by measuring
corticosterone levels. Furthermore, in some studies we have compared
both the behavioural and neuroendocrinological effects of stress in
BALB/c mice, with those in C57BL/6 mice. It has previously been sug-
gested that BALB/c mice are more sensitive to the effects of stress than
the C57BL/6 strain which are relatively stress resilient [21,22].
2. Methods
2.1. Animals
Male BALB/cAnNCrlmice (Charles River UK) andmale C57BL/6mice
(University of Bath)were 9–10weeks old (adults) or 4–5weeks old (ju-
veniles) at the start of experiments. Mice were either individually
housed (BALB/c mice) or housed in groups of 3–4 (C57BL/6 mice) in
35 × 20 × 15 cm polysulfone cages (Plexx, Elst, The Netherlands) with
woodchip bedding (Datesand, Manchester, UK) and paper nesting ma-
terial (Lillico/LBS Biotechnology, Horley, UK). The mice were main-
tained in a temperature (21 ± 1 °C) and humidity (50–60%)
controlled environment, under a 12 h light/dark cycle (lights on
07:00 h), with food and water available ad libitum. All mice were accli-
matised to the animal facility for at least 4 days prior to the start of ex-
periments, during which time they were handled on at least two
occasions by gentle cupping [23]. Experiments were conducted during
the light phase, between 08:00–13:00 h, with the exception of the su-
crose preference test which occurred during the dark phase. All proce-
dures were carried out under a Home Office project licence held in
accordance with the Animals (Scientific Procedures) Act 1986.
2.2. Restraint stress
Stressed mice were placed head first into a modified 50 ml syringe
with ventilation holes, which was plugged with the syringe plunger
and adjusted so that mice were unable to move forwards or backwards.
Mice were restrained for 2 h each day, for either 3, 7 or 14 consecutive
days. Stressedmice were weighed daily, and monitored for signs of dis-
tress using a scoring system adapted from Lloyd and Wolfensohn [24]
(Supplementary Fig. 1). Non-stressed control mice were weighed
daily, but otherwise remained in their home cage.
2.3. Behavioural testing
Behavioural testing in the elevated plus maze and forced swim test
occurred in a dimly lit room adjacent to the animal holding room.
Mice were left to acclimatise in the behavioural room for at least 1 h
prior to testing. Testing in the elevated plus maze, forced swim test
and sucrose preference test occurred one day following 3 days restraint,
or two days following 7 or 14 days restraint. Separate groups of mice
were used for each behavioural test. A diagram outlining the restraint
stress protocol is shown in Fig. 1.
2.4. Forced swim test (FST)
Mice were placed in a glass beaker (diameter 22 cm, height 34 cm),
filled to a depth of 23 cmwithwater (25 °C). Each 6min test sessionwas
filmed and behaviour in the last 4 min of the test was scored by an ex-
perimenter blind to treatment. Swimming was defined as horizontal
movement, and immobility defined as the minimal activity needed to
stay afloat. Following the test session, mice were dried with paper
towels and placed in a warm holding cage, before being returned to
the home cage. The water was replaced, and the beaker cleaned with
70% ethanol, between each mouse.
2.5. Sucrose preference test (SPT)
On the last day of restraint, micewere habituated to drinking from 2
bottles of water, for 12 h (19:00–07:00 h). The following day,micewere
given the choice to drink either water or 5%w/v sucrose (BALB/c mice),
or water and 2.5% w/v sucrose (C57BL/6 mice) during a 12 h test
(19:00–07:00 h). Inbredmouse strains are known to have differing sen-
sitivities to sucrose [25], so the concentration of sucrose required to pro-
duce preference was determined in preliminary experiments
(Supplementary Fig. 4). Bottles were weighed before and after the
test, and the preference for sucrose was determined as a percentage of
the total volume consumed. Total volume consumed was also
determined.
2.6. Elevated plus maze (EPM)
The elevated plus maze (Campden Instruments) consisted of four
arms (38 × 5 cm), arranged at right angles around a central intersection
(5 × 5 cm). Two of the arms were open, with a 0.5 cm rim, while the
other twowere enclosedwith 15 cmhighwalls. The entiremazewas el-
evated 65 cmoff the floor. Lighting on the open armsmeasured 20 lx for
experimentswith BALB/cmice, and 50 lx for experiments usingC57BL/6
mice. Mice were placed in the central intersection facing an open arm
and allowed to freely explore the maze for 5 min. Time spent in, and
number of entries into the open arms, and total locomotion over the
wholemaze, were recorded byMotorMonitor™ software using infrared
photobeams. Themazewas cleanedwith 70% ethanol after eachmouse.
2.7. Assessment of neuroendocrinological function
Blood sampleswere taken from allmice at baseline and immediately
following the last restraint stress. 40 μl sampleswere taken from the lat-
eral tail vein [26] and collected in heparinised capillary tubes
(Hawksley, Sussex, UK). Blood was transferred to micro-centrifuge
tubes containing EDTA (final concentration in sample 3 μg/μl) and
kept on ice until being centrifuged at 2000 rcf for 20min at 4 °C. Plasma
was removed and stored at−20 °C until analysis. The concentration of
corticosterone in plasma was determined using an ELISA (IBL Interna-
tional, Hamburg, Germany). All blood samples were taken between
11:00–13:00 h. To assess the effect of repeated restraint stress on adre-
nal glandweight, micewere killed by cervical dislocation two days after
the last session of restraint, and adrenal glands were removed and
weighed. Function of negative feedback inhibition of the HPA axis was
determined using the dexamethasone suppression test (DST), which
has been used extensively to indicate abnormalities in negative feed-
back of theHPA axis in depressed patients [27]. A baseline blood sample
was taken between 3 and 4 pm, on the day after the last session of
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restraint. The DST occurred 2 days after stress, when mice were admin-
istered 0.1 mg/kg dexamethasone (dexamethasone 21-phosphate
disodium, (Alfa Aesar), 10 ml/kg, i.p., dissolved in 0.9% w/v saline) be-
tween 9 and 10 am, and had a blood sample taken 6 h later to determine
corticosterone-induced suppression of corticosterone release. Blood
samples were processed and corticosterone levels in plasma deter-
mined as described above.
2.8. Statistical analysis
All statistical analysis was performed using InVivoStat software Ver-
sion 2.5.0.0 [28]. Elevated plus maze and forced swim test data were
analysed using unpaired t-tests to compare the effects of stress with
non-stressed control mice. Adrenal gland weights in BALB/c mice
were analysed by a two-way ANOVAwith post hoc least significant dif-
ference (LSD) test for planned pairwise comparisons followed by
Bonferroni's correction for multiple comparisons (Fig. 3). Adrenal
gland data in C57BL/6 mice were analysed using unpaired t-tests to
compare the effects of stress with non-stressed control mice because
of a different experimental design (Fig. 8). Sucrose preference tests
were analysed using two-way ANOVA, with age and stress as factors.
LSD test with Bonferonni's correction for multiple comparisons was
used for post-hoc comparisons. Corticosterone and DST data were
analysed using repeated measures mixed model analysis followed by
pairwise comparisons [28], with Bonferonni's correction for multiple
comparisons. The relationship between corticosterone and adrenal
gland weight was determined using a Pearson's correlation. For statisti-
cal analysis, all corticosterone data, and themajority of behavioural data
were log10 transformed to stabilise the variance. All data is presented as
mean ± SEM, and significance was taken as p b 0.05.
3. Results
3.1. Effects of repeated restraint stress on neuroendocrinological measures
To determine HPA activation in response to restraint stress, blood
samples were taken at baseline and following 3, 7 or 14 days restraint,
and plasma levels of corticosterone were determined (Fig. 2). At all
timepoints, blood samples were also taken from non-stressed control
mice for comparison. There were no differences between control and
stressed groups in baseline plasma corticosterone measures. After
3 days restraint stress, there was a significant effect of stress on plasma
corticosterone in both adult (F(1,29) = 49.75, p b 0.001) and juvenile
BALB/c mice (F(1,27) = 35.76, p b 0.001), with stress resulting in a
710% increase in corticosterone over baseline in adults, and a 2000% in-
crease in juveniles (p b 0.001). Similarly, therewas a significant effect of
7 days restraint on corticosterone in both adults (F(1,28) = 18.17,
p b 0.001) and juveniles (F(1,30) = 13.9, p b 0.001). In a separate group
of animals the sequential effects of 7, 10 and 14 days repeated restraint
on HPA function was examined in adults (Fig. 2E). For juvenile animals
only the effects of 7 and 14 days repeated restraint were compared be-
cause of limitations with blood volumes (Fig. 2F). A significant increase
in plasma corticosterone was evident at 14 days in both adult (F(1,29) =
69.86, p b 0.001) and juvenilemice (F(1,14) = 10.49, p b 0.01), compared
to handled, non-stressed control mice. However, at 14 days, there was
no significant difference in corticosterone responses in adult stressed
micemeasured at baseline (pre-stress) and after 14 days of repeated re-
straint stress, and the corticosterone response appeared attenuated
compared with 7 days restraint. The elevation in corticosterone levels
in stressed mice did not persist 24 h post-restraint in either adult or ju-
venile animals.















































































































Fig. 1. Experimental design formice undergoing either 3, 7 or 14 days restraint stress. CORT, blood taken for corticosterone analysis; DST, dexamethasone suppression test; EPM, elevated
plus maze; FST, forced swim test; SPT, sucrose preference test.
315A.M. Sadler, S.J. Bailey / Physiology & Behavior 167 (2016) 313–323
Adrenal glandweight, corrected for bodyweight, also demonstrated
that the restraint stress procedure impacted on the HPA axis (Fig. 3).
Following 3 days restraint stress, therewas a trend towards a significant
effect of stress (F(1,25) = 3.65, p b 0.07), and a significant effect of age
(F(1,25) = 12.23, p b 0.01) on adrenal gland weight. Stress resulted in a
3% increase in adrenal gland weight in adult mice, and a 10% increase
in juvenile mice compared with control, although this was not statisti-
cally significant. Extending the duration of the restraint stress to
7 days revealed a significant effect of stress (F(1,26) = 8.66, p b 0.01)
and age (F(1,26) = 19.72, p b 0.001) on adrenal gland weight. There
was an 8% increase in adrenal gland weight in adult mice (p = 0.2),
and a 9% increase in juvenile mice (p = 0.08), compared with non-
stressed controls. Juvenile controlmicehad significantly heavier adrenal
glands than adult control mice (p b 0.05). After 14 days restraint, there
was a significant effect of stress (F(1,25) = 8.55, p b 0.01) and age
(F(1,25) = 23.93, p b 0.0001) on adrenal gland weight. While there was
an increase in adrenal gland weight in both stressed adults (9% above
control, p = 0.2) and juveniles (8% above control, p = 0.1), this was
not significant following correction for multiple comparisons. Juvenile
control mice had significantly heavier adrenal glands than adult control
mice (p b 0.01).
A Pearson correlation coefficient was calculated to determine
whether there was a relationship between corticosterone levels imme-
diately following stress, and adrenal gland weight. There was a positive
correlation between corticosterone and adrenal gland weight in both
adult (r = 0.44, n = 49, p b 0.005) and juvenile (r = 0.50, n = 46,
p b 0.001) mice (Supplementary Fig. 2).
Finally, body weight was recorded daily to assess the effects of re-
peated stress. At the start of the experiment the mean body weight for
adult mice (9–10 weeks) was 26.0 ± 0.5 g (control) and 26.8 ± 0.5 g
(stressed), and for juvenilemice (4–5weeks)was 16.2±0.8 g (control)
and 17.4 ± 0.8 g (stressed). Fig. 4 shows the change in body weight,
expressed as a percentage of starting body weight, during 14 days re-
peated restraint stress. In adult mice, there was a significant effect of
stress on bodyweight (F(1,14) = 36.07, p b 0.001), with stressed mice
having up to 8% lower bodyweight than controls (p b 0.01). Similarly,
in juveniles there was a significant effect of stress on bodyweight
(F(1,14) = 8.92, p b 0.01), with stressed mice having up to 12% lower
bodyweight than non-stressed control mice (p b 0.01). Shorter duration
restraint stress had no significant effect on body weight, with adult
stressed mice showing a 3% reduction, and juvenile mice showing a 5–




Fig. 2. Effect of 3, 7 or 14 days restraint stress on plasma corticosterone in (A) adult and (B) juvenile BALB/c mice. Blood samples are taken at baseline, immediately following 3, 7 and
14 days restraint, and 24 h following the last session of restraint. All blood samples taken during the light phase 11:00–13:00 h. Results are expressed as mean ± SEM, n = 4–16/
group. *p b 0.05, **p b 0.01, ***p b 0.001 (repeated measures mixed model analysis).
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3.2. Effects of repeated restraint stress on depression-related behaviours
Adult and juvenile BALB/c mice experienced daily restraint stress
(2 h per day) for either 3, 7 or 14 days. To investigate the effects of re-
peated stress, rather than acute effects of restraint stress, behaviour in
the FST was assessed 24–48 h following the last restraint (Fig. 5). A sig-
nificant effect of restraint stresswas only observed in adult mice follow-
ing 3 days of restraint stress. This resulted in a 17% decrease in the time
spent immobile, and a 35% increase in the time spent swimming in the
FST (p b 0.05, t-test). Extending the restraint stress for 7 or 14 days in
adult mice had no significant effect on either the time spent swimming
or immobile (all p's N 0.3). In juvenile mice, behaviours in the FST were
not affected by 3 or 7 days of restraint stress (all p's N 0.6). Conversely,
increasing the duration of restraint to 14 days resulted in a significant
27% decrease in the time spent immobile, and 37% increase in the
time spent swimming in the FST (p b 0.05, t-test). To determinewhether
there was any persistent effect of restraint stress into adulthood,
juvenile mice who underwent 3 days restraint stress were re-tested in
the FST as adults, aged 9–10 weeks old. No significant difference be-
tween stressed and control mice was found in either the time spent im-
mobile, or swimming, in the FST (both p's = 0.6, Supplementary Fig.
3A).
The effect of 3, 7 and 14 days restraint stress in BALB/cmicewas also
assessed in the SPT (Fig. 6). In preliminary experiments, 2.5% sucrose
was not sufficient to induce a preference in BALB/c mice whereas a 5%
sucrose solution provoked a robust sucrose preference in BALB/c mice
(Supplementary Fig. 4). Interestingly, 2.5% sucrose was sufficient to in-
duce a clear preference in both control and stressed C57BL/6 mice
(Fig. 10B) reflecting the different sensitivities of inbred mouse strains
for sucrose [25]. The effect of both stress and age on sucrose preference
was determined for each duration of stress using a two-way ANOVA,
with age and stress as factors. There was a significant main effect of
stress in 3 days restraint stressed mice (F(1,25) = 4.58, p b 0.05). While
this was associated with a 10% decrease in sucrose preference in both
adult and juvenile stressed mice compared with control, this was not
statistically significant following pairwise comparisons (p = 0.2).
There was no significant difference in total consumption of both water
and sucrose between stressed and control mice in either adults or juve-
niles following 3 days restraint (p's N 0.1). Following 7 days stress, there
was a significant effect of stress (F(1,27) = 7.29, p b 0.05), age (F(1,27) =
7.91, p b 0.01) and age*stress interaction (F(1,27) = 5.35, p b 0.05) on su-




Fig. 3. Effect of 3, 7 or 14 days restraint stress on adrenal glandweight of adult and juvenile
BALB/cmice. Adrenal glandswere removed andweighed 2 days after restraint. Results are
expressed as mean ± SEM, n = 7–8/group. *p b 0.05, **p b 0.01 (2-way ANOVA).
B
A
Fig. 4. Effect of 14 days restraint stress on daily bodyweight of adult and juvenile BALB/c
mice. Results are expressed as mean ± SEM, n = 8/group. *p b 0.05, **p b 0.01
(repeated measures mixed model analysis).
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preference in stressedmice comparedwith controls (p b 0.01), although
the controls in this experiment showed nopreference for sucrose so this
apparent increase may be anomalous. This could have arisen because
we used a “threshold” sucrose concentration of 5% which induces pref-
erence in all other control animals, but not in this group of animals.
There was no effect of 7 days stress on sucrose preference in juvenile
mice. There was no effect of 7 days restraint on total consumption
(F(1,27) = 0.75, p = 0.4). 14 days restraint resulted in a 12% reduction
in sucrose preference in adult mice, and a 16% reduction in juveniles
(F(1,26) = 16.59, p b 0.001). This was accompanied by a significant de-
crease in consumption in juvenile, but not adult, stressed mice com-
pared with controls (p b 0.05).
Repeated restraint stress therefore provoked an apparent antide-
pressant-like effect on behaviours in the FST after 3 days restraint stress
in adults or 14 days restraint stress in juveniles. However, in the SPT, the
behavioural response to repeated stress manifested as a significant de-
crease in preference for sucrose in juveniles, and a trend towards a sig-
nificant decrease in adults, suggestive of an anhedonic or pro-
depressant response to 14 days restraint stress.
3.3. Effects of repeated restraint stress on anxiety-related behaviours
Separate groups of BALB/c mice underwent a similar restraint stress
protocol and behaviourwas evaluated in the EPM24–48h following the
last restraint session (Fig. 7). In adult mice, only 7 days restraint stress
resulted in a significant change in behaviour, evident as a 130% increase
in the time spent in the open arms in stressed mice compared with
control (p b 0.05, t-test). Importantly, there was no change in total loco-
motion in these mice indicating that this was an apparent anxiolytic-
like response. However, in juvenile mice, the duration of restraint stress
showed a mixed pattern of behavioural changes. After 3 days repeated
restraint there was no change in the time spent in the open arms but
a 200% increase in the number of open arm entries (p b 0.01, t-test)
was evident, associated with a 160% increase in locomotor activity
(p b 0.001, t-test). 7 days restraint resulted in a 220% increase in the
time in the open arms (p b 0.05, t-test), and a 170% increase in the num-
ber of open arm entries (p b 0.01, t-test) without a change in locomotor
activity. Following 14 days restraint a significant 71% increase in loco-
motor activity was evident (p b 0.01, t-test), although there was no
change in either the time spent in, or entries into, the open arms of
the EPM (both p's N 0.1, Fig. 7). To determine whether 3 days restraint
stress in juvenilemicewouldmanifest as a behavioural change in adult-
hood, juvenilemicewhounderwent 3 days restraint stresswere re-test-
ed in the EPM as adults, aged 9–10 weeks old (Supplementary Fig. 3).
There was no significant difference between stressed and control mice
in the time spent in, or the number of entries into the open arms, or
total locomotion in the EPM (all p's N 0.1, t-test). There was an apparent
increase in open arm entries in the EPM, suggestive that the anxiolytic-
like response seen as juvenile mice may persist into adulthood.
To compare the behavioural effects of repeated restraint stress with
a single application of restraint, adult and juvenile mice were tested in
either the FST, SPT or EPM the day after one2 h session of restraint (Sup-
plementary Fig. 5). There was no significant effect of acute stress on the




Fig. 5. Effect of 3, 7 or 14 days restraint stress on behaviour in the FST in adult and juvenile BALB/c mice. Time spent swimming and immobile were recorded in the last 4min of a 6minute
test. Results are expressed as mean ± SEM, n = 7–12/group. *p b 0.05 compared to control (unpaired t-tests).
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sucrose preference (p = 0.5), or on the time spent in the open arms,
number of open arm entries, or total locomotion in the EPM (all
p's N 0.2).
3.4. Effects of repeated restraint stress in C57BL/6 mice
The BALB/c mouse strain has been reported to be relatively stress
sensitive whereas the C57BL/6 strain is relatively stress resilient [22].
Therefore we compared the behavioural and neuroendocrinological ef-
fects of 3 days restraint stress in C57BL/6 adult and juvenile mice with
BALB/c mice. In both adult and juvenile C57BL/6 mice, 3 days restraint
stress was associated a 4% decrease in body weight (Adults: F(1,12) =
15.63, p = 0,002; Juveniles: F(1,14) = 1.97, p = 0.18). As with BALB/c
mice, there was a significant effect of stress on corticosterone in both
adult (F(1,27) = 109.79, p b 0.001) and juvenile (F(1,29) = 190.51,
p b 0.001) C57BL/6 mice (Fig. 8). 3 days restraint stress resulted in a
220% increase in corticosterone over baseline in adult mice, and a
310% increase in juvenile mice (p b 0.001). This was accompanied by a
9% increase in adrenal glandweight in stressed adultmice, and a 12% in-
crease in juvenile stressed mice, compared with non-stressed controls
(p b 0.01).
While qualitatively similar, the corticosterone response in stressed
BALB/c mice showed a bigger % increase compared to baseline than
that seen in C57BL/6 mice. To determine whether repeated restraint
stress differentially affected negative feedback of the HPA axis in these
two strains, we used thedexamethasone suppression test (Fig. 9). Dexa-
methasone significantly suppressed corticosterone release, compared
with baseline, in both adult and juvenile BALB/c (F(1,28) = 105.1,
p b 0.001) and C57BL/6 mice (F(1,28) = 64.7, p b 0.001). Stress had no
significant effect on dexamethasone-induced suppression of corticoste-
rone release in either strain (both p's N 0.1).
The behavioural effects of 3 days daily repeated restraint stress in
C57BL/6 mice were qualitatively similar to those seen in BALB/c mice.
In the FST behavioural changes were observed in adult, but not juvenile,
C57BL/6mice evident as a 50% decrease in the time spent immobile, and
a 65% increase in the time spent swimming, after 3 days of restraint
stress (p b 0.01, Fig. 10). In the SPT, a two-way ANOVA revealed a signif-
icant effect of age (F(1,26)= 4.35, p b 0.05) on sucrose preference, but no
significant effect of restraint stress (F(1,26) = 2.79, p = 0.1) or
stress ∗ age interaction (F(1,26) = 1.58, p = 0.2). Interestingly, there
was also a significant effect of age (F(1,26) = 41.9, p b 0.0001) and stress
(F(1,26) = 7.08. p = 0.01) on total sucrose consumption. Juvenile mice
drank significantly more than adult mice for both stressed and control
animals (p b 0.001). In the EPM, in juvenilemice restraint stress resulted
in a 100% increase in the time spent in the open arms (p b 0.01), without
a change in total locomotion, consistent with an anxiolytic-like effect.
Similarly, in adult mice, there was a 45% increase in time spent in the
open arms following 3 days restraint, which had a trend towards statis-
tical significance (p = 0.07, Fig. 10).
4. Discussion
We have shown for the first time the behavioural and hormonal ef-
fects of repeated restraint stress in both adult and juvenile BALB/c mice
and C57BL/6 mice. Repeated restraint stress of different durations (3, 7
and 14 days) provoked a robust physiological response in BALB/c mice.
Plasma cortisol levels increased and body weight decreased in stressed,
compared to control non-stressed, adult and juvenile mice. Interesting-
ly, adrenal glandweight, expressed as a percentage of bodyweight, was
higher in juvenile mice than in adult mice, and showed a trend to in-
crease in stressed, compared to control, adult and juvenile mice. In-




Fig. 6. Effect of 3, 7 or 14 days restraint stress on sucrose preference in adult and juvenile BALB/cmice. Preference for 5% sucrose solution, and total consumption of both sucrose andwater
were measured over a 12 h test period (7 pm–7 am). Dotted line represents position of no preference. Results are expressed as mean± SEM, n=6–8/group. **p b 0.01 (2-way ANOVA).
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greater in juvenile mice than in adults, in both strains of mice studied,
suggestive of the increased sensitivity of the HPA axis seen in juvenile
animals [29,30]. Previous studies have observed that restraint stress in
mice induced increases in corticosterone levels similar to those found
in the present study. For example, Romeo et al. showed a significant in-
crease in corticosterone levels, in trunk blood samples from both 30 day
old and adult BALB/c and C57BL/6 mice, immediately following a single
exposure (30 min) to restraint stress [31]. Corticosterone levels report-
ed were much higher (~700–1200 ng/ml) than the values we obtained
following 3 days repeated restraint stress in blood samples collected via
the tail nick method [26]. Romeo et al. also showed that restraint stress
in juvenile BALB/c mice induced a higher corticosterone response than
in adults [31]. However, our data shows a clear attenuation of the corti-
costerone response in both adult and juvenile BALB/cmicewith increas-
ing duration of restraint stress. Corticosterone was no longer
significantly increased above baseline in adult mice following 14 days
restraint, indicating habituation to the stressor. This is consistent with
previous reports in rats showing that the HPA axis is less responsive
to repeated restraint stress following either 8 or 14 days restraint, com-
pared to an acute exposure to the stressor [32,33].
The behavioural changes seen in response to repeated restraint
stresswere complex. In the EPM, in juvenilemice, 3, 7 and 14 days of re-
peated restraint stress produced behavioural changes that included an
increase in the number of open arm entries and/or time spent in the
open arms, with and without changes in locomotor activity. This effect
on exploratory behaviour in the EPM was not observed in adult mice.
Similar anxiolytic-like effects of repeated restraint stress were also evi-
dent in juvenile but not adult C57BL/6 mice after 3 days of exposure to
the stressor. Interestingly, there was little effect of restraint stress on
behaviours in the FST for BALB/c mice, where only the groups of adult
mice with 3 days restraint stress, and juvenile mice with 14 days re-
straint stress, showed a decrease in time spent immobile, consistent
with an antidepressant-like response. The same 3 day treatment in
adult C57BL/6 mice also produced an antidepressant-like effect in the
FST. In the SPT, a change in hedonic motivation was evident in both
adult and juvenile BALB/c mice. Only after 14 days of repeated stress
was a significant decrease in preference for sucrose observed, consistent
with a pro-depressant phenotype. The differing nature of the stress-in-
duced behavioural changes in the SPT, compared with the FST and EPM,
likely reflects the nature of each test. Both the FST and EPM assess a be-
havioural response to a stressful environment, whereas the SPT mea-
sures preference for a palatable substance in the home cage, a non-
stressful environment.
One interpretation of these data is that the repeated restraint stress
leads to a behavioural response that is an adaptive biological process. As
a result of prior stress exposure, mice may adapt their behaviour as a
stress-coping strategy. This behavioural change may be beneficial in fu-
ture stress challenges. Thus, after repeated restraint stress, behaviour in
the EPMmanifests as an apparent anxiolytic-like response or behaviour
in the FST manifests as an antidepressant-like response. Resilience has
been suggested to be either an active, adaptive response, resulting in an-
tidepressant and anxiolytic-like changes in behaviour [34,35], or amore
passive mechanism, manifesting in an absence of pathological changes
following chronic stress [34]. The results shown heremay reflect a mix-
ture of both active and passive mechanisms of resilience, as shown by
both an increased exploration of the open arms of the EPM following re-
straint stress in some cohorts of mice, as well as an absence of depres-






Fig. 7. Effect of 3, 7 or 14 days restraint stress on behaviour in the EPM in adult and juvenile BALB/c mice. Time spent in the open arms, number of entries into the open arms and total
locomotion over the whole maze were assessed by beam breaks in a 5 minute test period. Results are expressed as mean ± SEM, n = 7–12/group. *p b 0.05, **p b 0.01, ***p b 0.001
(unpaired t-tests).
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of the restraint stress protocol used heremaymake it comparatively less
stressful than unpredictable stressors [36]. This in turn could also con-
tribute to the development of resilience rather than an anxious or de-
pressive phenotype and may make this paradigm a useful approach to
studying the molecular mechanism underlying resilience.
In consideringwhether the behavioural changes are an active or pas-
sive adaptation to stress, the increase in locomotor activity in the EPM
may be an important factor. Rather than a typical passive avoidance of
the aversive open arms of the EPM, increased locomotor activitymay re-
flect an increase in a drive to escape the aversive environment [37]. In-
creased locomotion in an open field has also been seen following
restraint stress and this stress-induced hyperlocomotion has been
used as a marker of stress-responsivity in mice [38]. An increase in mo-
bility in the FST and the similar tail suspension test have also been re-
ported following chronic stress, again suggesting an active defence
mechanism in response to the aversive nature of the behavioural tests
[39]. The increased locomotion seen here in the EPM and the reduction
in immobility in the FST following stress, may be reflective of an active
response to stress, rather than being interpreted as a reduction in de-
pression- or anxiety-related behaviours.
Direct comparisons of this study with other reports in the literature
are difficult because of differences in restraint stress procedures. It is
known that the effects of restraint stress depend on the duration, fre-
quency and intensity of restraint [16]. Acute restraint stress, a single ap-
plication, is most commonly used in the literature with rats being
studied more often than mice. In comparing restraint paradigms used
in adolescent mice a variety of devices have been used; including a
modified 50 ml syringe tube as we have used [17,40], a plastic restraint
bag [41,42] or a wire mesh cage [31,43]. How control animals are
handled also varies across laboratories where non-stressed animals
may not be handled at all [44] or perhaps removed to a novel environ-
ment [40]. In our study the control non-stressed animals were gently
handled and weighed daily to ascertain that any behavioural or hor-
monal effects are due to the restraint stress itself, rather than the han-
dling which is itself a potential stressor [23]. This may account for
changes in control groups observed in some studies, particularly in the
longer duration studies where mice will have been handled for up to
14 successive days. The duration of restraint stress also varies across re-
ports in the literaturewith somemouse studies using single or repeated
restraint stress sessions of 15 min [42], 30 min [31], 3 h [40], 8 h [43] or
longer [17]. Behavioural assessments typically are conducted 30–
60 min post restraint stress in a variety of paradigms. In this study, we
have evaluated behaviour in a variety of tests including the elevated
plus maze, the forced swim test and the sucrose preference test 24–
48 h post-restraint to assess whether there was lasting impact on the
behaviour of the animal from the repeated restraint stress sessions.
For example, it has been shown that acute restraint stress in mice
does induce anxiety- and depression-related behaviours in the EPM
and FST [45,46]. In our experiments (Supplementary Fig. 5), 24 h follow-
ing an acute restraint stress, no significant changes in behaviour were
A:
B:
Fig. 8. Effect of 3 days restraint stress on plasma corticosterone (A) and adrenal gland
weight (B) in adult and juvenile C57BL/6 mice. (A) Blood samples were taken at
baseline and immediately following 3 days restraint stress. (B) Adrenal glands were
removed and weighed the day after the last session of restraint. Results are expressed as
mean ± SEM, n = 15–21/group. **p b 0.01, ***p b 0.001, repeated measures mixed
model analysis (A), unpaired t-tests (B).
A:
B:
Fig. 9. Effect of 3 days restraint on the dexamethasone suppression test in adult and
juvenile BALB/c (A) and C57BL/6 (B) mice. Blood samples were taken at baseline and
6 h following administration of dexamethasone (0.1 mg/kg, i.p.). Results are expressed
as mean ± SEM, n = 8/group. p b 0.05, **p b 0.01, ***p b 0.001 (repeated measures
mixed model analysis).
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seen in the FST, SPT or EPM. This timing of behavioural assessment is
important if we are to distinguish between the acute effects of restraint
stress and the long-lasting chronic effects of restraint. This appears to be
a novel feature of our experimental design and therefore comparable
data in adult and juvenile mice are limited. A final consideration is the
blood sampling methodology we have used. Different laboratories re-
port the impact of the restraint stress on corticosterone levels from
blood samples either immediately after restraint stress or 15–60 min
post-restraint and typically using post mortem trunk blood samples.
Romeo et al. have shown the dynamics of the corticosterone response
in adolescent mice following a single 30min restraint session [31]. Cor-
ticosterone levels are highest immediately post-stress but return close
to baseline levels 1 h post-stress. In this study, blood sampling was per-
formed at baseline and immediately following the last restraint session.
We have adapted a tail incision method for repeated sampling from the
lateral tail vein in juvenile mice that we have shown previously to be
non-stressful [26,47]. Thuswhile our experimental designmay preclude
the observation of acute behavioural effects following a single restraint
stress session (Supplementary Fig. 5); it does show that the behavioural
responses we have observed persist (24-48 h) after repeated restraint
stress and represent an adaptive response.
In this study we have compared the effects of restraint stress on two
different strains of mice. There have been several studies looking at
strain differences in stress responsiveness, with BALB/cmice considered
to bemore sensitive to the effects of stress than themore stress-resilient
C57BL/6 strain [22,36]. Consistent with this, our results show an in-
creased corticosterone response to 3 days restraint stress in BALB/c
mice (700% increase above baseline) compared with C57BL/6 mice
(220% increase above baseline). In the forced swim test, 3 days restraint
stress resulted in antidepressant-like reductions in immobility in both
BALB/c and C57BL/6 adult mice, and this appeared more pronounced
in C57BL/6 mice (50% decrease from control) than in the BALB/c strain
(20% decrease from control). Again, this suggests increased resilience
in C57BL/6 mice, compared to the more stress sensitive BALB/c strain.
BALB/c mice used throughout these studies were housed individually
to avoid fighting, whereas the less aggressive C57BL/6 mice were
housed in groups. While the effect of housing conditions in the present
study is unknown, it has previously been shown that individual housing
of male BALB/c and C57BL/6 mice had no effect on either corticosterone
levels or anxiety-related behaviour [48], suggesting the effect of housing
conditions may be limited.
In humans it has been shown that exposure to stress, particularly
during childhood and adolescence, promotes the development of resil-
ience [49,50]. In addition, heightened responses to stress reactivity in
adolescents, compared with adults, have been shown in both mice
and humans [51]. We have proposed here that when juvenile mice are
stressed and tested as juveniles, they respond with an adaptive behav-
iour thatmay represent a stress copingmechanism.Whenwe examined
whether stress-induced effects in juvenile animals persisted into adult-
hood (Supplementary Fig. 3), there was an apparent increase in open
arm entries into the EPM. This data is consistentwith the idea that juve-
nile mice show a greater anxiolytic-like response to stress than adult
mice dowhichmay persist into adulthood. This is consistentwith previ-
ous reports that social crowding stress is anxiolytic in juvenile mice, but
not in adults [52]. Heightened responses to stress reactivity in adoles-
cents, compared with adults, have also been shown in both mice and
humans [51]. The juvenile mice used in this study were aged 4–
6 weeks during exposure to stress and this period corresponds to ado-
lescence in humans [5]. It is known that brain areas such as the hippo-
campus, hypothalamus, prefrontal cortex and amygdala, key regions
involved in the stress response and regulation of emotion and behav-
iour, continue to develop throughout adolescence and into young adult-
hood [5]. Together, ourfindings support the idea that while adolescence




Fig. 10. Effect of 3 days restraint on behaviour in the forced swim test (A), sucrose preference test (B) and elevated plus maze (C) in adult and juvenile C57BL/6 mice. (A) Time spent
immobile and swimming was measured in the last 4 min of a 6 minute test. (B) Preference for 2.5% sucrose solution, and total consumption of both sucrose and water were measured
over a 12 h test period (7 pm–7 am). Dotted line represents position of no preference. (C) Time in the open arms, number of open arm entries and total locomotion over the whole
maze were assessed by beam breaks in a 5 minute test session. Results are expressed as mean ± SEM, n = 8–12/group. **p b 0.01, unpaired t-tests (A, C), 2-way ANOVA (B).
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[4,5,30]; repeated exposure to a predictable stressormay promote resil-
ience and adaptive stress coping behaviours.
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Validation of a refined technique for taking
repeated blood samples from juvenile
and adult mice
Annelisa M Sadler and Sarah J Bailey
Abstract
Repeated blood sampling from laboratory animals is desirable in certain experimental designs and also for
reducing the number of animals used in research. Biochemical methods for analysing blood samples require
only small blood volumes to be collected (typically 20–40 mL). In juvenile mice, the small blood volume of the
animals also requires only small samples to be taken. Furthermore, for behavioural studies it is desirable to
have a method that does not require anaesthesia or the use of invasive indwelling cannulae. We report the
validation of a refined method for repeated blood sampling (up to 3 times at 24 h intervals) in juvenile and
adult mice using the tail incision method to sample from the lateral tail vein. This method is not stressful, as
assessed by low basal levels of the stress hormone corticosterone. Since repeated blood samples can be
collected from the same animal at multiple time points, it is not necessary to increase group size for terminal
sample collection. Thus, in addition to being a refined method requiring no warming of the tail, no anaesthesia
and only gentle restraint, this method also reduces the numbers of mice used for experiments.
Keywords
rodents, stress, bleeding techniques, corticosterone, tail vein
Numerous techniques exist for the collection of blood
from mice.1 While taking blood samples from mice is a
common practice in the laboratory setting, the proced-
ure can be stressful due to the handling, restraint or
anaesthesia involved in the procedure.1,2 Taking
repeated blood samples from the same mouse allows
a significant reduction in the number of mice used
over the course of an experiment. Hence a refined min-
imally invasive method of blood sampling, which
allows multiple samples to be taken from the same
animal, is desirable.3 However, in the UK, Home
Office guidelines limit repeated sampling and indicate
that no more than 10% of the total blood volume from
a mouse may be taken on each occasion, with no more
than 25% being taken over a 28-day period.2,4
In our research we are interested in studying the
behavioural effects of stress, over time, in juvenile
mice and assessing the impact of stress via measure-
ments of neuroendocrine function, e.g. corticosterone
analysis. This presents several challenges when consider-
ing repeated blood sampling methodology. Firstly, the
stressful nature of the blood sampling technique itself
may confound the results of corticosterone analyses.
Secondly, when working with juvenile mice (3–6 weeks
old), which weigh as little as 12 g, this limits the volume
that can be taken on each occasion to less than 60 mL.
The lateral tail vein is an appropriate route for repeated
sampling of small blood volumes from mice without
anaesthesia, although vasodilation may be required.2,4
We compared three different blood collection tech-
niques in adult mice before adapting and validating
the method developed by Fluttert et al.5 as a refined
method for repeated blood sampling in juvenile mice.
Male BALB/cAnNCrl mice (Charles River,
Margate, UK), aged 3–4 weeks old (juvenile) or 7–8
weeks old (adult), were housed individually in
35 20 15 cm polysulfone cages (Plexx, Elst, The
Netherlands) with woodchip bedding (Datesand,
Manchester UK) and paper nesting material (Lillico/
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LBS Biotechnology, Horley, UK). The mice were main-
tained in a temperature (21 1C) and humidity (50–
60%) controlled environment, under a 12 h light/dark
cycle (lights on 07:00 h), with food and water available
ad libitum. All the mice were allowed to acclimatize to
the animal facility for at least one week prior to blood
sampling. During this time the animals were handled by
gentle cupping6 for 2–3min on 2–3 days prior to blood
sampling. All procedures were carried out under a
Home Office project licence held in accordance with
the Animals (Scientific Procedures) Act 1986.
Adult mice had a blood sample taken from the lat-
eral tail vein by one of three methods (n¼ 5 per treat-
ment group). All the samples were collected in
heparinized capillary tubes (Fisher Scientific,
Loughborough, UK) between 11:00 h and 13:00 h.
The first method involved warming the mice in a
thermostatically controlled warming chamber, at 38C
for 15min in line with guidelines on the NC3Rs micro-
sampling website.2 The mice were then briefly
restrained in a restraint device, a 25G needle was
inserted into the lateral tail vein, and resulting blood
droplets were collected. The second method involved
holding the mice by hand, and immersing the tail in
warm water at 42C for 20 s. A 25G needle was again
inserted into the lateral tail vein, and resulting blood
droplets were collected. The third method was the tail
incision method5 which involved one person gently cup-
ping the mice by hand,6 while the operator held the tail
gently on the bench and made a small nick (approxi-
mately 2mm wide 0.5mm deep) in the tail with a
razor blade, perpendicular to the tail vein, approxi-
mately 2 cm from the tip of the tail. Blood droplets
were directly collected into capillary tubes. In the tail
incision method blood flow was encouraged by gently
stroking the tail and in the majority of cases, blood flow
stopped spontaneously when stroking was stopped. On
occasion it was necessary to apply a small amount of
pressure to the tail to stop bleeding. In all cases, the
blood samples were immediately transferred to micro-
centrifuge tubes containing EDTA (final concentration
in sample 3 mg/mL), and stored on ice. Twenty-four
hours after the blood sample was taken, all the mice
were culled by cervical dislocation, rapidly decapitated
and a second, terminal blood sample was collected dir-
ectly into microcentrifuge tubes containing EDTA
(final concentration in sample 3 mg/mL). All the tubes
were centrifuged at 2000 relative centrigual force (rcf)
for 20min at 4C. Plasma was removed and stored at
20C until analysis. The concentration of cortico-
sterone in each plasma sample was determined using
a corticosterone enzyme-linked immunosorbent assay
(ELISA) (IBL International, Hamburg, Germany).
Plasma was diluted 1:10, and the ELISA was carried
out according to the manufacturer’s instructions.
In adult mice (Figure 1), two-way repeated measures
mixed model analysis7 revealed a significant main effect
of sampling method (F(2,12)¼ 7.08, P< 0.01), baseline
or terminal sample (F(1,12)¼ 21.16, P< 0.001) and a sig-
nificant method*sample interaction (F(2,12)¼ 10.78,
P< 0.005). Post hoc analysis revealed that cortico-
sterone was significantly higher in samples taken
by the warming cabinet method compared with both
the tail warming method (330 58 ng/mL versus
110 13 ng/mL, P< 0.005) and the tail incision
method (330 58 ng/mL versus 74 13 ng/mL,
P< 0.001), clearly indicating that the warming cabinet
was stressful (Figure 1). There was no significant differ-
ence between the tail warming and tail incision methods
(110 13 ng/mL versus 74 13 ng/mL, P¼ 0.18), or
between the tail warming/incision methods and their
respective terminal samples (Figure 1).
We then went on to develop the tail incision method
for repeated sampling in juvenile mice (n¼ 4/5 per
treatment group). Blood samples were taken from
juvenile mice (1) at baseline, (2) 24 h later following a
2 h restraint stress and (3) 24 h post-stress. A tail inci-


































Figure 1. Effect of three different blood sampling methods
on plasma corticosterone levels in adult (7–8 weeks old)
BALB/cAnNCrl male mice. ‘Baseline’ samples were
obtained from the lateral tail vein following either warming
in a cabinet, or tail warming by immersion in water or tail
incision method (no warming). Animals were killed 24 h
later by cervical dislocation and ‘terminal’ samples were
obtained. Results are expressed as meanSEM,
n¼ 5/group. **P< 0.005, ***P< 0.001 (two-way repeated
measures mixed model analysis).
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of the tail, and on repeated sampling a different loca-
tion was used, working towards the base of the tail in
0.5 cm increments. Corticosterone was significantly
increased by 2 h of restraint stress compared with base-
line (720 59 ng/mL versus 21 9.8 ng/mL), and
this increase had returned to baseline within 24 h fol-
lowing stress (24 3.4 ng/mL versus 720 59 ng/mL,
Figure 2a). We then confirmed that heating and
restraining mice to take a blood sample was stressful
in juvenile mice in the same way as in adults. Mice had
a blood sample taken at baseline by the warming cab-
inet method. Twenty-four hours later they were
restrained for 2 h and a second blood sample was
taken in the same way. The results confirmed our pre-
vious findings that this method of taking blood is stress-
ful (Figure 2b).
Here, we have demonstrated that the tail incision
method is a refined method of taking repeated blood
samples from juvenile mice. The low basal levels of the
stress hormone corticosterone obtained using the tail
incision method compared with the warming cabinet
method indicate that this is not a stressful procedure.
Furthermore, the repeated nature of sampling is not
stressful as the third sample taken using the tail incision
method did not increase plasma corticosterone levels
above the baseline sample on the first day of sampling
(Figure 2a). This method was originally developed for
use in adult rats,5 particularly for use in behavioural
studies where implantation of indwelling cannulae is
not desirable or methods like tail-cuts are unsuitable
for repeated sampling. Our data demonstrate that
this methodology is applicable to juvenile mice.
Furthermore, we have shown that in both adult and
juvenile mice, the use of a warming chamber is stressful,
producing a significant 3-fold increase in plasma cor-
ticosterone levels. The stressful nature of these tech-
niques therefore precludes their use in studies
examining effects of stress. An additional benefit of
the tail incision method is that it allows blood flow to
be started and stopped easily, facilitating the collection
of very small volumes of blood (typically 20–40mL)
from juvenile mice. Pilot studies in our laboratory
involving the use of the saphenous vein were not suc-
cessful in this respect. Finally, the ability to take
repeated samples from the same mouse at multiple
time points reduces the number of animals required
for an experiment, compared with the taking of ter-
minal blood samples from large numbers of mice,
and is thus in keeping with the principles of both reduc-
tion and refinement of animal use in laboratory
research.3
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